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ABSTRACT
A critical step in cellular signaling through transmembrane receptors is the down-regulation of
activated receptors through the multivesicular body (MVB) pathway to the lysosome. MVB
generation is mediated by the highly conserved ESCRT (0, I, II, and III) protein complexes.
Though the ESCRT-III complex provides the core function of the ESCRT machinery, it is the
least characterized of the ESCRT complexes. The Chmp1 protein is an ESCRT-III component
and a putative tumor suppressor that has been linked to pancreatic and renal cancers in humans.
However, published data on Chmp1 activity are conflicting and its role during tissue
development is not well defined.
Drosophila melanogaster (the common fruit fly) provides a powerful model system for
investigating the function of genes involved in human development and disease. In this study,
knockdown and over-expression techniques were used to investigate the function of Chmp1 in
Drosophila. RNAi was used to reduce Chmp1 expression, and transgenic fly lines that allow for
expression of either wild-type or epitope tagged Chmp1 were used to investigate overexpression, as well as the subcellular localization of Chmp1.
Knockdown of Chmp1 expression using RNAi was lethal in the fly, suggesting that Chmp1 is an
essential gene for Drosophila development. In the wing, loss of Chmp1 activity caused a cell fate
change from intervein to vein, which was likely a result of de-regulation of the Drosophila
Epidermal Growth Factor Receptor (DER) pathway. Genetic interactions between Chmp1 and
regulators of DER signaling suggest that Chmp1 negatively regulates DER signaling.
Furthermore, Chmp1 knockdown also decreased Blistered expression, which is repressed by
DER signaling.

xvi

Over-expression of Chmp1 had mild phenotypic effects, suggesting that dosage of Chmp1 is not
critical for cellular function. Some of the epitope tagged Chmp1 protein was detected at the late
endosome in Drosophila embryonic epithelial cells. This is consistent with Chmp1 functioning as
an ESCRT-III component during MVB formation. Therefore, Drosophila Chmp1 may negatively
regulate DER signaling through its role in MVB formation as an ESCRT-III component.

xvii

CHAPTER 1
BACKGROUND AND INTRODUCTION
For over 100 years Drosophila melanogaster, or the common fruit fly, has been used as
model for biological and medical research (Figure 1.1). From Thomas Hunt Morgan’s fly room
at Colombia University in the early 1900’s to the sequencing of the genome in 2000, the fruit fly
has become one of the most studied organisms around the world. The sequencing of the fly
genome provided an important resource to biologists and identified about 14,000 genes [4]. After
many years of work on Drosophila, today’s researchers are supplied with an extensive base of
knowledge of this species, along with many sophisticated genetic and molecular tools that have
been developed for studying gene and protein function, many of which are unique to this
organism [2]. Although Drosophila is particularly useful in the fields of genetics and
developmental biology, it is increasingly becoming a useful model for human disease, especially
neurodegenerative disorders [5, 6]. Importantly, there is a great deal of homology between
human genes and Drosophila genes; it is thought that about 75% of human disease genes have
homologues in Drosophila [7, 8].
In the research presented in this dissertation, Drosophila was used as a model organism to
study proteins involved in human development and disease. Therefore, it is appropriate to
describe relevant aspects of Drosophila research, including the fly life cycle, the development
and anatomy of the eye and wing, and the genetic tools and techniques used in these studies.
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Figure 1.1 Timeline of major developments in Drosophila research [9, 10]

I.

Fly development
The short life cycle of the fruit fly is one of the attributes that make it such a fine model

organism. Drosophila development is well studied and includes multiple stages: embryogenesis,
three instar larval stages, the pupal stage, and adult. Under ideal conditions, the entire life cycle
is completed in 9-10 days, allowing for the analysis of multiple generations over a short period
of time.
A. Life cycle
The length of the Drosophila life cycle is temperature dependent, completing in only 10
days at room temperature (Table 1.1) [11]. The life cycle begins with embryogenesis (described
in [12]). There are 17 well documented stages of embryogenesis that take place in 21-22 hours at
25oC [13]. Early embryonic cellular divisions are synchronous and rapid, occurring nearly every
10 minutes. Division of the cytoplasm does not occur at this early stage, and consequently a
single multinucleate cell, or syncytium, is formed. After 13 divisions forming about 6000 nuclei,
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cellularization begins, which is followed by gastrulation and segmental patterning along the
anteroposterior axis of the embryo. Embryogenesis is followed by three instar larval stages, each
with a molt in between. The larval stages are followed a very short prepupal period before
progressing on to the pupal stage. Morphogenesis from larva to fly takes place in the pupal stage.
During embryogenesis, tissues called imaginal discs form. These tissues will become
most of the external adult structures, e.g., the eyes, antennas, wing, legs, etc. Imaginal discs grow
and become patterned throughout the larval and pupal stages.

Table 1.1 The effect of temperature on life cycle length in Drosophila
B. Wing development
In most of the studies presented in this dissertation, the developing or adult Drosophila
wing was used to investigate the function of the Drosophila Chmp1 protein. The adult
Drosophila wing is a cuticular structure that is quite a lot like a flattened balloon (wing
development reviewed in [14, 15]). It has opposing dorsal and ventral surfaces, both decorated
with a regular array of distally-pointing hairs (Figure 1.2A and B). The major cell types that
compose the adult Drosophila wing are vein cells and intervein cells. The vein cells form
conduits called wing veins that span the surface of the wing. The wing veins provide rigidity and
support for the wing, and also carry trachea and neurons. There are four longitudinal wing veins
(L2-L5), two marginal wing veins (L1 and L6), and two shorter transverse veins (anterior cross
vein [acv] and posterior cross vein [pcv]) (Figure 1.2A). The longitudinal veins L3, L5, and
3

distal portion of L4 are positioned on the dorsal surface of the wing, while L2 and the remainder
of L4 are on the ventral surface of the wing.
Wing development begins in the embryo, when imaginal disc precursor cells are
specified. As the larva grows, the wing disc becomes larger through cell proliferation, and cell
fates become established through activation of and interaction between many signaling
pathways, including Decapentaplegic (Dpp, Bone Morphogenetic Protein [BMP] in humans)
signaling, Wingless (Wg, Wnt in humans) signaling, Hedgehog (Hh) signaling, the Drosophila
Epidermal Growth Factor Receptor (DER) pathway, Notch signaling, and the Frizzled (Fz)
Planar Cell Polarity (PCP) pathway. The mature wing disc is a pear shaped tissue that can be
divided into three parts, each giving rise to different structures of the adult fly: the wing pouch,
which will form the wing blade; the hinge region, which will form the wing hinge; and the body
wall region, which is composed of cells that will become part of the thorax (Figure 1.2C). The
wing disc is composed of three major types of cells: disc proper cells, which are columnar
epithelial cells that give rise to the epidermis in the adult fly and make up the majority of the
disc, including the wing pouch; peripodial cells, which are squamous cells that form a thin
membrane overlaying the wing disc; and adepithelial cells, which are myoblasts that will form
the trachea and flight muscles (Figure 1.2D).
DER, Notch, Wg, Hh, and Dpp signaling pathways interact to form an adult wing with
the wild-type wing vein pattern (reviewed in [14, 15]). First, provein and intervein territories are
established in the imaginal wing disc. The proveins are broad stripes, 5-6 cells in width that are
vein competent, i.e., they have the potential to differentiate into wing vein [16]. The DER and
Notch signaling pathways interact extensively during wing vein specification. DER signaling is
activated in the center of the provein and promotes vein cell fate, while Notch signaling is
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activated in the cells bordering the provein and represses vein cell fate [17-20]. The fate of vein
and intervein cells is refined to produce a narrow stripe of vein cells as development progresses
through the pupal stage. In fact, some genes involved in vein specification are active quite late in
pupal development, suggesting that the final choice between differentiation into vein and
intervein cells is not settled until late developmental stages [15, 21].

Figure 1.2 Development of the Drosophila wing. A. Light microscope image of an adult
female fly wing. Wing veins are labeled: L2-L5 (longitudinal), L1 and L6 (marginal), acv and
pcv (transverse). Dorsal and ventral surfaces are in the plane of the page. B. Individual wing
cells are hexagonally packed and each cell produces a distally pointing hair. C. The wing
imaginal disc gives rise to cells of the body wall (orange), the wing hinge (blue) and the wing
blade (pink). D. A schematic side view of the wing disc shown in C. There are three cell
layers. Cells that give rise to the body wall, wing hinge, and wing blade are ce cells. The pm is
composed of squamous cells. The apical surfaces of the pm and ce cells are adjacent. m form a
third layer. P is posterior, D is distal, Ant is anterior, Post is posterior, acv is anterior cross
vein, pcv is posterior cross vein, pm is peripodial membrane, m is myoblast, ce is columnar
epithelium. Images generated by M. Valentine. Panels C and D modified from [1].
At the pupal stage of development the wing disc undergoes major structural changes in
which the layer of epithelial cells of the wing pouch everts (pushes out) to form a folded layer of
epithelial cells. The basal surfaces of these cell layers adhere to one another and form the dorsal
and ventral surfaces of the wing. Each wing cell produces a hair and secretes a layer of cuticle
on its apical surface. When metamorphosis has completed and the fly emerges, the intervein
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wing cells delaminate, die, and are cleared out of the wing, leaving behind the cuticle of the adult
wing.
C. Eye development
The Drosophila eye was also used in these studies to investigate the function of the
Drosophila Chmp1 protein. Like the wing, the development and structure of the eye are well
understood, making it a suitable tissue for investigating protein function. The adult Drosophila
eye is a typical insect eye, composed of around 800 hexagonal ommatidia, or facets (Figure
1.3A). Each ommatidium is composed of eight photoreceptors (R1-R8) in an asymmetric pattern,
four cone cells, pigment cells, and a sensory bristle, totaling 22 cells. The ommatidia are
arranged in a symmetrical fashion with respect to the equator, or the dorsal/ventral boundary of
the eye, so that cells of the dorsal and ventral halves are mirror images (Figure 1.3B).
The Drosophila eye, like the wing, begins as a set of precursor cells specified in the
embryo and grows into the eye-antennal disc during larval development (eye development
reviewed in [3]). This disc gives rise to the adult eye and antenna, as well as the head capsule
and mouthparts (Figure 1.3C). Throughout the first and second instar larval stages, the cells of
the eye disc proliferate in an undifferentiated state. During the third instar larval stage, the cells
of the eye begin to differentiate from posterior to anterior of the disc. This process appears as a
wave of differentiation traveling from posterior to anterior, called the morphogenetic furrow, and
is visible as an indentation in the disc (Figure 1.3C). As the morphogenetic furrow passes,
ommatidial cells are recruited and specified sequentially. The first cell to differentiate is the R8
photoreceptor, followed in pairs by R2 and R5, R3 and R4, R1 and R6, and lastly R7. As
differentiation occurs, the photoreceptor clusters rotate 90o away from the equator (clockwise in
the dorsal half of the eye, counter-clockwise in the ventral half), producing the symmetrical
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arrangement of the eye (Figure 1.3B and C). Morphogenesis occurs during the pupal stage of
development, and the eye-antennal discs evert and fuse to form the head.
As in the wing disc, the development of the eye disc requires the work of many signaling
pathways. For example, DER signaling is required for differentiation of all of the photoreceptor
cells, except R8, and is important for proper rotation as well [22, 23]. Additionally, Fz PCP and
Notch signaling are required for the R3 and R4 photoreceptor cell fate decision, which
determines the chirality, or handedness, of the photoreceptor clusters, and likely direction of
rotation as well [24, 25].

Figure 1.3 Development of the Drosophila eye. A. SEM image of the adult fly eye.
Ommatidia and eye bristles are easily identified. B. A light microscope image of a one micron
thick tangential section of a Drosophila eye stained with toluidine blue. Individual ommatidia
are composed of 8 photoreceptor cells and arranged in a symmetrical fashion around the
equator (drawn in black). C. The eye imaginal disc is compound and gives rise to cells of the
eye (yellow) and antenna (blue). The MF progresses from posterior to anterior. Cells posterior
to the MF become progressively more differentiated and begin to rotate 90o away from the
equator. MF is morphogenetic furrow, ant is anterior, post is posterior. Images generated by
M. Valentine. Panel C modified from [3].
II.

Fly genetics
As discussed above, the quick life cycle and well-studied development of Drosophila

make it a useful model organism. A second attribute of the fruit fly that contributes to its facility
as a model organism is its genetics. Drosophila genetics are rather simple compared to mammals.
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The fruit fly is a diploid organism and its genome includes about 14,000 genes on four
chromosomes: X/Y (1), 2, 3, and 4 (very small). In most cases the fly genome carries only one
copy of a gene, which eliminates problems of genetic redundancy that are often encountered in
studies with mammals. Additionally, there are many useful tools and techniques that were used
for the research presented here that make studying the fly particularly convenient, including
balancer chromosomes, UAS-Gal4, and FLP/FRT (discussed below).
A. Balancer chromosomes
One of the advantageous tools available for Drosophila genetics is the balancer
chromosome, which was used in nearly every fly cross performed in this research (Table 1.2).
Balancer chromosomes are artificially generated chromosomes that were introduced into fly
research in 1918 by H.J. Muller, who had been a student of T.H. Morgan at Colombia University
[26]. Balancer chromosomes carry multiple inversions, as well as dominant marker mutations or
transgenes. The multiple inversions carried by balancer chromosomes suppress recombination
with wild-type homologous chromosomes during meiosis. If recombination does occur between
a wild-type and a balancer chromosome, the recombinant chromosomes carry deletions,
duplications and/or lose the centromere, all of which are usually lethal in the progeny. Balancer
chromosomes are also homozygous lethal, so progeny receiving two copies of a balancer should
not been seen in the offspring. Therefore, the advantage of balancers is that they allow for the
stable maintenance of homozygous lethal mutations in a heterozygous condition as neither
chromosome is homozygous viable, and the lethal mutation cannot switch to the balancer
chromosome through recombination. Additionally, they carry dominant markers that allow for
easy identification by phenotype and tracking of the balancer chromosome through single or
multi-generation crosses (Table 1.2). There are balancer chromosomes for the first/X (first
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multiple [FM]), second (second multiple [SM]), and third (third multiple [TM]) chromosomes
(Table 1.2). There are also several fly lines, or balancer stocks, that carry multiple balancers and
can be used to “balance” homozygous lethal mutations or transgenes.

Table 1.2 Summary of balancer chromosomes and dominant markers used in this
research. FM: first multiple, CyO: Curly of Oster, TM: third multiple
B. UAS-Gal4
The UAS-Gal4 system is a gene expression system that was used throughout the research
presented in this dissertation [27]. This system is a standard procedure used in fly labs to control
the expression of a transgene in the fly. It is a fairly simple system requiring only two
components, a UAS (upstream activating sequence) enhancer and the Gal4 transcription factor
(Figure 1.4). The disadvantage to the system is that it requires two transgenic fly lines. The
advantage is the many combinatorial possibilities. Due to its popularity in the fly research
9

community, many transgenic lines have already been created and are available for immediate
use.

Figure 1.4 The UAS-Gal4 System. The UAS-Gal4 system requires two components: a Gal4
transgene under the control of a specific promoter or a genomic enhancer, and the gene of
interest downstream of a UAS (upstream activating sequence) enhancer. When both of these
components are in a fly, Gal4 is expressed in specific cells and binds the UAS enhancer to
activate expression of the gene of interest.
The UAS-Gal4 system requires that the gene of interest is under the control of a UAS
enhancer (Figure 1.4). There are many plasmids available that allow for insertion of cDNA of a
gene of interest downstream of the UAS enhancer, followed by insertion into the fly’s genome.
The UAS enhancer allows for controlled expression of the transgene, as it is only responsive to
the Gal4 transcription factor (Figure 1.4). So control of expression of the transgene is dependent
on control of expression of Gal4. Consequently, there are thousands of Gal4 lines, often called
drivers, available from Bloomington Drosophila Stock Center at Indiana University. These lines
vary in Gal4 expression, ranging from ubiquitous expression, to expression in specific tissues, to
expression at specific time points during development, giving the researcher fine spatial and
temporal control over transgene expression. The UAS-Gal4 system is also increasingly effective
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with increasing temperature, from 18oC to 30oC. This gives control over the strength of each
individual driver as well, as raising progeny at varying temperatures can provide a range of
driver strengths and thus phenotype strength.
C. RNAi in flies
The UAS-Gal4 system is a useful way of controlling expression of a transgene in
Drosophila. However, for years its main use was to study the effects of over-expression of a
wild-type or mutated Drosophila gene, or expression of a gene from another organism. In 2007,
Dietzl et al. published their work of generating a genome wide transgenic library of RNAi fly
lines (Vienna Drosophila RNAi Center [VDRC]), which allowed for the controlled knockdown
of genes in specific cells and tisues of the organism using the UAS-Gal4 system, providing an
invaluable resource to the fly research community [28]. Several RNAi fly lines were used in the
research presented in this dissertation, so it is appropriate to review their mechanism of action.
The RNAi fly lines were generated using short inverted DNA repeats complementary to
specific mRNAs. These were inserted into a plasmid downstream of a UAS enhancer and then
inserted into the genome of the fly. When transcribed, a short hairpin RNA (shRNA) is formed
and cleaved by the enzyme DICER into pieces of short double stranded RNA (dsRNA), each
about 21 nucleotides in length. Then, the RNAi induced silencing complex (RISC) unwinds the
dsRNA into a single stranded short interfering RNA (siRNA) and uses it as a template to find the
native complementary mRNA in the cell. Binding of the siRNA to its complementary mRNA
induces its degradation, thus expression of the target is lowered. Since the creation of the first
genome wide RNAi library, other libraries have been created, including Harvard’s Transgenic
RNAi Project (TRiP) [29]. Since these lines were created for use with the UAS-Gal4 system, fly
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researchers now have the ability to control the intensity, tissue, and/or developmental timing of
knockdown of any gene in the Drosophila genome.
D. FLP/FRT
Another technique available to the Drosophila research community is FLP/FRT, a
method of targeted DNA recombination that is similar to Cre/Lox in mammals [30]. The
FLP/FRT system provides a way of generating clones, or groups of cells descendant from the
same parent cell, of a desired genotype within the living fly (Figure 1.5). Unlike vertebrates, cell
migration and integration during development are limited in Drosophila. So often, daughter cells
descendant from a single parent cell remain clustered together within the tissue. The FLP/FRT
system can be used to cause a genomic change in the parent cell to generate, for example, clones
of cells homozygous for a mutation in a heterozygous tissue, or clones of cells expressing a
transgene that is not expressed in the rest of the tissue. A marker is generally used to identify the
clones, making borders of clones obvious and providing a useful method for studying the effects
of protein mutation and expression on cells within a developing tissue.
Like UAS-Gal4, FLP/FRT is a two-component system derived from yeast. It requires
FLP recombinase (FLPase), an enzyme that mediates recombination between FLPase
recombination targets (FRTs). FRTs are 34 base pair DNA sequences
(GAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC) and have been inserted into many
places within the Drosophila genome. So when FLPase is expressed, it can mediate
recombination between two FRT sites. Several transgenic FLPase stocks have been generated,
including the commonly used hs-FLPase (hs-flp), which expresses FLPase under the control of
the heat shock promoter, hsp70. When using hs-flp to generate clones in flies, an increase in

12

ambient temperature activates expression of FLPase. This gives the researcher temporal control
over the developmental time point at which the recombination takes place.

Figure 1.5 The Inducible FLP/FRT System: generate homozygous clones in
heterozygous tissue. The FLP/FRT system for generating homozygous mutant clones
requires two components: FRT sites on identical loci of homologous chromosomes (in
yellow), and FLPase, which mediates recombination between those sites. The gene mutation
of interest (in blue) must be distal to the FRT site on the chromosome, and having a visible
marker such as GFP (in green) on the wild-type chromosome makes finding clones easier. A.
During mitosis, homologous chromosomes are duplicated and the daughter cells receive one
copy of each chromosome. B. If flies carry chromosomes with FRT sites on identical loci
and hs-flp, heat shocking the flies during development will activate expression of FLPase,
which can then mediate recombination between the two FRT sites. One of the daughter cells
will receive two copies of the gene mutation of interest and no copy of the marker, while the
other daughter cell receives two copies of the marker and no copy of the gene mutation of
interest.
FLP/FRT recombination rates are generally quite low, so that only a few cells within a
tissue experience a successful recombination event. However, the number of clones obtained can
vary, depending on the induction conditions used and the position of the FRT sites. Additionally,
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the recombination rate is similar for the same induction conditions, so that the size of clones
generated is dependent upon the developmental time point at which FLPase was induced, i.e.,
clones generated at early time points will be fewer but larger, while those generated at late
developmental time points will be smaller but numerous.
E. Variations of FLP/FRT
Since the development of the FLP/FRT system, variations on the system using the
FLP/FRT components have been generated. When clones were generated in the research
presented here, a variation which brings together the FLP/FRT and UAS-Gal4 systems was used
(Figure 1.6). This merged system allowed for the generation of clones of knockdown or overexpression of the gene of interest, and allows for temporal control over the generation of those
clones during development. This system required three components, two of which have already
been discussed: the hs-flp transgene, which provided the temporal control over FLPase
expression and thus clone generation, and the gene or RNAi of interest under the control of a
UAS enhancer, allowing for either over-expression or knockdown. The third component was a
transgene containing the Gal4 coding sequence downstream of an Actin promoter, but separated
by a fragment containing a transcription stop (CD2-polyA) sequence flanked by FRT sites. This
means transcription from the Actin promoter will terminate before the Gal4 coding sequence is
reached. When these three transgenes are in the same fly, a heat shock activates expression of
FLPase, which mediates recombination between the FRT sites, removing the CD2-polyA
sequence. The Actin promoter can then activate expression of Gal4, which binds to the UAS
enhancer and activates expression of the gene of interest in the clone. Again, this may be used to
over-express a Drosophila gene, express a transgene, or knockdown expression of a gene using
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an RNAi fly line. Like the traditional FLP/FRT system, the recombination is induced in only a
few cells, so usually a small number of clones are generated in each fly.

Figure 1.6 Variation of the FLP/FRT system with UAS-Gal4. This system allows for
generation of clones of over-expression or knockdown of a gene of interest. It requires three
transgenes, labeled 1-3. Heat shock induces production of FLPase, which mediates
recombination between FRT sites and removes the CD2-polyA sequence. This removes the
transcription stop signal and allows expression of Gal4 regulated by the Actin promoter.
Gal4 then binds to the UAS enhancer, activating expression of the gene of interest. The gene
of interest may be a copy of a cDNA for over-expression analysis, but may also be sequence
to express hpRNA, to allow for knockdown analysis.
F. Fly crosses
The advantages of using Drosophila as a model organism culminate in the fly cross. The
short life cycle and many genetic tools available make it possible to accomplish sophisticated
genetics in a relatively short period of time. However, multiple generation fly crosses may be
required to drive expression of a transgene or RNAi using the UAS-Gal4 system, to test for
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genetic interactions between proteins and pathways, or to generate mutant clone cells within the
developing tissues of the fly.
Setting up a fly cross in Drosophila is usually simple, and there are many features of the
fly that make it convenient. In Drosophila, homologous recombination between chromosomes
does not occur in males. This means chromosomes can be transmitted unaltered through the male
line. Also, it is usually possible to generate large numbers of offspring from Drosophila crosses.
A healthy female fly can lay up to 60 eggs per day. However, females can store males’ sperm
after mating, so the females used in a cross must be virgin, otherwise, the genotype of the
offspring cannot be predicted. Adult flies do not mate for several hours after eclosion, so female
virgins can be identified by an immature phenotype. This can include a light body color and
large body indicating immature cuticle, folded wings, or a dark spot, the meconium (the remains
of the last meal before pupation), on their ventral abdomen. For most crosses, it is a good idea to
mate at least 10 virgin females of one genotype to a similar number of males of the second
genotype. By moving the adult flies to a new containment vial with fresh food every 2 to 3 days,
a large number of offspring can be collected.
There is a standard nomenclature used for denoting fly genotypes [2]. As in other
organisms, wild-type chromosomes or alleles are represented as plus sign. Homologous
chromosomes are separated with forward slash. So for a wild-type fly, the third chromosome
would be represented as +/+. However, if a fly was heterozygous for UAS-Chmp1, a Chmp1
over-expression transgene, on the third chromosome, the genotype of the fly would be written as
UAS-Chmp1/+. Another custom is to separate two genes that are on the same chromosome with a
comma. Additionally, different chromosomes are separated with a semicolon. One fly line used
often in these studies is en-Gal4, UAS-GFP. en-Gal4 is a driver that expresses Gal4 in the
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pattern of the gene engrailed, and UAS-GFP is a transgene that allows for expression of GFP;
both are located on second chromosome and so are separated with a comma. A fly with the
genotype en-Gal4, UAS-GFP/+; UAS-Chmp1/+ would represent a fly that has en-Gal4 and
UAS-GFP on one copy of the second chromosome, and UAS-Chmp1 on one copy of the third
chromosome, while the remaining second and third chromosomes are wild-type.
When performing crosses, Punnett Squares are useful for keeping track of chromosomes
to identify progeny of the correct genotype. In an example for homozygous parents, virgin
females of the genotype ey-Gal4/ey-Gal4 (on the second chromosome, expresses Gal4 in eye)
can be crossed to males of the genotype UAS-Chmp1/UAS-Chmp1 (on the third chromosome,
allows expression of Chmp1) to generate progeny over-expressing Chmp1 in the eye (Figure
1.7A). Using a Punnett Square to track each chromosome would show that all offspring obtained
from this cross will be of the genotype: ey-Gal4/+; UAS-Chmp1/+. Therefore, 100% of the
offspring will over-express Chmp1 in the eye.
However, there are many cases in which the flies to be crossed are not homozygous
viable for the mutation or transgene of interest, and so are balanced in the heterozygous state. In
an example of heterozygous parents, virgin females of the genotype ey-Gal4/CyO can be crossed
to males of the genotype UAS-Chmp1/TM3Ser, again to generate flies over-expressing Chmp1 in
the eye (Figure 1.7B). However, this time the Punnett Squares would show that there are several
possible genotypes in the offspring. On the second chromosome, the genotype of the progeny
will be either ey-Gal4/+ or CyO/+. On the third chromosome the genotype will be either UASChmp1/+ or TM3Ser/+. So only flies that are not Cy (curly wings) and not TM3Ser (notched
wings) will be of the correct genotype. This example shows how quickly crosses can become
complex, and at the same time illustrates the utility of balancer chromosomes and dominant
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markers. Without balancers in this scenario, it would be much more difficult to know which
offspring were of the correct genotype.

Figure 1.7 Examples of crosses in Drosophila. A. When crossing two homozygous stocks to
drive expression of a transgene using UAS-Gal4, all offspring are of the correct genotype. B.
Crosses are more complicated when dealing with heterozygous stocks. Only a quarter of the
offspring will have the correct genotype. The dominant markers on balancer chromosomes are
very useful in this situation, as they help to keep track of the chromosomes in the progeny. P is
parental generation, F1 is the first filial generation. GOI = gene of interest. Roman numerals
represent the chromosome on which the transgenes are located: II = second chromosome, III =
third chromosome.
III.

The DER pathway
The DER pathway (Figure 1.8) is involved in multiple stages of development and in

multiple tissues in Drosophila, including but not limited to embryogenesis, oogenesis, and wing
and eye development [31]. The DER is a traditional receptor tyrosine kinase (RTK) that signals
through the Mitogen-Activated Protein Kinase (MAPK) pathway. The DER is expressed almost
ubiquitously in the fly, so the patterned DER signaling that is required throughout development
is specified through localized expression/activation of activators and repressors of the DER.
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The DER has four activating ligands: Vein (Vn), Spitz, Gurken, and Keren. Gurken is an
activator of the DER limited to the oocyte where it is required for early development in
Drosophila [32]. Spitz is similar to the mammalian ligand, TGFα, and is the primary DER
activating ligand during the development of most Drosophila tissues [33-35]. Spitz, Gurken, and
Keren are all expressed as transmembrane proteins that must be cleaved by Rhomboid (Rho), a
transmembrane protease that resides in the Golgi, in order to become active [32, 34, 36-38].
Additionally, these transmembrane activating ligands require the activity of Star, which is
involved in the trafficking of these proteins from the endoplasmic reticulum to the Golgi where
they are cleaved by Rho [37]. Vn is different from the other activating DER ligands in that it is
secreted and constitutively active [39]. Comparatively, Vn is a weak activator of the DER, but it
acts as a major ligand during wing, leg, and muscle development [40-42].
There are three inhibitors of DER signaling that were investigated in this study: Argos
(Aos), Kekkon-1 (Kek-1) and Sprouty (Sty). Argos is a secreted protein that binds to the
activating ligand Spitz, inhibiting its ability to activate the DER [43, 44]. Kek-1 is a
transmembrane protein that binds and inhibits the DER, so its inhibiting ability is limited to the
cell that expresses it [45, 46]. Sty is a general intracellular inhibitor of tyrosine kinase signaling,
as it inhibits Ras1 [47]. The DER is the only RTK known to signal during the development of the
Drosophila wing.
Activation of the DER by ligand binding is followed by dimerization, phosphorylation
and activation of a classical RTK signaling cascade through Ras and the MAPK pathway. In
Drosophila, the activated receptor binds the adaptor protein Downstream of Receptor Kinase
(Drk, mammalian GRB2 homologue), which then activates the guanine nucleotide exchange
factor, Son of Sevenless (SOS). SOS then activates Ras1 by exchanging guanosine diphosphate
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(GDP) for guanosine triphosphate (GTP). Ras1 then activates the MAPKKK, Raf1, which
phosphorylates and activates the MAPKK, Downstream of Ras1 (DSOR1). DSOR1 then
phosphorylates and activates the MAPK, Rolled (mammalian ERK homologue). In the nucleus,
Rolled induces changes in gene expression, including the repression of Blistered (Bs) through
phosphorylation of transcription factors, including Yan and Pointed [48, 49].
Proper cell signaling requires regulation of activation cellular signaling. Signaling
pathways must be activated at the proper time. Additionally, it is crucial for signaling to be
down-regulated when appropriate. Many receptors, including the DER, require a group of
protein complexes called the Endosomal Sorting Complexes Required for Transport (ESCRT)
for proper down-regulation.

Figure 1.8 A simplified diagram of the DER pathway. Vein (Vn) is a secreted activating
ligand of the Drosophila Epidermal Growth Factor Receptor (DER). Rhomboid (Rho) activates
the DER from the Golgi by cleaving the transmembrane proteins Spitz, Gurken, and Keren (not
shown) into DER activating ligands. When the DER is active, it activates the canonical MAPK
pathway. Ras1 activates Raf1 (a MAPKKK), which phosphorylates Downstream of Ras1
(DSOR1, a MAPKK), which phosphorylates Rolled (homologue of ERK1/2, a MAPK). One
effect of DER signaling is repression of Blistered (Bs) expression. Argos (Aos), Kekkon-1
(Kek-1) and Sprouty (Sty) negatively regulate DER signaling. Positive regulators are in green,
negative regulators are in red.
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IV.

The ESCRT machinery
The membrane of a cell is decorated with membrane receptor proteins that work to

transmit an extracellular signal to the inside of the cell. Many of these are transmembrane
receptors, such as the DER, that follow a classical signaling cascade: the signal (a ligand) binds
the extracellular portion of the receptor, causing a conformational change in the receptor that
relays the signal to the inside of the cell and usually results in changes in gene expression. As
important as it is for a cell to be able to recognize and transmit the signal, down-regulation of the
signal is also crucial for proper cellular signaling. The multivesicular body (MVB) pathway is
one method of signal down-regulation of activated transmembrane receptors in the cell. MVB
generation requires the ESCRT (Endosomal Sorting Complexes Required for Transport) protein
complexes, which are highly conserved in eukaryotes. These complexes are involved in many
cellular processes in addition to MVB generation, including HIV budding, membrane abscission
during cytokinesis, autophagy, sorting lysosomal/vacuolar proteins from the Golgi, and others
[50-55]. Essentially, the ESCRT complexes modify the shape of cellular membranes. All of the
processes mentioned above are similar membrane modification events. They involve the
deformation and budding of the membrane away from the cytoplasm to form a vesicle, followed
by scission, or “pinching off” of the membrane. For example, during HIV budding, ESCRTs aid
in the budding of the plasma membrane away from, i.e., out of the cell. There are four ESCRT
complexes that are recruited sequentially to membranes through lipid and proteins interactions:
ESCRT-0, -I, -II, and –III, as well as the Vacuolar Protein Sorting 4 (Vps4, Suppressor of K+
transport growth defect [SKD1] in humans) complex and several accessory proteins. However,
some ESCRT-mediated processes do not require all of the ESCRT complexes. For example,
ESCRT-II is not required for HIV budding or cytokinesis [56, 57].
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MVB formation is the best described of all ESCRT-mediated cellular process and it
requires the activity of all four ESCRT complexes. As mentioned above, the MVB pathway is
important for regulation of cellular signaling pathways through down-regulation of
transmembrane receptors. At the membrane, activated receptors are ubiquitinated and
endoytosed into the endosome. The ESCRT machinery aids in the formation of the MVB from
the endosome by mediating the invagination of the late endosomal membrane to form
intralumenal vesicles (ILVs) (Figure 1.9A). This separates the receptors from the cytoplasm,
thereby silencing the signals. The ILVs are then sorted to the lysosome where the receptors are
degraded. Many membrane receptors have been reported to require ESCRT components for
proper signaling in Drosophila and cultured mammalian cells, including the Epidermal Growth
Factor Receptor (EGFR) and the Notch receptor [50, 58-61].
Ubiquitin acts as a sorting signal to target proteins, either activated membrane receptors
or endosomal proteins from the trans-Golgi network to the endosome [62, 63]. MVB formation
begins at the endosome with the ESCRT-0 complex, which organizes ubiquitinated cargo on the
membrane into clusters and recruits deubiquitinating enzymes. ESCRT-I and –II assemble next
on the membrane and begin the inward budding of the MVB membrane. Next, ESCRT-III is
recruited and provides the scission activity of the ESCRT machinery. It still is not completely
clear how this occurs and several models have been proposed [64, 65]. Studies have shown in
vivo and in vitro that ESCRT-III components homo- and heteropolymerize with each other on
membranes to form helical structures in circular arrays [66-69]. One model for membrane
scission is that the ESCRT-III components oligomerize on the MVB membrane in a spiral and
constrict the neck of the ILV (Figure 1.9B). Then the Vps4 complex binds and mediates the
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disassembly of the ESCRT-III complex in an ATP-dependent process, completing MVB
formation and recycling the ESCRT components back to the cytosol.

Figure 1.9 ESCRT-III function on the endosome. A. A multivesicular body (MVB) is
formed by formation of intralumenal vesicles (ILVs) from the membrane of the late endosome.
The ILVs contain activated receptor proteins (green and yellow) from the cell membrane.
ESCRT-III components (red) assemble at the neck of the forming ILV (indicated by black
arrow) and mediate the scission of the membrane. B. A view looking down onto the endosomal
membrane (blue) on the constriction neck of the forming ILV. ESCRT-III components (red
spiral) assemble into helical tubes and form a ring structure that closes the neck (dark blue) of
the ILV.
The ESCRT-III complex is required for all ESCRT-mediated activities and provides the
core function of the ESCRT machinery, which is the scission activity or “pinching off” of the
membrane [70, 71]. ESCRT-III components are recruited late during ESCRT processes and are
only transiently present on the membrane [72, 73]. Most of the proteins that make up the
ESCRT-III complex are known as Chmps and they are highly conserved among eukaryotes.
There are seven Chmps (1-7), all of which are structurally similar. Chmps have a charged five
helical core, a basic helical N-terminus that targets localization to membranes, and an acidic Cterminal region that often binds regulatory factors through a MIT (microtubule interaction and
transport) -interacting motif (MIM) [74-76]. The MIM allows Chmps to bind proteins that
contain MIT domains [77]. The C-terminal region of Chmps can bind and autoinhibit the N-
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terminal region to form a closed, or inactive conformation of the protein. This blocks membrane
localization and interaction with other proteins [78, 79]. The open, or active, conformation is
able to bind regulatory proteins and also allows for homo- and heterodimerization of Chmps [75,
80]. It is not known what causes the change in conformation from inactive to active protein.
V.

Structure and function of Chmp1
A. Chmp1 Structure
Chmp1 (Chromatin Modifying Protein; Charged Multivesicular Protein) is a component

of the ESCRT-III complex. Chmp1 is highly conserved from simple to complex eukaryotes and
is known by different names in different organisms: Chmp1 (Drosophila melanogaster),
VPS46p/Did2p (Saccharomyces cerevisiae), and Sal1 (Zea mays). To avoid confusion, I will
refer to all homologues as Chmp1 from now on. Many organisms, including yeast, Drosophila,
and some plants, express a single Chmp1 protein. Other organisms, including many insects,
zebrafish, mammals and Arabidopsis thaliana express two Chmp1 proteins that are similar in
sequence, called Chmp1A and Chmp1B. Chmp1 is a charged protein, about 200 amino acids in
length. The N-terminus contains a nuclear localization sequence (NLS) and the extreme Cterminal region contains a MIM, (D/E/Q)-XX-L-XX-(Q/R)L-XX-L(K/R), where the indicated
amino acids are those known to be involved in binding to an MIT domain (Figure 1.10) [81-84].
A protein BLAST identified two conserved domains in the Drosophila Chmp1 sequence, a Snf7
domain and a Vps24 domain (Figure 1.10). The Snf7 domain is found in the SNF multidomain
family proteins that are involved in protein sorting and transport from the endosome to the
vacuole/lysosome in eukaryotes. The Vps24 domain is found in a superfamily of conserved
proteins involved in secretion. Additionally, an analysis of the primary amino acid sequence of
Drosophila Chmp1 using protein structure prediction software Jpred3 (University of Dundee)
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identifies 5 alpha helices, consistent with previous analyses of Chmp structures (Figure 1.10)
[76].

Figure 1.10 Chmp1 protein structure in Drosophila. The Drosophila Chmp1 protein is 203
amino acids in length. It contains putative Snf7 (green) and Vps24 (purple) domains, as well as
5 alpha helices (red). It has a basic N-terminus and an acidic C-terminus. The N-terminal region
contains a nuclear localization sequence (NLS, blue) and the C-terminal region contains a MITinteraction motif (MIM, yellow).
Published studies on Chmp1 have mostly been performed in either yeast or mammalian
cell culture. These studies have identified roles for Chmp1 in regulating growth, protein sorting,
and mitosis, and have found evidence of two seemingly distinct roles for Chmp1 in the nucleus
and in the cytoplasm.
A. Chmp1 and survival
Most investigations of Chmp1 function have been performed in cell culture. However, a
few studies have been performed in developing organisms and addressed the essentiality of
Chmp1 for survival. In Nicotiana benthamiana, a close relative of the tobacco plant, loss of
Chmp1 activity had no apparent negative effect on development or viability and only caused
slight changes in leaf morphology and color [85]. Additionally, in the filamentous fungus
Aspergillus nidulans, Chmp1 was not essential for survival [86]. On the other hand, in
Arabidopsis thaliana, Chmp1A/1B mutation caused lethal developmental defects in embryos
[87]. The results of these studies are inconsistent, suggesting that the requirement of Chmp1 for
survival is different depending upon the organism. Given the conservation of the Chmp1
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sequence and ESCRT function, it is possible, and likely, that Chmp1 is involved in the same
cellular processes across species. However, it seems that the overall consequences of Chmp1
loss, i.e., the developmental defects that may be caused by mis-regulation of signaling pathways,
vary between organisms.
B. Control of growth
Studies in plant and mammalian cell culture, as well as in zebrafish and plants, suggest
that Chmp1 plays a role in regulation of growth. However, the results of these studies on are
inconsistent. While some studies suggest that Chmp1 negatively regulates growth, others suggest
that Chmp1 positively regulates growth.
Several in vitro studies have suggested Chmp1 has a role in controlling growth,
specifically proposing that Chmp1 is a novel tumor suppressor. For example, in HEK293T
(Human Embryonic Kidney, non-tumorigenic) and PanC1 (human pancreatic ductal tumor)
cultured cells, knockdown of human Chmp1A promoted cell growth [88, 89]. On the other hand,
over-expression of human Chmp1A halted the cell cycle in S-phase in EcR-293 cells (human
embryonic kidney, stably expresses the ecdysone receptor), and also reduced cell growth in
PanC1 and A498 (renal cell carcinoma) cell lines, compared to controls [81, 88, 89]. Together,
these studies suggest Chmp1 negatively regulates cell growth.
A few in vivo studies also support a role for Chmp1 as a negative regulator of growth and
even as a tumor suppressor. Similar studies from two different labs showed that HEK293T cells
with reduced human Chmp1A activity formed tumors when injected into nude mice, while
control HEK293T cells did not [88, 89]. Interestingly, when tumorous cells, either PanC1 or
A498, were injected into mice and tumors formed, over-expression of human Chmp1A, either by
Dox activation or injection of a Chmp1 over-expression plasmid, reduced the growth of the
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tumor [88, 89]. Additionally, reduction of Chmp1A activity has been linked to pancreatic and
renal cancer in humans, as these tumors showed a considerable reduction of Chmp1 activity [8890]. Taken together, these data strongly support a role for Chmp1 as a negative regulator of
growth, and possibly as a tumor suppressor.
Contrary to the evidence for Chmp1 as a tumor suppressor, some studies showed that loss
of Chmp1 had the opposite effect that would be expected from a tumor suppressor. For example,
in the study with Aspergillus nidulans, loss of Chmp1 caused conidiation (production of asexual
spores) and impaired growth [86]. Additionally, in the Arabidopsis thaliana study, a Chmp1A/1B
mutant caused stunted growth in seedlings [87]. Of course, this might be attributed to the
requirement for Chmp1A/1B for survival in this species, rather than a specific effect on growth.
However, in 2013 a study in humans linked homozygous Chmp1A mutations to pontocerebellar
hypoplasia (small, underdeveloped cerebellum) and microcephaly (small head) [91]. The same
study showed that cells grown in culture from the Chmp1A-mutant individuals had a very slow
growth rate [91]. Additionally, Chmp1A knockdown in zebrafish reduced the size of the
cerebellum and forebrain [91]. Together, these studies suggest a possible role for Chmp1 in
positive regulation of growth.
There is also evidence of a role for Chmp1 in regulating cell fate decisions. In Zea mays
(maize), loss of the Chmp1 homologue supernumerary aleurone layers 1 (sal1) caused extra
layers of aleurone cells to form in cultured endosperm [92, 93]. Though this could be an overgrowth phenotype caused by over-proliferation, the authors of this study claimed that it was due
to increased fate specification of aleurone cells caused by faulty endosomal trafficking [92, 93].
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C. Chmp1 in the nucleus
Chmp1was first discovered in a yeast two-hybrid screen for conserved proteins that
interacted with the mammalian Polycomb-group (PcG) protein, polycomblike (mPcl1), and the
Drosophila homolog, Pcl [81]. The PcG proteins, which were discovered in Drosophila, are a set
of proteins that induce chromatin condensation, mediating gene silencing epigenetically during
development. Chmp1 interacted with Pcl, suggesting that it may play a role in gene silencing.
Additionally, a bipartite NLS was found within the Chmp1 N-terminus [81]. The NLS is a
conserved feature of the Chmp1 sequence. In Nicotiana benthamiana the Chmp1 N-terminus
(but not the whole protein) localized to the nucleus [85]. Chmp1 was also detected in the nucleus
in zebrafish and human cultured cells [81, 90, 91]. So it is possible that, although the Chmp1
protein may normally localize to the cytosol, it is targeted to the nucleus upon an unknown cell
signal.
On western blots, the human Chmp1 protein is detected as a doublet with bands at 32kD
and 35kD, and cell fractionization studies showed that these bands corresponded to cytoplasmic
and nuclear Chmp1, respectively [81]. Twelve years after the initial discovery of the two Chmp1
bands, it was reported that they are likely due to different phosphorylation states of human
Chmp1, as phosphatase treatment of cellular lysates resulted in a single band [94]. This study
reported the identification of three phosphorylation sites within the human Chmp1 C-terminus
[94].
Interestingly, the nuclear form of human Chmp1 was only detectable by immunostaining
during M phase of the cell cycle. It was closely associated with chromatin and recruited the PcG
protein and transcriptional repressor, BMI1, to condensed chromatin [81]. Supporting this study,
more recent investigation showed a genetic interaction between Chmp1 and BMI1 in zebrafish,
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which suggested that they function together in regulating gene expression during neural
development [91]. This same study showed that cultured cells from humans carrying Chmp1A
mutations expressed high levels of the cell cycle regulator and tumor suppressor protein INK4,
whose expression is normally suppressed by BMI1. The function of BMI1 was likely reduced
due to the Chmp1A mutation, supporting a functional interaction between BMI1 and Chmp1.
Although Chmp1 and BMI1 did not co-localize in zebrafish, this finding supports previous
results suggesting a function for Chmp1 in negatively regulating gene expression [91].
Additional studies demonstrate interaction of Chmp1 with other nuclear proteins. In
2009, a study connected Chmp1 with All-trans Retinoic Acid (ATRA) signaling [95]. The study
found that over-expression of human Chmp1A in PanC1 cells reduced cell growth and increased
cellular levels of retinol binding protein 1 (CRBP-1) [95]. Treatment of PanC1 cells with ATRA
caused an increase in total Chmp1A protein, as well as an increase in nuclear Chmp1A [95]. This
increase in Chmp1A nuclear localization suggested a function for Chmp1A in the nucleus.
Additionally, the same group showed that Chmp1A may regulate Ataxia Telangiectasia Mutated
(ATM) through activating phosphorylation [90]. They showed that over-expression of human
Chmp1A activated ATM and that Chmp1A colocalized with ATM in the nucleus and also
increased the amount of phospho-p53 in the nucleus [89, 90]. Although ATM could be activated
when the Chmp1A MIM was deleted, the increase in phospho-p53 in the nucleus required the
NLS in the N-terminal region of Chmp1A, suggesting a nuclear requirement for Chmp1A [90].
p53 is a substrate for ATM, so the results of this study suggested that the ability of overexpressed Chmp1A to reduce cell growth might have been mediated through ATM signaling.
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D. Chmp1 in the cytoplasm
Chmp1 also plays a role in the cytoplasm as a component of the ESCRT-III complex in
MVB generation. Many localization studies, from yeast to plants to mammalian cell culture
support this role for Chmp1, showing that it localizes in the cytoplasm to early and late
endosomes [85, 86, 90, 91, 93, 96, 97]. Information from studies in yeast, fungus, and cell
culture help to delineate the steps of MVB formation that require Chmp1. Late in the ESCRT
pathway, Chmp1 is recruited to the endosomal membrane. Then, through the MIM, Chmp1 binds
the MIT domain protein, AAA-ATPase Vps4 [82]. This binding mediates the ATP-dependent
dissociation and recycling of ESCRT-III complex, completing MVB formation [96, 98]. This
model for Chmp1 function is consistent with cell fractionization studies with human Chmp1,
showing that most of Chmp1 in the cell is soluble, but some is peripherally associated with
membranes [97]. It appears that binding of Chmp1 to Vps4 to mediate ESCRT-III disassembly is
not crucial for MVB biogenesis, as MVBs are still formed when Chmp1 function is lost in yeast
and Aspergillus nidulans [86, 96]. However, Chmp1 mutations do cause protein trafficking
defects: in Arabidopsis, Chmp1A/1B mutation reduced the number of ILVs detected in the MVB;
in human cell culture, expression of a functionally mutant Chmp1 protein caused enlarged
endosomes; and in yeast, Chmp1 mutations caused accumulation of ESCRT-III components on
endosomes [78, 87, 96, 97]. Additionally, studies show that Chmp1 mutations in yeast,
Aspergillus nidulans, and Arabidopsis thaliana cause broad protein sorting defects, i.e., protein
transport from Golgi to MVB is altered [82, 86, 87, 96]. Of course, it is possible that Chmp1 has
different or additional roles in different organisms. Therefore, studies in yeast and plants may not
be equivalent to flies or humans.
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Many of the studies discussed above suggest that Chmp1 plays a role in the nucleus, as
well as the cytoplasm. In the cytoplasm, Chmp1 is required for proper ESCRT-III function
during MVB generation, protein sorting, and cytokinesis. Chmp1 is also involved in
chromosome stability and gene silencing, but it remains unknown how Chmp1 interacts with
chromatin. There are reports of ESCRT components in the nucleus, including the tumor
suppressor and ESCRT-I component, Tumor Susceptibility Gene 101 (Tsg101) [99].
E. Chmp1 and mitosis
Mutations in Chmp1 can result in severe mitotic/cytokinetic defects. In HeLa cells
knockdown of both Chmp1A and Chmp1B was associated with multiple defects during mitosis,
including multinucleated cells, fragmented nuclei, unaligned metaphase chromosomes, visible
midbodies (Flemming bodies, narrow intracellular bridges dense with microtubules that connect
two daughter cells near the end of cell division), and multipolar spindles [69, 100]. Although
human Chmp1A and Chmp1B are similar in sequence to Chmp1 in other species, they may have
separate functions. Unlike human Chmp1A, human Chmp1B is involved in membrane abscission
during cytokinesis in cell culture, where it recruits and binds Spastin, a microtubule-severing
enzyme, at the midbody [69, 77, 101]. Indeed, in HeLa cells knockdown of both human Chmp1A
and Chmp1B induced cytokinesis arrest [69]. This implies that the ESCRT-III complex may
recruit a different version of the Chmp1 protein depending on the cellular process involved.
Chmp1A and Chmp1B may have different binding partners (see below), giving the ESCRT
machinery a way of recruiting different proteins for different jobs in the cell.
F. Conserved binding partners of Chmp1
Chmp1 has multiple known binding partners, many of which are part of the ESCRT
machinery and most of which are conserved between species. For example, through its MIM
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motif, Chmp1 in Aspergillus nidulans and yeast binds the MIT of the ATPase, Vps4/SKD1 [82,
84, 86, 96]. Chmp1-Vps4 binding was also observed in Arabidopsis thaliana and human cultures
cells, and was required for completion of MVB biogenesis and the disassociation of ESCRT-III
complexes from the MVB membrane [75, 83, 84, 87, 96, 97]. Multiple studies in human cells
and yeast showed that Chmp1 also binds Increased Sodium Tolerance-1 (Ist1), a component of
the Vps4 complex that inhibits Vps4 activity [69, 94, 102-104]. Studies in yeast, Arabidopsis,
and human cultured cells showed an interaction with Chmp1 with the MIT domain protein LIP5
/Vta1p (Lyst-interacting protein 5/ Vps twenty associated 1 protein), an important component of
the Vps4 complex which binds and activates Vps4 [84, 87, 98, 105-107]. Human Chmp1A and
1B also bound the endosome associated ubiquitin hydrolases, AMSH (Associated Molecule with
the SH3-domain of STAM) and UBPY (Ubiquitin-specific processing Protease Y) [75, 108].
Additionally, the first study that identified Chmp1 in human cells showed that it physically
interacted with both the human and Drosophila PcG protein, Pcl [81]. Human Chmp1 proteins
also interact with each other, through both homodimerization and heterodimerization with other
Chmps [75]. All of these proteins reported to bind Chmp1 are either ESCRT components (i.e. the
Chmps) or recruited to the site of ESCRT activity (e.g. Vps4, AMSH).
Many organisms, including humans, express two Chmp1 proteins: Chmp1A and
Chmp1B. Their sequences are similar, and they share many binding partners, they do not share
the same binding affinities. For example, human Chmp1A and 1B both interacted and
colocalized with Calpain-7, a calcium-dependent cysteine protease, but Chmp1B bound much
more strongly than Chmp1A [109]. Additionally, Chmp1B associated with the ATPase Spastin
during cytokinesis, but Chmp1A did not [77, 101].
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G. Binding partners of Drosophila Chmp1
There have been no functional studies on Chmp1 in Drosophila. However, Chmp1 has
been included in some large scale protein interaction studies, including the Drosophila Protein
Interaction Map (DPiM), the goal of which is to generate a protein interaction map of the entire
Drosophila proteome [2, 110, 111]. These have identified many binding partners for Chmp1 in
Drosophila (Table 1.3). Interestingly, although several of these proteins are involved in protein
transport and phagocytosis, both of which are known to require ESCRTs, other cellular processes
are represented. Of the 27 binding partners of Chmp1, 5 play a role in translation, 6 in mRNA
processing, and 2 in regulation of gene expression. This suggests that Chmp1 may play a role in
regulation of gene expression, possibly at the level of translation. However, it is important to
note that these interactions were identified through co-immunoprecipitation and mass
spectroscopy, and so are purely physical and have not yet been confirmed through genetic
studies in Drosophila. Interactions between Chmp1 and several of the binding partners listed, for
example, CG10103, Vps4, and Chmp4B, have been observed in other organisms as well [69, 75,
82, 86, 97]. This suggests that these interactions are conserved and are therefore much more
likely to be true binding partners in Drosophila.
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Table 1.3 Protein interactions with Drosophila Chmp1. *Predicted function based on
sequence similarity. Information retrieved from [2].
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CHAPTER 2
RATIONALE, SPECIFIC AIMS AND HYPOTHESIS
I.

Rationale
Many cellular signaling pathways share a common cascade structure, in which an

extracellular signal is transmitted into the cell through a transmembrane receptor, ultimately
causing a change in gene expression. Down-regulation of the signal is crucial for proper cellular
function. One method for down-regulation of activated transmembrane receptors is the MVB
pathway, which utilizes the ESCRT protein complexes, 0, I, II, and III. The ESCRT-III complex
provides the core function of the ESCRT machinery, which is the scission of the neck of the ILV
at the MVB. This step is crucial for MVB biogenesis, as failure to complete ILV formation
impedes down-regulation of the receptor and leads to prolonged signaling to the cytoplasm.
Chmp1 is a component of the ESCRT-III complex. As an ESCRT-III component, Chmp1
binds the AAA ATPase Vps4, which completes formation of the ILV and mediates
disassociation of the ESCRT-III components from the MVB membrane. There are numerous
studies in yeast on Chmp1 and other ESCRT components, which focus heavily on the physical
binding domains and partners of Chmp1. Other work in mammalian cell culture focuses mainly
Chmp1 as a regulator of growth. Many of the results of these studies are contradictory. For
example, results of over-expression and knockdown studies have linked Chmp1 to pancreatic and
renal cancers in humans, and identified Chmp1 as a putative tumor suppressor [81, 88-90, 92,
95]. On the other hand, some studies show that loss of Chmp1 has minimal negative effects on
cellular function, and others that loss of Chmp1 impairs growth, which seems to contradict its
role as a tumor suppressor [85-87, 91].

35

As most information on the activity of Chmp1 has been inferred from its biochemical
interactions or from studies of single cells, little is known about its role in tissue development
and differentiation. Indeed, few studies have investigated the mechanisms, i.e., genetic or
biochemical pathways, underlying the Chmp1 phenotypes that have been reported. Two studies
from the Park lab suggest the effect of Chmp1 on growth is due to its role in the nucleus, as it
appears to be involved in ATRA and ATM/p53 signaling [89, 90, 95]. Another study showed
that Chmp1 may regulate expression of the BMI-INK4 locus in humans, and suggested that
Chmp1 functions in the nucleus through a physical interaction with BMI [91]. Apart from these
few studies, however, there is little information about the pathways by which Chmp1 has an
effect on cell development and differentiation. In addition, the only studies on the role of Chmp1
in a multicellular organism have been completed in plants or fungus, rather than in an animal
model [85-87, 92].
No investigation of Chmp1 function in invertebrates has been published. Drosophila
provides an easily manipulated model system for the analysis of Chmp1 function and its
importance for development. In this research, the effects of loss (knockdown) and gain (overexpression) of Chmp1 activity on tissue development were investigated with the aim of
identifying the genetic or biochemical pathways Chmp1 may regulate. Because Chmp1 has not
been studied in Drosophila, resources are limiting, i.e., no Chmp1 mutant or antibody exists.
However, with the development of the genome-wide Drosophila RNAi libraries, the effects of
loss of Chmp1 activity could be investigated with Chmp1 mRNA knockdown. Additionally,
transgenic fly lines that can express either wild-type or epitope-tagged Chmp1 protein were
generated to investigate effects of Chmp1 over-expression, as well as Chmp1 subcellular
localization. The results of these studies should help to characterize the cellular function of
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Chmp1. Additionally, the results should provide some mechanisms (e.g., regulation of cellular
signaling pathways) underlying Chmp1 phenotypes.
II.

Specific Aims and Experimental Design

A. Specific Aim 1: Establish that Drosophila is an appropriate model to investigate Chmp1
function. Conservation of amino acid sequence, functional domains, and protein interaction
domains would suggest that Chmp1 function is conserved between flies and other species.
Therefore, conclusions obtained from studies on Chmp1 function in Drosophila would be
suggestive of its function in other organisms.
1. Align Drosophila and human Chmp1 protein sequences to identify the degree of sequence
similarity.
2. Identify conserved domains and binding partners through sequence analysis and data
mining.
B. Specific Aim 2: Investigate the effects of loss of Chmp1 in the developing fly. No Chmp1
mutant exists, so loss of Chmp1 was investigated using fly lines that express RNAi specific for
Chmp1 mRNA. Analysis of Chmp1 knockdown phenotypes in the fly should provide
information to address the following questions:
1. Is Chmp1 essential? No investigation of the essentiality of Chmp1 has been published in
invertebrates.
I.

Verify that RNAi is effective and specific. RNAi is likely effective and specific if
similar phenotypes are observed from the expression of Chmp1 RNAi with
independently created RNAi lines.
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II.

Verify whether flies survive ubiquitous Chmp1 knockdown. Lethality associated
with ubiquitous Chmp1 knockdown during fly development would suggest that
Chmp1 is essential to development.

2. What is the phenotypic effect of Chmp1 knockdown in specific tissues in the fly (i.e., the
wing and eye)? Phenotypes obtained should give clues about which developmental
pathways Chmp1 regulates.
I.

Knock down Chmp1 expression in the wing and eye using specific Gal4 drivers.
Analyze the phenotypes that result and hypothesize which signaling pathways are
altered by Chmp1 loss.

3. What signaling pathways does Chmp1 regulate?
I.

Investigate whether the Chmp1 knockdown phenotype is enhanced/suppressed by
altered activity of the specific developmental pathways identified in B.2.I.

II.

Investigate whether downstream targets of pathways regulated by Chmp1 are
affected when Chmp1 is knocked down.

C. Specific Aim 3: Investigate the effects of gain of Chmp1 in the developing fly. No fly line that
allows for Chmp1 over-expression exists, so transgenic fly lines were generated that allow for
expression of wild-type or his-myc (HM)-tagged Chmp1 protein. Analysis of Chmp1 overexpression phenotypes in the fly should provide information to address the following questions:
1. What is the phenotypic effect of Chmp1 over-expression in specific tissues in the fly (i.e.,
the wing and eye)? Phenotypes observed should give clues about which developmental
pathways Chmp1 regulates.
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I.

Verify that Chmp1 over-expression lines express functional Chmp1 protein.
Rescue of Chmp1 knockdown by Chmp1 over-expression would suggest that the
transgenic fly lines generated express functional Chmp1 protein.

II.

Over-express Chmp1 in the eye and wing of the fly using specific Gal4 drivers.
Analyze the phenotypes that result and hypothesize which signaling pathways are
altered by Chmp1 over-expression.

2. What signaling pathways does Chmp1 regulate? Investigate whether the Chmp1 overexpression phenotype is enhanced/suppressed by altered activity of specific
developmental pathways identified in C.1.II.
D. Specific Aim 4. What is the subcellular localization of Chmp1 in fly tissues? No antibody has
been developed specifically against Drosophila Chmp1. To investigate subcellular localization of
Chmp1 protein, express HM-Chmp1 in tissues of the developing fly (i.e., embryos and larval
tissues).
1. How does HM-Chmp1 localize in cells of fly tissues? It is reported that Chmp1 functions
in the cytoplasm and the nucleus. The subcellular localization of HM-Chmp1 should
indicate where Chmp1 functions in Drosophila cells.
I.

Express HM-Chmp1 in the embryo and larval tissues using specific Gal4
drivers. Detect HM-Chmp1 localization with an anti-c-Myc antibody.

2. Does HM-Chmp1 localize to the endosome?
I.

Express HM-Chmp1 in the embryo using specific Gal4 drivers and
investigate co-localization with endosomal markers, including Rab5 and
Rab9, markers for the early and late endosome, respectively.
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Figure 2.1. Experimental design
III.

Hypotheses
A. Sequence alignments suggest that the structure of Chmp1 is conserved across species.
Hypothesis: Alignment of amino acid sequence between Chmp1 from flies and other
species will likely indicate a high degree of sequence similarity. Therefore, Chmp1
function as a component of the ESCRT-III pathway and in the nucleus is likely
conserved in Drosophila. Additionally, conclusions inferred from studies in
Drosophila should give insight into Chmp1 function in other species.

B. & C. Chmp1 is a ubiquitously expressed protein and a component of the ESCRT-III
complex, which is required for receptor down-regulation. Hypothesis: Chmp1 is
essential for Drosophila development. Loss or gain of Chmp1 function will disrupt
ESCRT-III function, including MVB biogenesis, and alter the activity of cell
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signaling pathways. The resulting phenotypes will provide clues as to which specific
pathways are regulated by Chmp1.
D. Chmp1 is a component of the ESCRT-III complex, which is required for MVB
biogenesis from the endosome. Numerous studies report Chmp1 localization to the
early and/or late endosome. Chmp1 localization has also been observed in the
nucleus. Hypothesis: Drosophila Chmp1 localizes to the endosome and nucleus.
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CHAPTER 3
MATERIALS AND METHODS
I.

Alignment of Chmp1 sequences
Chmp1 protein sequences were obtained from the National Center for Biotechnology

Information (NCBI) webpage (http://www.ncbi.nlm.nih.gov/). Accession numbers for protein
sequences used are as follows: NP_649051.3 for Drosophila melanogaster Chmp1,
NP_065145.2 for Homo sapiens Chmp1B, and NP_002759.2 for Homo sapiens Chmp1A.
Conserved domains were identified through the NCBI webpage and confirmed in the literature
when possible. Alignment of the Chmp1 protein sequences was performed through the European
Bioinformatics Institute (EBI) webpage (www.ebi.ac.uk/ena/) using the program ClustalX.
Identical residues were labeled with an asterisk, and similar residues were labeled with one or
two dots, depending on the degree of similarity.
II.

Generation of transgenic fly lines
Transgenic fly lines that express Chmp1 under the control of a Gal4 responsive UAS

enhancer were generated. The clone GH26351, which contains Chmp1 cDNA in the pOT2
vector, was obtained from the Drosophila Genomics Resource Center (DGRC). Two plasmids
were used, pUAST and pUASHM, which allow for insertion into the Drosophila genome. The
Chmp1 coding sequence was amplified by PCR with the following primer pairs (Invitrogen):
UAS-HM-Chmp1 forward (GGGCCCGGATCCACGTCGCATATGTCTACGAGTTCCATGG)
and UAS-HM-Chmp1 reverse (TACCACCTCGAGTTATTCAGCCTGGCGGAGACG) for
insertion into pUASHM, and UAS-Chmp1 forward
(ACGTCGGAATCCATGTCTACGGAGTTCCATGG) and UAS-Chmp1 reverse
(TACCACCTCGAGTTATTCAGCCTGGCGGAGACG) for insertion into pUAST. These
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primers added Nde1, Xho1, and EcoR1 restriction enzyme recognition sites (underlined) that
allowed for insertion of the Chmp1 cDNA into the pUAST and pUASHM plasmids. Chmp1
cDNA was inserted downstream of a UAS enhancer into the EcoR1/Xho1 sites of pUAST and
the Nde1/Xho1 sites of pUASHM. The pUASHM vector allows the expression of Chmp1 protein
tagged with an N-terminal His-Myc (HM) tag. The amplified and cloned Chmp1 sequence was
verified by nucleotide sequencing. The UAS-HM-Chmp1 and UAS-Chmp1 plasmids were sent to
BestGene Inc., where the transgenic flies were generated. Balanced stocks carrying the UASHM-Chmp1 and UAS-Chmp1 transgenes were produced in the Collier fly lab.
III.

Fly stocks and genetics
All flies were cultured on standard cornmeal/yeast media at 25oC, unless otherwise

stated. The fly stocks used in this study are listed in Table 3.1. P[GD11219]v21788 (UASChmp1-RNAi VDRC) and P[GD1443]v33200 (UAS-forked-RNAi ) were obtained from the
Vienna Drosophila Resource Center (VDRC). TRiP.HM05117 (UAS-Chmp1-RNAi TRiP) was
obtained from the Transgenic RNAi Project (TRiP) stocks at Harvard. N55e11/FM7Bar, UASDx17, and car1; dpp-Gal4/TM6b were a gift from Martin Baron. All other fly lines were from
Bloomington Stock Center at Indiana University. Additionally, six transgenic fly lines were
generated that were used in this study (Table 3.2): the UAS-HM-Chmp1-1 through UAS-HMChmp1-4 lines can express HM-tagged Chmp1 protein; the UAS-Chmp1-1 and UAS-Chmp1-2
lines can express wild-type Chmp1 protein.
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Table 3.1 Fly stocks used. The white- fly stock carries a mutation in the white gene, the
function of which is required for the red eye color present in wild-type flies. Transgenic fly
stocks or mutants are often generated in flies with white eyes (white-), which is why the first
chromosome is listed as an affected chromosome in nearly all of the stocks used in this
study.

Table 3.2 Fly lines generated in this study.

IV.

Mounting fly wings
Flies were anesthetized with CO2 and wings were dissected from flies using fine tipped

forceps under a light microscope. Wings were mounted in Gary’s Magic Mountant (GMM),
which is an approximately 1:1 mixture of Canada balsam and methyl salicylate.
V.

Measurements and statistics
To quantify changes in vein thickness, the area of the L3 wing vein was measured from

its junction with the anterior cross vein and for 200µm in the distal direction using ImageJ
software [112]. At least 10 individual wings were measured for each genotype. For each wing,
the L3 wing vein area was measured three times and the mean of the measurements was used for
the quantification. Measurements for each genotype were represented in a box and whisker plot
generated with Microsoft Excel 2007.
To determine rescue of Chmp1 knockdown by Chmp1 over-expression, L3 wing vein
areas of less than 3400µm2 were considered fully rescued. The value of 3400µm2 was chosen as
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the threshold of complete rescue because of the wild-type wing veins measured, wing vein areas
approached but were never more than 3400µm2. An L3 wing vein area of greater than 5200µm2
was considered not rescued. The value 5200µm2 was chosen as the threshold of no rescue
because of the Chmp1 knockdown wing veins measured, wing vein areas approached but were
never less than 5200µm2. Therefore, L3 wing vein areas between 3400µm2 and 5200µm2 were
considered partially rescued.
All statistical analyses were performed using IBM SPSS Statistics software. First, a twotailed student’s t-test (p<0.05) was used to determine whether the mean L3 wing vein area of
wild-type and Chmp1 knockdown wings were different. Then, a one-way ANOVA with a posthoc Dunnett’s t-test (p<0.05) was used to determine whether the mean L3 wing vein area of
Chmp1 knockdown wings was different from wings expressing Chmp1-RNAi in varying genetic
backgrounds (e.g., wings carrying heterozygous mutations for regulators of DER signaling,
wings carrying heterozygous deletions of the Chmp1 gene, etc.). Statistically significant
differences were denoted with an asterisk on the box and whisker plot.
VI.

Immunohistochemistry of embryos
Embryos were collected for 20-24 hours onto a yeasted apple juice agar plate in an

embryo collection bottle at 25oC, unless otherwise stated. The embryos were washed with
distilled water into a mesh basket. The Drosophila embryo is protected by a shell composed of an
outer chorion, as well as an inner impermeable vitelline membrane. These layers must be
removed to use Drosophila embryos for immunostaining. The embryos were first dechorionated
in 50% bleach solution and then washed well with distilled water. 0.5mL of 4% formaldehyde
fix and 0.5mL of heptane were added to a microcentrifuge tube. The heptane and formaldehyde
formed distinct upper (heptane) and lower (formaldehyde) layers. The embryos were collected
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gently from the mesh basket with a fine brush and added to the microcentrifuge tube, where they
settled to the bottom of the heptane layer. To fix the embryos, the microcentrifuge tube was
shaken vigorously for 10 minutes. The fixative was then removed and the embryos were
devitellinized by the addition of ice cold methanol, followed by shaking. The methanol was
removed and followed by a second addition of ice cold methanol. The methanol was removed
and the embryos were blocked for 1 hour in 0.1% bovine serum albumin in 0.1% PBS-Triton-X
(BSA-PBST) with rotating. A fresh solution containing the primary antibody diluted in BSAPBST was added to the embryos in the microcentrifuge tube, and they were incubated for 1 hour
to overnight (at 4oC if overnight) with rotating. After incubation with the primary antibody, the
embryos were washed two times in BSA-PBST for 10 minutes each with rotating. A
fluorescently-tagged secondary antibody diluted in BSA-PBST was added to the microcentrifuge
tube containing the embryos, and they were incubated for 1 to 3 hours with rotating. The tube
was wrapped in foil during this step and for the remainder of the protocol to shield the
fluorescently tagged secondary antibody from light. After incubation with the secondary
antibody, the embryos were washed two times in BSA-PBST for 10 minutes each with rotating.
They were then mounted onto a glass slide in Vectashield mounting media with DAPI, sealed
with nail polish, and stored at 4oC protected from light until the time of imaging. Embryos were
imaged on a Leica confocal microscope. All steps were carried out at room temperature, unless
otherwise stated.
VII.

Immunohistochemistry of imaginal discs

Imaginal discs were dissected from crawling 3rd instar larvae in 1X PBS. Using forceps,
the larva, with its dorsal side up, was held about a third or half way from its posterior end. Using
a second pair of forceps, the anterior end of the larva was pinched and pulled anteriorly. If pulled
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slowly, the wing discs are usually easily identified. To prevent damage to the discs by handling,
they were left attached to either a portion of the head or the trachea of the larva, if possible. The
discs were collected into a small mesh basket filled with 1X PBS contained in a well of a 24 well
plate. The basket was moved to a new well for each solution used in the following protocol. The
discs were fixed in 4% formaldehyde fix for 20 minutes to 1 hour with rocking. They were
washed twice for 30 minutes each in 1mL of 0.1% bovine serum albumin in 0.1% PBS-Triton-X
(BSA-PBST) with rocking. The discs were blocked in 1mL BSA-PBST for 1 hour with rocking.
They were then incubated in 1mL primary antibody diluted in BSA-PBST and incubated for 1
hour to overnight (at 4oC if overnight) with rocking. Then, the discs were incubated with the
fluorescently-tagged secondary antibody and incubated for 1 to 3 hours with rocking. During this
incubation and the remaining steps of the protocol, the discs were protected from light. The discs
were then washed twice in 1mL of BSA-PBST for 30 minutes each with rocking. Under a
dissecting microscope, the wing discs were dissected away from the head/trachea in 80%
glycerol on a glass microscope slide. The discs were mounted in Vectashield mounting media
with DAPI onto a microscope slide and imaged using a Leica confocal microscope. All steps
were carried out at room temperature, unless otherwise stated.
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VIII.

Antibodies used for immunostaining

Table 3.3 Antibodies used in these studies for immunostaining of embryos and imaginal wing
discs.

IX.

Eye preparation and sectioning
Flies were anesthetized on a CO2 pad, the heads were cut off using a scalpel, and very

carefully a part of one eye was cut off to allow for penetration of the fixative. The heads were
transferred to 200μL of 2% gluteraldehyde in 0.1M sodium phosphate buffer pH 7.2 in a
microcentrifuge tube on ice. The heads were fixed for 10 minutes and spun in a microcentrifuge
for 1 minute at 10,000 rpm. Then 200μL of 2% OsO4 in 0.1M sodium phosphate buffer pH 7.2
(osmium solution) was added and the eyes were fixed for 1 hour on ice. The
gluteraldehyde/osmium solution was replaced with 200μL of osmium solution and the eyes were
incubated on ice for 1-6 hours. The fixative was removed and the eyes were dehydrated in 10
minute steps with an ethanol (EtOH) series on ice: 30%, 50%, 70%, 90%, and then twice with
100% EtOH at room temperature. The eyes were then washed in propylene oxide (Fisher,
reagent grade) twice for 10 minutes each at room temperature. The propylene oxide was replaced
with a 1:1 propylene oxide:Durcupan resin mixture and rotated slowly overnight at room
temperature. The following mixture of components created a suitable soft resin of Durcupan for
mounting and sectioning the eyes: 13.5g resin A, 11.125g hardener B, 0.625g accelerator C, and
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2.5g plasticizer D. The 1:1 mixture of propylene oxide:Durcupan was replaced with a 100%
Durcupan mixture and incubated for 3 hours at room temperature. The heads were then
transferred to 100% Durcupan resin and arranged within a mold (Figure 3.1A). They were baked
overnight at 70oC. The sectioning surface of the resin containing the fly heads was then trimmed
with a razor blade into an asymmetric trapezoid (Figure 3.1B). This minimized the area of the
block for better sectioning, and provided a way to identify the orientation of the eye tissue within
the sections. The embedded eyes were sectioned with a newly cut glass knife on a Sorvall
MT5000 into 0.5 to 1.0μm thick sections, which were transferred with a small wooden spatula to
drops of water on a glass slide. The water was dried on an 80oC hot plate and cooled to adhere
the sections to the slide. Drops of 0.1% Toluidine blue (w/v) were applied to the sections, and the
microscope slide was set on an 80oC hot plate for 20 seconds (just until the Toluidine dye began
to bubble). The slides were rinsed thoroughly with distilled water and air dried. A drop of DPX
mounting medium was added on top of the sections. A cover slip was laid onto the DPX and
weighted with two pennies. The DPX was allowed to dry overnight. The sections were imaged
on a compound light microscope with a 60X oil immersion lens.

Figure 3.1 Orientation of fly heads in resin block for eye sectioning. A. The uncut eye of the
fly head was positioned anterior side up near the edge of the mold. B. The sectioning surface of
the resin block was trimmed into an uneven trapezoid shape so that the dorsal and ventral eye
could be identified in the sections.
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CHAPTER 4
RESULTS
I.

Chmp1 is conserved and essential
The Drosophila Chmp1 protein (Flybase ID: FBgn0036805) is encoded by the Chmp1

gene (CG4108), which is located in the region 75D6 on the left arm of the third chromosome
(Figure 4.1A). The Drosophila genome carries a single Chmp1 gene. The genomes of many
model organisms, including mammals, contain two Chmp1 genes, Chmp1A and Chmp1B, both of
which are highly homologous to Drosophila Chmp1. This makes Drosophila an ideal model to
study Chmp1 function as there is not the complication of genetic redundancy caused by the
activity of closely related genes. Alignment of the Drosophila Chmp1 protein sequence with
human Chmp1A and Chmp1B reveals that they share a conserved NLS, as well as an MIM
(Figure 4.1B). Drosophila and human Chmp1 proteins also share Snf-7 and Vps24 domains. In
amino acid sequence, Drosophila Chmp1 is most like human Chmp1B; they are 74% identical
and 90% similar (Figure 4.1B). Through co-immunoprecipitation assays and mass spectroscopy,
Drosophila Chmp1 has been shown to bind many proteins, including Vps4 and the Drosophila
homologue of Ist1, CG10103 (Table 1.3) [111]. Reports show that Chmp1 binds these proteins in
yeast and human cultured cells, suggesting that the function of Chmp1 is well conserved between
yeast, humans, and Drosophila [82, 104]. Interestingly, other Chmp1 binding partners include
quite a few proteins involved in translation and mRNA processing, as well as phagocytosis
(Table 1.3). To summarize, as Drosophila expresses only one Chmp1 protein that shares binding
partners and sequence features of mammalian Chmp1 proteins, it provides a good model to study
the function of Chmp1.
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Figure 4.1 Chmp1 is conserved. A. Genomic region surrounding the Chmp1 gene (boxed in
red). The genomic regions removed by the chromosomal deletions Df(3L)BSC832 and
Df(3L)BSC416 are indicated. The positions of genes located near Chmp1 are indicated by blue
arrows. B. ClustalX alignment of the human and Drosophila Chmp1 protein sequences. The
Chmp1 protein contains a nuclear localization sequence (NLS, purple), an MIT-interacting
motif (MIM, yellow), and Snf-7 (blue) and Vps24 (green) domains as predicted by sequence
analysis. Phosphorylation sites identified for human Chmp1A are highlighted in pink. Residues
that are similar in all three sequences are indicated by one or two dots (depending upon the
degree of similarity) below the alignment, and identical residues are indicated by an asterisk.
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Most information on the activity of Chmp1 has been inferred from biochemical or cell
culture studies, so little is known about its role in tissue development and differentiation.
Expression analysis has revealed that Drosophila Chmp1 is expressed throughout development in
all larval and adult tissues assayed, which suggests that Chmp1 activity can be studied in a range
of tissues [2, 113]. Observing the phenotypic effects of loss of Chmp1 activity should give novel
insights into Chmp1 function, i.e., what proteins it interacts with or which signaling pathways it
regulates. The effect of loss of Chmp1 was assessed using two independent Drosophila RNAi
lines, one from the VDRC (UAS-Chmp1RNAi-VDRC) and one from the TRiP stocks (UASChmp1RNAi-TRiP) that allowed for targeted Chmp1 knockdown (UAS-Chmp1RNAi) [28]. These
fly lines express hpRNAs under the control of a Gal4-responsive UAS enhancer that target
different regions of the Chmp1 mRNA. To test whether Chmp1 was essential for viability,
Chmp1 was knocked down ubiquitously throughout development. tub-Gal4/TM3Sb and act5cGal4/TM6Tb males were crossed to UAS-Chmp1RNAi-TRiP and UAS-Chmp1RNAi-VDRC/Cy
virgin females in four separate crosses (Figure 4.2). Because the UAS-Gal4 system is
temperature dependent, the F1 generation from each cross was raised at 25oC, 28oC, and 30oC to
compare phenotypes at different temperatures.
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Figure 4.2 Cross design to test ubiquitous Chmp1 knockdown. A. Cross design for
ubiquitous Chmp1 knockdown using the VDRC RNAi insert, located on the second
chromosome. B. Cross design for ubiquitous Chmp1 knockdown using the TRiP RNAi insert,
located on the third chromosome. P is parental generation, F1 is filial generation. Only F1
progeny of the desired genotype are shown.
When Chmp1 was knocked down ubiquitously during fly development at 30oC and 28oC,
the only progeny that eclosed were Sb, Tb, or Cy, indicating that they either did not carry the
Gal4 driver or did not carry the UAS transgene (i.e. they were not Chmp1 knockdown flies). At
25oC, no flies survived ubiquitous knockdown using the TRiP RNAi line. Additionally, no flies
survived when Chmp1 was knocked down ubiquitously using the VDRC RNAi line with tubGal4. In these crosses, expression of Chmp1 RNAi was lethal at or before the pupal stage of
development. However, occasional escapers, all of which were female, survived ubiquitous
Chmp1 knockdown using the VDRC RNAi line with act5c-Gal4. The surviving flies had
thickened wing veins, mildly rough eyes, and a general failure to thrive. This is possibly
indicative of degree of Chmp1 knockdown, i.e., the RNAi line from the TRiP stocks may have
provided a more effective knockdown than the VDRC line. It is also possible that the tubGal4/TM3Sb fly line drives Gal4 expression stronger than the act5C-Gal4/TM6Tb fly line.
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It is possible that the lethality observed with Chmp1 RNAi expression was caused by off
target RNAi effects. In fact, according to the VDRC website, the UAS-Chmp1RNAi-VDRC line
has a potential off-target of the gene natalisin (CG34388), which is involved in male mating
behavior [114]. Additionally, knockdown of natalisin using a VDRC RNAi fly line is lethal
before the pupal stage, similarly to Chmp1 knockdown [115]. The fact that only female survivors
were observed could also support the possibility of the off-target effects causing lethality.
However, Chmp1 knockdown was lethal using two independent RNAi lines that target different
portions of the Chmp1 mRNA. Therefore, Chmp1 may be essential for proper development in
Drosophila.
II.

Chmp1 knockdown produces a cell fate change in the wing
Because ubiquitous Chmp1 knockdown was lethal, the UAS Gal4 system was used to

limit knockdown to the wing, a well-characterized tissue that is not essential for Drosophila
development. MS1096-Gal4, salm-Gal4, ptc-Gal4, or en-Gal4 drivers were used to drive Chmp1
knockdown. Each driver expresses Gal4 in the pattern of a developmental gene in the wing
(Figure 4.3).
The MS1096-Gal4 driver expresses Gal4 protein relatively strongly in the dorsal
compartment of the wing. This is a useful driver for several reasons. First, as sometimes overexpression or knockdown of a gene has weak phenotypic effects, the MS1096-Gal4 driver allows
for stronger over-expression or knockdown of the gene-of-interest to generate stronger
phenotypes. Second, the MS1096-Gal4 driver only expresses Gal4 on the dorsal wing, so it only
affects the dorsal wing veins: L3, L5 and distal L4 (Figure 4.3). When studying genes involved
in wing vein patterning, the ventral wing veins remain unaffected and can provide an in-tissue
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negative control. Third, the MS1096-Gal4 transgene is inserted on the X chromosome, which can
increase the ease with which genetic crosses can be performed.
The salm-Gal4, ptc-Gal4, and en-Gal4 driver transgenes are each located on the second
chromosome and drive Gal4 expression on both dorsal and ventral wing surfaces. salm-Gal4 and
ptc-Gal4 are moderate drivers. salm-Gal4 drives Gal4 expression from the posterior of the L2
wing vein to midway between the L4 and L5 wing veins (Figure 4.3). ptc-Gal4 has a similar but
narrower region of expression between the L3 and L4 wing veins (Figure 4.3). en-Gal4 is a
stronger driver and has a very precise boundary of expression. en-Gal4 expresses Gal4 in the
pattern of the engrailed gene, in the anterior cells of each parasegment of the developing fly. In
the wing, this corresponds to the posterior compartment. The anterioposterior (AP) compartment
boundary in the wing is located a few cells anterior of the L4 wing vein. The expression of
engrailed begins a few cells anterior to the AP compartment boundary (Figure 4.3).

Figure 4.3 Expression patterns of wing drivers. Diagrams of the Drosophila wing showing
expression of Gal4 in color by different drivers. Distal is right, anterior is uppermost.
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To achieve Chmp1 knockdown in the wing, UAS-Chmp1RNAi-TRiP homozygous and
UAS-Chmp1RNAi-VDRC/Cy virgin females were crossed to MS1096-Gal4, salm-Gal4, ptc-Gal4,
or en-Gal4 homozygous males and the progeny was grown at 25oC, 28oC, and 30oC (Figure 4.4).
Straight winged (not Cy) flies were of the correct genotype. Wings from females were dissected
and mounted onto a microscope slide in GMM.

Figure 4.4 Chmp1 knockdown cross design. A. Cross design for Chmp1 knockdown in the
wing using the TRiP RNAi insert, located on the third chromosome. B. Cross design for Chmp1
knockdown in the wing using the VDRC RNAi insert, located on the second chromosome. P is
parental generation, F1 is filial generation. Only F1 progeny of the desired genotype are shown.
Knockdown of Chmp1 primarily on the dorsal side of the wing (MS1096-Gal4/X; UASChmp1RNAi-VDRC/+) resulted in thickening of the dorsal wing veins, L3, L5, and distal L4
(Figure 4.7B). Thickening of the wing veins was observed with Chmp1 knockdown using several
Gal4 drivers, and the phenotype was only observed in the pattern of the driver (i.e., en-Gal4
expresses Gal4 in the posterior wing, and only posterior wing veins were thickened), suggesting
that the vein phenotype was specifically due to expression of Chmp1 RNAi, rather than due to
other genetic interactions (Figures 4.7E and G).
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Similar thick vein phenotypes were observed using the independently created TRiP RNAi
fly line that targeted a different portion of the Chmp1 mRNA, showing that the vein thickening
was likely due to Chmp1 knockdown rather than off target effects, in which the hpRNA causes
degradation of other mRNAs (Figure 4.7D, F, and H). Chmp1 knockdown with the TRiP line
resulted in a stronger wing vein phenotype (i.e., thicker wing veins) than was observed with the
VDRC line, suggesting that the TRiP line produced more effective knockdown than the VDRC
line, which is consistent with the findings with ubiquitous Chmp1 knockdown.
In order to produce the thick veins phenotype, it seemed that Chmp1 expression had to be
reduced rather strongly. That is, strong drivers (MS1096-Gal4 and en-Gal4) and higher
temperatures (28oC and 30oC) were required to observe a phenotype that differed much from
wild-type. At 25oC, the wing vein thickening was discernible, at 28oC it was moderate, and at
30oC it was severe. In fact, at 30oC the wing veins became so thick that they could not easily be
distinguished from the intervein tissue (Figure 4.5). Therefore, 28oC was used to analyze the
effects of Chmp1 knockdown on wing vein development, as this would allow identification of
both enhancement and suppression of the vein phenotype. Although the Chmp1 protein levels
were not measured to quantify the level of Chmp1 knockdown, the mildness of the vein
thickening phenotype may suggest that, at least during wing development, a relatively small
amount of functional Chmp1 was sufficient for cellular function and tissue development.
However, it could also indicate that the RNAi fly lines are not particularly effective, or that
Chmp1 is highly expressed and therefore difficult to reduce significantly, or that the Chmp1
protein perdures though mRNA levels are reduced.
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Figure 4.5 Chmp1 knockdown at 30oC. Light micrographs of wings from female Drosophila
raised at 30oC. Distal is right, anterior is uppermost. A. en-Gal4/UAS-Chmp1RNAi-VDRC. B.
MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+.
The change in wing vein thickness between wild-type and Chmp1 knockdown wings was
statistically significant. To quantify the change in wing vein thickness between genotypes, the
area of the L3 wing vein was measured for 200 microns past the anterior cross vein (acv) in at
least 10 individual flies. The measured values were plotted in a box and whisker plot (Figure
4.8). A student’s t-test (p<0.05) was used to compare the area of the L3 wing vein between
Chmp1 knockdown and wild-type flies.
To provide further evidence that the observed phenotype was due to Chmp1 knockdown,
Chmp1 was knocked down in flies heterozygous for loss of the Chmp1 gene. No Chmp1 mutant
currently exists, so two chromosomal deletions, Df(3L)BSC416 and Df(3L)BSC832 that remove
the Chmp1 gene were used (Figures 4.1 and 4.6). MS1096-Gal4; GlaBc/Cy virgin females were
crossed to UAS-Chmp1RNAi-VDRC/Cy males. From the F1 generation, males that were
MS1096-Gal4/Y; Gla/UAS-Chmp1RNAi-VDRC were collected and crossed to virgin females that
were either Df(3L)BSC832/TM6Sb or Df(3L)BSC419/TM6Sb. From this cross, flies that were
female, not Gla, and not Sb were of the correct genotype (MS1096-Gal4/X; UAS-Chmp1RNAiVDRC/+; Df(3L)BSC832/+ and MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+;
Df(3L)BSC419/+).
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Figure 4.6 Cross design for Chmp1 knockdown in Chmp1 heterozygous background. P is
parental generation, F1 is first filial generation, F2 is second filial generation. Only F1 and F2
progeny of the desired genotypes are shown.
When Chmp1 was knocked down in the wings of flies carrying heterozygous
chromosomal deletions that removed the Chmp1 gene, the Chmp1 knockdown phenotype was
enhanced (Figures 4.7I and J). To quantify the changes in wing vein thickness, the area of the L3
wing vein was measured for 200 microns past the anterior cross vein (acv) in at least 10
individual flies and the values were represented in a box and whisker plot (Figure 4.8). A oneway ANOVA with a post-hoc Dunnett’s t-test (p<0.05) compared the area of the L3 wing vein of
flies with Chmp1 knockdown in a Chmp1 heterozygous background to flies with Chmp1
knockdown alone and showed that they were not significantly different (Figure 4.8). However,
the general enhancement of the Chmp1 knockdown phenotype observed in a Chmp1
heterozygous background supports the finding that the thick vein phenotype is due to loss of
Chmp1.
As reduced Chmp1 activity results in thickened wing veins, it appears that one role of
Chmp1 is to negatively regulate wing vein size. Thickened wing veins are classically associated
with a cell fate change from intervein to vein cell in the wing [14]. So it is important to note that,
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although it appears that Chmp1 knockdown causes wing veins to overgrow, the wing vein
thickening was not due to extra growth, but a change in cell fate. In wild-type wings, veins are
only a few cells in width. However, when Chmp1 was knocked down, cells that would normally
border the wing vein as intervein cells adopted a vein fate instead, causing a thickened wing vein
in the adult. This caused the number of cells between veins to appear reduced, and was especially
obvious when Chmp1 was knocked down with ptc-Gal4 (Figure 4.7H). So, as Chmp1
knockdown results in thickened wing veins, Chmp1 appears to be a negative regulator of wing
vein differentiation, favoring an intervein cell fate over a vein fate.
Driving Chmp1 knockdown on the dorsal wing with MS1096-Gal4 produced an upward
curving of the wing at the margin, resulting in a concave wing. This phenotype was likely caused
by a reduction in the area of the dorsal wing surface, perhaps due to smaller cell size. During
wing development, each wing cell produces one hair. This means that hair density on the wing
surface gives an indication of the apical surface size of wing cells [116, 117]. When Chmp1
knockdown was driven by MS1096-Gal4 or en-Gal4, intervein regions had increased wing hair
density, suggesting a smaller cell size than wild-type cells (compare Figure 4.7K with 4.7L).
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Figure 4.7 Chmp1 knockdown results in thickened wing veins. Light micrographs of adult
female wings raised at 28oC. The L3 or L4 wing vein is indicated, distal is right, anterior is
uppermost. A. Oregon R. B, D, F, and H. Chmp1 knockdown in the wing with the TRiP line
caused thickened wing veins. B. MS1096-Gal4/X; UAS-Chmp1RNAi-TRiP/+. D. salm-Gal4/+;
UAS-Chmp1RNAi-TRiP/+. F. en-Gal4/+; UAS-Chmp1RNAi-TRiP/+. H. ptc-Gal4/+; UASChmp1RNAi-TRiP/+. C, E, and G. Chmp1 knockdown using the VDRC line causes thick
veins. C. MS1096-Gal4/X; UAS-Chmp1RNAi-TRiP/+. E. en-Gal4/UAS-Chmp1RNAi-VDRC. G.
en-Gal4/UAS-Chmp1RNAi-VDRC. I and J. Heterozygosity for two chromosomal deletions
(Figure 4.1) containing the gene encoding Chmp1 enhances the Chmp1 knockdown phenotype.
I. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; Df(3L)BSC832/+. J. MS1096-Gal4/X; UASChmp1RNAi-VDRC/+; Df(3L)BSC416/+. K. Wing hairs are spaced evenly in MS1096-Gal4
wings. L. Chmp1 knockdown results in a higher density of wing hairs. Region shown is
posterior to the L5 wing vein. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC. Images A-J taken at
the same magnification. Images K and L taken at the same magnification.

Figure 4.8 Chmp1 knockdown in wings heterozygous for the Chmp1 gene: wing vein
measurements. A box and whisker plot depicting the area of the measured L3 wing vein in
square microns. The upper and lower brackets represent the maximum and minimum
measurements, respectively. Heterozygosity for the Chmp1 gene enhances the Chmp1
knockdown phenotype, though not statistically significantly. All genotypes shown had wing
veins that were significantly thicker than wild-type. Statistical differences were determined by a
one-way ANOVA with post-hoc Dunnett’s, p<0.05.
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To further evaluate Chmp1 function in Drosophila, two transgenic fly lines were
generated that allowed for over-expression of either the wild-type Chmp1 protein or an Nterminal His-Myc (HM) tagged Chmp1 [118]. Two vectors, pUAST and pUASHM were used to
generate these fly lines (see Chapter 3 Section I for method). The vectors contained a white+
marker and a multiple cloning site downstream of a UAS enhancer, all flanked by p-element
ends that mediated insertion into the genome of the fly. The Chmp1 cDNA was inserted into the
multiple cloning site of each vector. The pUASHM vector added an HM tag to Chmp1. The
pUAST and pUASHM vectors containing the Chmp1 cDNA were sent to BestGene Inc., where
the transgenic flies (UAS-Chmp1 and UAS-HM-Chmp1, respectively) were generated.
Transgenic flies were crossed to a fly stock containing multiple balancer chromosomes to
determine the chromosomal location of each insertion, and to generate a balanced stock. Twenty
independent lines were generated that carried a random insertions of one of the constructs within
their genome, usually on the second and/or third chromosomes. Transgenes in different
chromosomal locations may show different levels of expression, so having a selection of
different insertions is useful. Also, having insertions on different chromosomes provides more
flexibility when generating specific genetic combinations.
As the insertions were marked with white+, dark red eyes in transgenic fly lines usually
indicate that the insertion can be expressed at higher levels than flies with lighter orange or
yellow eyes. Varying eye colors were likely due to the site of insertion, i.e., if the insertion was
located within a highly expressed portion of the fly genome, then a darker eye resulted. On the
other hand, if the insertion was located within a portion of the genome that is not highly
expressed, a lighter eye resulted. Dark red eyes can also indicate the presence of multiple
insertions. So of the twenty fly lines received, those with the darkest eyes were chosen first for
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balancing in an attempt to select for highly expressing lines. When balancing the fly lines, the
chromosome carrying the insertion was determined through crossing to a fly stock carrying
multiple balancers and dominant markers. All insertions were on either the second or the third
chromosome, and only fly lines with a single insertion chromosome were used in the study.
If the Chmp1 transgenes can produce functional Chmp1 protein, then they should rescue
the Chmp1 knockdown phenotype. To test this, UAS-Chmp1 or UAS-HM-Chmp1, UASChmp1RNAi, and a driver had to be present in the same fly. Different crosses were required for
lines carrying UAS-Chmp1 or UAS-HM-Chmp1 on the second chromosome (UAS-Chmp1-1 and 2, UAS-HM-Chmp1-3) or the third chromosome (UAS-HM-Chmp1-1, -2, and -4) (Figure 4.9A
and B). For lines carrying UAS-Chmp1 or UAS-HM-Chmp1 on the second chromosome (Figure
4.9A), UAS-Chmp1 or UAS-HM-Chmp1/Cy; D1/TM3Ser virgin females were crossed to If/Cy;
UAS-Chmp1RNAi-TRiP/TM3Sb males. From the progeny of that cross, Cy, D1 males (UASChmp1 or UAS-HM-Chmp1/Cy; UAS-Chmp1RNAi-TRiP/ D1) were collected and crossed to
MS1096-Gal4 virgin females. From this cross, females that were not Cy and not D1 were of the
correct genotype (MS1096-Gal4/X; UAS-Chmp1 or UAS-HM-Chmp1/+; UAS-Chmp1RNAiTRiP/+). For lines carrying UAS-Chmp1 or UAS-HM-Chmp1 on the third chromosome (Figure
4.9B), If/Cy; UAS-HM-Chmp1/TM6Sb or TM3Ser virgin females were crossed to UASChmp1RNAi-VDRC/Cy; D1/TM3Ser males. From the progeny, Cy, D1 males (UAS-Chmp1RNAiVDRC/Cy; UAS-HM-Chmp1/ D1) were collected and crossed to MS1096-Gal4 virgin females.
From this cross, females that were not Cy and not D1 were of the correct genotype (MS1096Gal4/X; UAS-Chmp1RNAi-VDRC/+; UAS-HM-Chmp1/+). Wings were dissected and mounted
in GMM on a microscope slide.
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As a control, a fly line that allows for expression of GFP under Gal4 control, UAS-GFP
was used in place of the Chmp1 over-expression transgene. In this case, the UAS-GFP and UASChmp1RNAi transgenes had to be present in the same fly, along with a driver (Figure 4.9C).
UAS-GFP males were crossed to MS1096-Gal4; GlaBc/Cy virgin females. From the progeny,
males that were Gla and not Cy (MS1096-Gal4/Y; UAS-GFP/Gla) were collected and crossed to
UAS-Chmp1RNAi-VDRC/Cy virgin females. From this cross, females that were not Cy and not
Gla were of the correct genotype (MS1096-Gal4/X; UAS-GFP/UAS-Chmp1RNAi-VDRC).

Figure 4.9 Cross design for rescue of Chmp1 knockdown with Chmp1 over-expression. A.
Cross design for lines in which UAS-Chmp1 or UAS-HM-Chmp1 was located on the second
chromosome. B. Cross design for lines in which UAS-Chmp1 or UAS-HM-Chmp1 was located
on the third chromosome. C. Cross design for control cross, using UAS-GFP. P is parental
generation, F1 is first filial generation, F2 is second filial generation. Only F1 and F2 progeny
of the desired genotypes are shown.
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To quantify the changes in wing vein thickness, the area of the L3 wing vein was
measured for 200 microns past the anterior cross vein (acv) in at least 10 individual flies and the
values were represented in a box and whisker plot (Figure 4.11). A one-way ANOVA with a
post-hoc Dunnett’s t-test (p<0.05) compared the area of the L3 wing vein of flies expressing
Chmp1RNAi, concomitant with UAS-Chmp1, UAS-HM-Chmp1, or UAS-GFP to flies expressing
Chmp1RNAi alone (Figure 4.11). Expression of UAS-Chmp1 or UAS-HM-Chmp1 concomitant
with Chmp1RNAi under MS1096-Gal4 control significantly decreased the thick vein phenotype
in all lines tested. In fact, expression of UAS-Chmp1 completely rescued the thick vein
phenotype in over 60% of wings (Figure 4.10E and F, 4.11, and Table 4.1), while partial rescue
was observed in 34% of wings (Figure 4.10E’ and F’, 4.11, and Table 4.1). Only 3% of wings
showed no rescue of the Chmp1 knockdown phenotype by Chmp1 over-expression (Figure
4.10E’’, 4.11, and Table 4.1). Expression of the HM-Chmp1 partially rescued the Chmp1
knockdown phenotype in over 80% of wings analyzed (Figure 4.10A’- 4.10D’, 4.11, and Table
4.1), while full rescue was observed in about 13% of wings (Figure 4.10A - 4.10D, 4.11, and
Table 4.1), and no rescue in 5% of wings (Figure 4.10A’’- 4.10B’’, 4.11, and Table 4.1). The
rescue observed in these experiments was not simply the result of reduced Gal4 binding to the
Chmp1RNAi promoter due to the presence of a second UAS promoter, as wings with overexpression of a gratuitous protein (UAS-GFP) concomitant with Chmp1RNAi were not
significantly different from wings with Chmp1 knockdown alone. Additionally, expression of
UAS-GFP concomitant with Chmp1RNAi never fully rescued the wing vein phenotype and only
provided partial rescue in approximately 30% of wings (Table 4.1, Figure 4.11).
These results suggest that the Chmp1 over-expression transgenes can produce a
functional Chmp1 protein. The low frequency of failure to rescue might be explained by the
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activity of Chmp1 RNAi, which inevitably targets both Chmp1 mRNA from both the endogenous
Chmp1 gene and the Chmp1 over-expression transgenes. The ability of wild-type Chmp1 to
provide better rescue than HM-Chmp1 suggests that HM-Chmp1 may be less active or less stable
than the wild-type Chmp1. This could be due to the epitope tag that either caused HM-Chmp1 to
be degraded more quickly than the wild-type Chmp1, or inhibited some of the function of
Chmp1. It could also be due to the insertion site of the transgenes; perhaps by chance the HMChmp1 transgenes tested were in regions of chromatin that are less accessible to transcription
compared to the wild-type Chmp1 transgenes. The finding that over-expressed Chmp1 can rescue
the thick vein phenotype further supports the conclusion that this phenotype results specifically
from Chmp1 knockdown, rather than off-target effects. It also supports the proposal that Chmp1
negatively regulates wing vein differentiation and promotes intervein cell fate. Additionally, it
confirms that the Chmp1 over-expression lines are functional and may be used for further
studies.

68

69

Figure 4.10 Chmp1 over-expression rescues the Chmp1 knockdown phenotype. Light
micrographs of adult female wings raised at 28oC. L3 vein is indicated, distal is right, anterior
is uppermost. A-F. Complete rescue of Chmp1 knockdown with Chmp1 over-expression. Area
of L3 wing vein less than 3400µm2. A’-F’. Partial rescue of the Chmp1 knockdown phenotype
with Chmp1 over-expression. Area of L3 wing vein between 3400 and 5200µm2. A’’-E’’. No
rescue of the Chmp1 knockdown phenotype with Chmp1 over-expression. Area of L3 wing
vein larger than 5200µm2. A-A’’. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; UAS-HMChmp1-1/+. B-B’’. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; UAS-HM-Chmp1-2/+. C-C’.
MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/UAS-HM-Chmp1-3. All wings of this genotype
displayed at least partial rescue. D-D’. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; UASHM-Chmp1-4/+. All wings of this genotype displayed at least partial rescue. E-E’’. MS1096Gal4/X; UAS-Chmp1RNAi-VDRC/UAS-Chmp-1. F-F’. MS1096-Gal4/X; UAS-Chmp1RNAiVDRC/UAS-HM-Chmp1-2. All wings of this genotype displayed at least partial rescue.

Table 4.1 Chmp1 over-expression can rescue the Chmp1 knockdown phenotype.
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Figure 4.11 Chmp1 over-expression rescues Chmp1 knockdown: wing vein measurements.
A box and whisker plot depicting the area of the measured L3 wing vein in square microns. The
upper and lower brackets represent the maximum and minimum measurements, respectively.
All genotypes shown had wing veins that were significantly thicker than wild-type. Asterisks
mark genotypes with wing veins that were significantly thinner than Chmp1 knockdown.
Significant differences were determined by a one-way ANOVA with post-hoc Dunnett’s,
p<0.05.
III.

Chmp1 interacts with regulators of DER signaling
Studies suggest that ESCRT machinery negatively regulates EGFR signaling. For

example, in mammalian cells over-expression of the ESCRT-0 component hepatocyte growth
factor receptor substrate (Hrs) or loss of the ESCRT-I component Tsg101 [58, 119] caused
impaired EGFR degradation. Additionally, losing activity of Hrs in Drosophila impaired
degradation of the DER, causing enhanced EGFR signaling indicated by increased phospho-ERK
[59, 120]. In Drosophila, the DER signaling pathway promotes the development of wing veins.
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When the activity of two positive regulators of DER, Rhomboid (Rho) and Vein (Vn), is lost (a
rhove-1, vn1 homozygous mutant wing), veins are lost as well (Figure 4.13C). On the other hand,
enhanced DER signaling, e.g., by over-expression of rho, causes thickened and extra wing veins
[36]. So the thick wing veins observed with Chmp1 knockdown might have been caused by overactive DER signaling, due to a failure of ESCRT machinery to down-regulate the DER. If
Chmp1 negative regulates the DER signal, then reducing DER signaling in a Chmp1 knockdown
wing should suppress the thick vein phenotype. On the other hand, increasing DER signaling
should enhance the Chmp1 knockdown phenotype.
To test this, Chmp1 was knocked down in wings heterozygous for loss of function alleles
of either positive or negative regulators of DER signaling. To achieve this, the Chmp1 RNAi
transgene, a driver, and one loss of function allele for regulators of the DER had to be present in
the same fly (Figure 4.12). Positive regulators of the DER tested were Rho and Vn, and negative
regulators tested were Kekkon-1 (Kek1), Sprouty (Sty) or Argos (Aos). MS1096-Gal4; Cy/Sco
virgin females were crossed to UAS-Chmp1RNAi-VDRC/Cy males. From this cross, Sco males
(MS1096-Gal4/Y; UAS-Chmp1RNAi-VDRC/Sco) were crossed to virgin females carrying loss of
function alleles for regulators of DER signaling that were either homozygous viable or balanced
with TM3Sb. From the progeny, females that were not Sco and not Sb were of the desired
genotype. Wings were dissected off and mounted in GMM on a microscope slide.
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Figure 4.12 Cross design testing for interaction between Chmp1 and DER regulators. All
loss of function alleles for regulators of DER signaling used were on the third chromosome, as
was the aos over-expression transgene (UAS-aos). The loss of function alleles used were rhove1
, vn1, kek1, styΔ5, aosΔ7, aosrlt, and aosw11. styΔ5, aosΔ7, and aosw11 were balanced with TM3Sb,
the others alleles and UAS-aos were homozygous. P is parental generation, F1 is first filial
generation, F2 is second filial generation. Only F1 and F2 progeny of the desired genotypes are
shown
To quantify the changes in wing vein thickness, the area of the L3 wing vein was
measured for 200 microns past the anterior cross vein (acv) in at least 10 individual flies and the
values were represented in a box and whisker plot (Figure 4.14). A one-way ANOVA with a
post-hoc Dunnett’s t-test (p<0.05) compared the area of the L3 wing vein of flies expressing
Chmp1RNAi in backgrounds heterozygous for mutations in DER regulators to flies expressing
Chmp1RNAi alone (Figure 4.11).
In Chmp1 knockdown wings that were also heterozygous for loss of function alleles of
two positive regulators of the DER pathway, rhove-1 and vn1 (MS1096-Gal4/X; UASChmp1RNAi-VDRC/+; rhove-1, vn1/+), the wing vein phenotype was partially suppressed (Figure
4.13D). This genetic interaction was a first indication that Chmp1 may regulate DER signaling in
the Drosophila wing. Wings that were just heterozygous for rhove-1 vn1 appeared wild-type,
which means that the suppression of the vein thickening phenotype was not simply an additive
effect. No suppression was observed when Chmp1 was knocked down in rhove-1 heterozygous
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wings, although partial suppression was observed in vn1 heterozygous wings (Figure 4.13E and
F). This suggests that the suppression observed in rhove-1, vn1 heterozygous wings was due to loss
of vn, rather than loss of rho. An interaction with Vn rather than Rho, is interesting, especially as
these two proteins are reported to have a synergistic role in the wing [121, 122]. This result could
be due to the relatively strong ability of Rho to activate the DER, while Vn is considered a
relatively weak activator. Thus, a single copy of the rho gene might still enhance DER signaling
significantly, but a single copy of the vn gene may provide little activity.
Reduced activity of positive regulators of the DER pathway suppressed the Chmp1
knockdown phenotype in the wing, suggesting that Chmp1 negatively regulates DER signaling.
If Chmp1 negatively regulates the DER signal, then reduced activity of negative regulators of
DER signaling should enhance the Chmp1 knockdown phenotype. When Chmp1 was knocked
down in wings heterozygous for loss of function alleles for negative regulators of DER signaling,
Kek-1 (MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; kek1DG23812/+), Sty (MS1096-Gal4/X;
UAS-Chmp1RNAi-VDRC/+; styΔ5/+), Aos (MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+;
aosΔ7/+, MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; aosr/t/+, and MS1096-Gal4/X; UASChmp1RNAi-VDRC/+; aosw11/+), wing veins were thicker than those observed with Chmp1
knockdown alone (Figure 4.13F-J). However, wings that were heterozygous for just kek1DG23812,
styΔ5, aosr/t, aosw11, or aosΔ7 appeared wild-type, suggesting that the enhancement of the vein
phenotype is not simply an additive effect. The opposite effects of the loss of positive and
negative DER regulators on the Chmp1 knockdown phenotype are consistent with a role for
Chmp1 in negative regulation of the DER signaling pathway.
Argos negatively regulates DER signaling by binding to and suppressing the function of
Spitz and Keren, which are DER activating ligands. Over-expression of aos with MS1096-Gal4

74

causes loss of portions of the dorsal wing veins. Interestingly, when MS1096-Gal4 drove both
Chmp1 RNAi and aos over-expression, the portions of the wing vein normally lost with aos
over-expression are absent, but the remaining veins are thickened (Figure 4.13L). The inability
of Chmp1 knockdown to restore wing vein differentiation suggests that loss of Chmp1 cannot
restore the DER signaling lost when aos is over-expressed. This is consistent with a role for
Chmp1 downstream of Aos.
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Figure 4.13 Chmp1 interacts with regulators of DER signaling in Drosophila. Light
micrographs of adult female wings raised at 28oC. Distal is right, anterior is uppermost. A.
Oregon R. B. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+. Chmp1 knockdown caused thick
wing veins. C. rhove-1, vn1. Wings homozygous for loss of function alleles of positive regulators
of DER signaling, rhove-1, vn1 have lost most wing veins. D. MS1096-Gal4/X; UASChmp1RNAi-VDRC/+; rhove-1, vn1/+. A heterozygous rhove-1, vn1 background partially
suppressed the Chmp1 knockdown phenotype. E. MS1096-Gal4/X; UAS-Chmp1RNAiVDRC/+; rhove-1/+. Heterozygous rhove-1did not suppress the Chmp1 knockdown. F. MS1096Gal4/X; UAS-Chmp1RNAi-VDRC/+; vn1/+. Heterozygous vn1 suppressed the Chmp1
knockdown phenotype. G-K. Wings heterozygous for loss of function alleles for negative
regulators of DER enhanced the Chmp1 knockdown phenotype. G. MS1096-Gal4/X; UASChmp1RNAi-VDRC/+; kek1DG23812/+. H. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; styΔ5/+.
I. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; aosΔ7/+. J. MS1096-Gal4/X; UASChmp1RNAi-VDRC/+; aosrlt. K. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; aosw11. L.
MS1096-Gal4/UAS-aos; UAS-Chmp1RNAi-VDRC/UAS-aos. Wing veins that are not lost
through over-expressing aos are thickened due to Chmp1 knockdown. The wings shown for
each genotype are representative of the means of all the wings analyzed. For quantification see
Figure 4.9.
When the mean of L3 wing vein area of each genotype was plotted in a box and whisker
plot, it became apparent that wild-type wings and Chmp1 knockdown wings had a narrower
range of wing vein areas than Chmp1 knockdown wings that were heterozygous for loss of
function alleles of DER signaling regulators (Figure 4.14). As Chmp1 knockdown driven with
Gal4 is sensitive to temperature, this could reflect an increased sensitivity of the Chmp1
knockdown phenotype to changes in ambient temperature in different genetic backgrounds.
However, though Chmp1 did not genetically interact with Rho, the mean for the other Chmp1DER regulator interaction genotypes was consistent with the proposal that Chmp1 negatively
regulates DER signaling. First, loss of function alleles for all the negative regulators of DER
signaling tested increased the wing vein area in Chmp1 knockdown wings. Three different
negative regulators of DER signaling were investigated, each with a different mechanism of
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action on DER signaling. Second, positive and negative regulators of DER had opposite effects
on the thickened wing veins caused by Chmp1 knockdown.

Figure 4.14 Wing vein measurements for Chmp1 knockdown flies with altered DER
signaling. A box and whisker plot depicting the area of the measured L3 wing vein in square
microns. The upper and lower brackets represent the maximum and minimum measurements,
respectively. Heterozygosity for loss of Vn activity, a positive regulator of DER signaling,
partially suppressed the Chmp1 knockdown phenotype. Heterozygosity for loss of activity of
Sty, Kek, or Aos, negative regulators of DER signaling, show an enhanced Chmp1 knockdown
phenotype. All genotypes shown had significantly thicker wing veins than wild-type. Asterisks
represent a statistically significant difference from Chmp1 knockdown. Significant differences
were determined by a one-way ANOVA with post-hoc Dunnett’s, p<0.05.
IV.

Chmp1 negatively regulates DER signaling
The results presented in the previous section suggest that Chmp1 negatively regulates

DER signaling, as reduced activity of positive and negative regulators of DER signaling had
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opposite effects on the thick wing vein phenotype caused by Chmp1 knockdown. If Chmp1
regulates DER signaling, then the expression of genes regulated by the DER signaling pathway
should be altered under Chmp1 knockdown conditions. Blistered (Bs, also called Drosophila
Serum Response Factor [DSRF]) is a transcription factor whose expression is negatively
regulated by DER signaling. So if Chmp1 knockdown causes an over-active DER signaling
pathway, Bs expression should decrease in Chmp1 knockdown cells. To test this, Chmp1 was
knocked down in third instar wing discs under the control of en-Gal4 (Figure 4.15). UASChmp1RNAi-TRiP homozygous males were crossed to en-Gal4, UAS-GFP homozygous virgin
females and progeny were grown at 30oC. Crawling third instar larvae wing discs were dissected,
immunostained for Bs, and imaged on a confocal microscope. en-Gal4 drove Chmp1 knockdown
in the posterior of the wing disc (marked by GFP fluorescence from UAS-GFP), so that Bs
staining intensity could be compared between the anterior and posterior of the disc.
Unexpectedly, there was no striking difference in the intensity of fluorescence between the
halves of the disc.

Figure 4.15 Cross design for Chmp1 knockdown marked with GFP in the posterior wing
disc. P is parental generation, F1 is first filial generation, F2 is second filial generation.
As an alternative approach, clones of Chmp1 knockdown marked by GFP expression
were generated in the wing disc. To achieve this, hs-flp; UAS-Chmp1RNAi-TRiP virgin females
were crossed to FRT-Gal4; UAS-GFP males (Figure 4.16). The progeny were developed at 25oC,
heat shocked at 37oC for 1 hour between 48-72 hours into development to induce Chmp1
79

knockdown clones (see Chapter 1, Section II.E.). To induce maximal Chmp1 knockdown in
clones, larvae were grown for the remaining developmental time at 30oC, as the UAS-Gal4
system is more active at higher temperatures. Female crawling third instar larvae (hs-flp/FRTGal4; UAS-GFP/+; UAS-Chmp1RNAi-TRiP/+) were of the correct genotype and so were
selected, and wing discs were dissected and immunostained for Bs.

Figure 4.16 Cross design for generating Chmp1 knockdown clones marked with GFP in
wing discs. Developing flies of the F1 generation were heat shocked for 1 hour between 48-72
hours of development. All F1 females were of the correct genotype. P is parental generation, F1
is first filial generation. Only the desired F1 progeny is shown.
Some flies from this cross were allowed to develop to the adult stage to ensure that clones
were being generated. The GFP marker was not visible in adult wings, but areas of thickened
wing veins were present, suggesting that clones of Chmp1 knockdown were being generated
(Figure 4.17D and E). Bs is normally expressed in the intervein regions of the wing disc and
repressed in provein regions (Figure 4.17A and A’). Large clones (>120 cells) of Chmp1
knockdown that spanned vein and intervein regions reduced Bs expression within the clone
(Figures 4.17B, B’ and C, C’). However, smaller clones of Chmp1 knockdown did not have an
observable effect on Bs expression even though similar sized clones could induce vein formation
(shown below, Figure 4.19C). This was possibly because Bs levels were observed in imaginal
disc clones, but the final fate decision between vein and intervein cell does not occur until well
into the pupal stage, by which time Bs levels may be altered [15, 21]. Therefore, it is possible
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that it takes more time to see an effect of Chmp1 knockdown on Bs expression than had elapsed
since the induction of these small imaginal disc clones. Alternatively, Chmp1 protein may
perdure through clone formation, so it may still be present in small clones even though the
Chmp1 mRNA levels are reduced.
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Figure 4.17 Chmp1 knockdown reduced Bs staining in imaginal discs. A-C’. Confocal
images showing clones of Chmp1 knockdown marked with GFP (green) in the third instar wing
disc from larvae raised at 30oC. All wings shown were of the genotype hs-flp/FRT-Gal4; UASChmp1RNAi-TRiP/+; UAS-GFP/+. Discs were immunostained for Blistered (Bs). Scale bar is
20μm. A. Bs (red) is expressed in the intervein regions of the wing disc and is repressed in the
provein territories. Longitudinal proveins, L3, L4, and L5, and wing margin are labeled. A’.
The same disc as A, but thresholded. B and C. Large clones (>120 cells) of Chmp1 knockdown
marked by GFP expression (green). B’ and C’. Same clones as B and C respectively, but
thresholded with the GFP fluorescence removed and clones outlined in green. D and E. Light
micrographs of adult female wings showing clones of Chmp1 knockdown indicated by regions
of wing vein thickening. Distal is right, anterior is uppermost.
To investigate the effect of Chmp1 knockdown in the wing further, clones of both Chmp1
and forked knockdown were generated in the adult wing. forked knockdown caused a wing hair
phenotype in the clones, giving a way to distinguish the clone cells from the rest of the wing
cells. To achieve this, FRT-Gal4/FM6B1; Cy/UAS-forkedRNAi virgin females were crossed to
hs-flp/Y; UAS-Chmp1RNAi-VDRC/Cy males (Figure 4.18). The progeny were allowed to grow
for 120-144 hours at 25oC, and then heat shocked for 1 hour at 37oC, and grown at 28oC for the
remaining development. Adult females that were not Cy and not B1 were of the correct genotype
(FRT-Gal4/hs-flp; UAS-forkedRNAi/UAS-Chmp1RNAi-VDRC).

Figure 4.18 Cross design for Chmp1 and forked knockdown clones in the adult wing. The
developing F1 generation was heat shocked for 1 hour at 37oC 120-144 hours into
development. Adult F1 females that were not Cy and not B1 were of the correct genotype and
are the only F1 progeny shown. P is parental generation, F1 is first filial generation.
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Clones of Chmp1 knockdown in adult wings that overlapped veins caused a cell fate
change from intervein to vein, resulting in widening of the wing vein (Figure 4.19B). In these
clones, only cells adjacent to the wing vein were converted to vein cells (i.e., the number of cells
making up the thickness of the wing vein increased), even when the clone extended well into
intervein tissue. The cell fate change was also restricted to clone cells, implying that the effect of
Chmp1 knockdown is cell autonomous. Most of the Chmp1 knockdown clones had smooth
edges, in contrast to the usual irregular edges observed in clonal analyses. Smooth edges were
also characteristic of bs- clones, which is compatible with the finding that Bs expression was
reduced in Chmp1 knockdown clones [123]. Interestingly, some of the Chmp1 knockdown
clones that were located entirely within intervein tissue did not induce vein cell differentiation
(Figure 4.19A), while other intervein clones did (Figure 4.19C). Therefore, it seems that the
effect of Chmp1 on wing vein differentiation is spatially dependent, suggesting that Chmp1 does
not directly determine whether a cell differentiates into a vein or intervein cell. Rather, Chmp1
knockdown altered the balance of signaling within these cells and pushed towards adopting a
vein fate, rather than an intervein fate. In fact, clones of Chmp1 knockdown typically caused
intervein to vein cell fate changes in regions adjacent to normal veins, where the DER pathway
should be most active. These results are consistent with a role for Chmp1 in negatively
regulating the DER signaling pathway.
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Figure 4.19 Clones of Chmp1 and forked knockdown in the adult wing. Light microscope
images of adult female wings. Distal is right, anterior is uppermost A. Chmp1 knockdown clone
located entirely within intervein tissue, posterior to the L5 wing vein showing no vein
differentiation. B. Chmp1 knockdown clone that overlapped the L3 wing vein caused wing vein
thickening. C. Chmp1 knockdown clone located within intervein tissue induced wing vein
formation.

V.

Over-expression of Chmp1
Transgenic lines were created to investigate the effects of Chmp1 over-expression in the

fly. If Chmp1 knockdown caused thick wing veins due to over-active DER signaling, then overexpression may cause narrowing or loss of wing veins due to inhibited DER signaling. Chmp1
knockdown and over-expression had opposite effects on growth in the mammalian cell culture
studies, so the same antagonistic effects might be expected in Drosophila.
To investigate the effect of Chmp1 over-expression, Chmp1 was over-expressed in the
dorsal wing using MS1096-Gal4. Males carrying UAS-Chmp1 and UAS-HM-Chmp1 balanced
with Cy, TM3Ser, or TM6SbTb were crossed to MS1096-Gal4 virgin females and progeny were
grown at 25oC, 28oC, or 30oC (Figure 4.20A and B). Adult female and male flies that were not
Cy, Ser, or Sb were of the correct genotype (MS1096-Gal4/+; UAS-Chmp1 or UAS-HMChmp1/+), and their wings were mounted on a microscope slide in GMM.
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Figure 4.20 Cross design for achieving Chmp1 over-expression in the Drosophila wing. A.
Cross for over-expressing wild-type or HM-tagged Chmp1 protein from a second chromosome
insertion with MS1096-Gal4. B. Cross for over-expressing HM-tagged Chmp1 protein from a
third chromosome insertion with MS1096-Gal4. C. Cross for over-expressing wild-type or HMtagged Chmp1 protein from a second chromosome insertion with salm-Gal4 or en-Gal4. D.
Cross for over-expressing wild-type or HM-tagged Chmp1 protein from a third chromosome
insertion with salm-Gal4 or en-Gal4. UAS-Chmp1-1 and -2, and UAS-HM-Chmp1-3 insertions
are on the second chromosome and balanced with Cy. UAS-HM-Chmp1-2 and -4 insertions are
on the third chromosome balanced with TM3Ser. The UAS-HM-Chmp1-1 insertion is on the
third chromosome and balanced with TM6SbTb. P is parental generation, F1 is first filial
generation. Only F1 progeny of the desired genotype are shown.
Chmp1 over-expression in the dorsal wing most commonly resulted in deltas, or
widening of the distal tips of the dorsal wing veins (Figure 4.21A-F). Additionally, some wings
showed ectopic wing vein formation (Figure 4.21A, C and D, white arrows). The overexpression phenotype only increased slightly in penetrance and severity with the increasing
culture temperature, which is expected to increase the activity of the UAS-Gal4 system. These
over-expression phenotypes were mainly observed in male wings, while most female wings
appeared wild-type. The MS1096-Gal4 transgene is located on the X chromosome and normally
shows higher activity in males than females. Additionally, the MS1096-Gal4 transgene is
inserted near the beadex gene and can increase beadex expression [2]. Beadex negatively
regulates expression of Apterous, which in turn negatively regulates Serrate and Fringe, both of
which are activating ligands of the Notch receptor [124-126]. Therefore, MS1096-Gal4
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occasionally interacts with certain genetic backgrounds to cause a phenotype in the wing,
including the formation of deltas. So, it was possible the delta formation observed was an
artifact. In fact, this idea is supported by the observation that there is little increase in phenotype
with temperature.
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Figure 4.21 Chmp1 over-expression with MS1096-Gal4 in the Drosophila wing causes vein
deltas. Light micrographs of wings from adult males at 25, 28, and 30oC. Distal is right,
anterior is uppermost. A-D. Over-expression of HM-Chmp1 under the control of MS1096-Gal4
causes wing vein deltas that do not become more prominent with increasing cultivation
temperature (i.e., increasing levels of Chmp1 expression). Ectopic vein formation indicated by
white arrows. E and F. Over-expression of wild-type Chmp1 under the control of MS1096Gal4 also causes wing vein deltas that do not become more prominent with increasing
temperature.
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To test whether the deltas observed were a genuine result of Chmp1 over-expression
rather than an artifact of an interaction with MS1096-Gal4, Chmp1 was over-expressed in the
wing with two other drivers, salm-Gal4 and en-Gal4 (see Figure 4.4 for expression pattern).
UAS-Chmp1 or UAS-HM-Chmp1 males were crossed to salm-Gal4 and en-Gal4 females and the
progeny were grown at 25oC, 28oC, and 30oC (Figure 4.20). Male and female flies that were not
Cy, Ser, or Sb were of the correct genotype.
When Chmp1 was over-expressed with these different drivers, there were no deltas
formed at 25oC or 28oC. However, at 30oC occasional deltas were observed, though the effect
was much weaker than with MS1096-Gal4, and they were only present in a small number of
wings (Figure 4.22). This may suggest that the delta phenotype observed was caused by Chmp1
over-expression and was not due to a genetic interaction with the MS1096-Gal4 driver, though it
was enhanced by the presence of the MS1096-Gal4 insert. The levels of over-expression of
Chmp1 were not tested as there is no antibody against Drosophila Chmp1. However, the
detection of HM-Chmp1 in Drosophila tissues (shown in Chapter 4, Section IX) and the ability
of Chmp1 over-expression to rescue the Chmp1 knockdown wing vein phenotype suggest that
functional Chmp1 protein is expressed from these transgenes. So the minor wing defects
observed under presumably strong Chmp1 over-expression suggest that the development of this
tissue is not especially sensitive to increased levels of Chmp1 protein.
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Figure 4.22 Chmp1 over-expression in the Drosophila wing causes deltas. Light
micrographs of wings from adult females at 30oC. Distal is right, anterior is uppermost. A and
A’. en-Gal4/+; UAS-HM-Chmp1-1/+. A’ is an enlarged from A. Over-expression of HMChmp1 caused loss of anterior cross vein (indicated in upper right box) and wing vein deltas. B
and B’. en-Gal4/UAS-Chmp1-2. B’ is enlarged from B. Chmp1 over-expression caused
occasional wing vein deltas.
In addition to the phenotypes discussed above, a second phenotype was observed
occasionally in Chmp1 over-expression wings. Although it was only present in flies overexpressing wild-type Chmp1 protein, this phenotype was observed with both the MS1096-Gal4
and en-Gal4 drivers. In addition to vein defects (Figure 4.23B), wings from these flies also had
disorganized hairs (discussed in Chapter 6). Often, the veins on these wings had ill-defined
borders compared to wild-type (Figure 4.23). In some cases the wing vein appeared thickened
(compare the L3 veins in Figure 4.23B and A), and in other cases small portions of wing veins
were missing (Figure 4.23A). Some wings also had opaque regions, indicating a failure of
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imaginal disc cells to clear out of the wing at maturation, as well as wing vein deltas (Figure
4.23B). The same phenotype appeared in both male and female flies and at all temperatures,
though it was strongest at 30oC.

Figure 4.23 Rare phenotypes caused by Chmp1 over-expression in the Drosophila wing.
Light micrographs of wings from adult male cultivated at 30oC. Distal is right, anterior is
uppermost. A and B. Over-expression of wild-type Chmp1 causes slightly thicker wing veins,
deltas, disorganized hairs, and failure of clearing of imaginal cells out of the wing. A. enGal4/UAS-Chmp1-2. B. MS1096-Gal4/Y; UAS-Chmp1-2/+.
VI.

Investigation into Chmp1 regulation of Notch-Delta signaling
Reduced activity of Delta, a Notch receptor ligand, causes the formation of ‘deltas,’ or

distal widening of wing veins, in the Drosophila wing. Like the DER signaling pathway, NotchDelta signaling is involved in wing vein development. In fact, the DER and Notch signaling
pathways interact antagonistically during wing vein specification. While the DER pathway
promotes wing vein formation/fate, Notch signaling restricts wing vein formation/fate. So a gain
of DER signaling can cause thickened wing veins, and a loss of Notch signaling can produce the
same phenotype. Signaling through Notch is also important for formation of the wing margin and
bristles; loss of Notch signaling can cause notching, or loss of the wing margin and loss of
bristles (e.g. Figure 4.26A).
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In Drosophila, loss of the ESCRT-II component Vps25 caused an increase in Notch
signaling, suggesting a requirement for ESCRT machinery for negative regulation of NotchDelta signaling [61]. Loss of other Drosophila ESCRT components, including Hrs, Tsg101, and
Vps20, have been shown to cause mis-regulation of Notch signaling in Drosophila as well [59,
61]. Thus, it is possible Chmp1 regulates Notch signaling. Although no classic Notch
phenotypes, such as ectopic wing margin or notching of the wing margin, were observed under
Chmp1 knockdown or over-expression conditions, the widened wing veins and deltas observed
through Chmp1 over-expression may indicate that Chmp1 regulates Notch signaling. A
hypomorphic Notch allele, N55e11, was used to investigate the possibility of Chmp1 regulating
Notch signaling in the wing. Heterozygous N55e1/+ flies lose some Notch receptor function.
Wings from these flies have slightly thicker wing veins, deltas, and show mild notching of the
wing margin in approximately 20% of wings (Figure 4.26A). To test whether Chmp1 regulates
Notch signaling, Chmp1 was knocked down under the control of the MS1096-Gal4 driver in a
heterozygous N55e11 background (Figure 4.24). If Chmp1 negatively regulated Notch signaling,
the concomitant loss of Notch and Chmp1 activity should cause the frequency and/or size of
notches to decrease. On the other hand, if Chmp1 positively regulated Notch signaling, loss of
both Notch and Chmp1 activity should cause the frequency and/or size of notches to increase.
In order to test whether Chmp1 regulates Notch signaling, the Chmp1RNAi transgene, a
driver, and the N55e11 allele had to be combined into the same fly. w; GlaBc/Cy virgin females
were crossed to MS1096-Gal4 males (Figure 4.24A). From the progeny of that cross, Gla
straight winged virgin females were collected (MS1096-Gal4/X; GlaBc/+) and crossed to UASChmp1RNAi-VDRC/Cy males. From the progeny of this cross, Gla (not Cy) males with the
Chmp1 knockdown phenotype (MS1096-Gal4/Y; UAS-Chmp1RNAi-VDRC/GlaBc) were
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collected. These males were crossed to N55e11/FM7Bar virgin females. Progeny from this cross
were grown at 28oC to maintain consistency with previous Chmp1 knockdown crosses. Females
among these progeny that were not Bar and not Gla were of the correct genotype (MS1096Gal4/N55e11; UAS-Chmp1RNAi-VDRC/+). Wings were dissected and mounted onto a glass slide
in GMM. For a negative control cross, N55e11/FM7Bar virgin females were crossed to MS1096Gal4/Y males (Figure 4.24B). These flies carry the same Notch mutation and Gal4 transgene as
the experimental flies, but do not carry the Chmp1-RNAi transgene, and so do not experience
Chmp1 knockdown. The progeny were grown at 28oC to maintain consistency with the
experimental cross. Females from the progeny of this cross that were not Bar were of the correct
genotype (MS1096-Gal4/N55e11) and wings were mounted on a glass slide in GMM.

Figure 4.24 Cross design to test for an interaction between Chmp1 and Notch using the
MS1096-Gal4 driver. A. Achieving Chmp1 knockdown under MS1096-Gal4 control in a
heterozygous N55e11 background. The F3 generation was grown at 28oC. B. Control cross. F1
generation was grown at 28oC. P is parental generation, F1 is first filial generation, F2 is second
filial generation, F3 is third filial generation. Only progeny of interest are shown in each
generation.
When Chmp1 knockdown was driven with MS1096-Gal4 in the N55e11 heterozygous
wing, the notches associated with N55e11 were completely suppressed (Figure 4.26D). Out of 31
wings, none experienced notching. This result suggested that Chmp1 negatively regulated Notch
signaling, and was consistent with expectations based on the established role of the ESCRT
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complexes in negatively regulating signaling pathways. However, notching was completely
suppressed in the control wings (MS1096-Gal4/N55e11) as well, with zero out of 48 wings
showing notching (Figure 4.26B). This suggested that the presence of the MS1096-Gal4
transgene, rather than Chmp1 knockdown, suppressed the wing notches associated with the
N55e11 allele. To test whether the MS1096-Gal4 insertion suppressed wing notching in general,
the ability of MS1096-Gal4 to suppress the wing notching associated with the dominant Serrate
(Ser) mutation was tested. MS1096-Gal4 virgin females were crossed to If/Cy; D1/TM3Ser males
and progeny were grown at 28oC to maintain consistency with previous crosses. Flies from the
offspring that were not D1 and therefore should carry the Ser mutation were analyzed (MS1096Gal4/X or Y; TM3Ser/+). These flies showed a complete suppression of notching, suggesting
that the MS1096-Gal4 insertion indeed suppressed wing notching. Because Serrate is a Notch
ligand, this result suggests that the MS1096-Gal4 insertion increases Notch signaling. This could
occur through increased expression of Beadex, since the MS1096-Gal4 transgene is inserted near
the beadex gene. As Beadex negatively regulates Notch ligands, increased Beadex activity might
cause a decrease in Notch signaling.
Because MS1096-Gal4 was unsuitable for driving Chmp1 knockdown in the N55e11/X
background, the experiment was repeated with a different driver, dpp-Gal4, which is located on
the third chromosome (Figure 4.25A). UAS-Chmp1RNAi-VDRC/Cy; D1/TM3Ser virgin females
were crossed to wgSp1/Cy; dpp-Gal4/TM6Tb males. Larvae that were not Tb were collected, and
Cy and D1 males that emerged from these larvae were of the genotype needed (UASChmp1RNAi-VDRC/Cy; dpp-Gal4/D1). These males were crossed to N55e11/FM7Bar virgin
females and progeny were grown at 28oC to maintain consistency with previous Chmp1
knockdown crosses. From these progeny, wings from females that were not Cy, not D1, and not
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Bar (N55e11/X; UAS-Chmp1RNAi-VDRC/+; dpp-Gal4/+) were dissected and mounted in GMM
on a microscope slide. Several control crosses were completed to verify that any changes
notching frequency observed were in fact due to Chmp1 knockdown (Figure 4.25B-D). The first
control cross generated flies that were N55e11/X to ensure that the FM7Bar balancer did not affect
notching frequency. Oregon R males were crossed to N55e11/FM7Bar virgin females. From the
progeny, wings from females that were not Bar were of the correct genotype (N55e11/X) and were
mounted. In previous experiments, the presence of the MS1096-Gal4 transgene altered the
notching frequency typically observed in N55e11 flies. To ensure this was not the case for the dppGal4 driver, a second control cross was performed that generated flies carrying the N55e11 allele
and the dpp-Gal4. wgSp1/Cy; dpp-Gal4/TM6Tb males were crossed to N55e11/FM7Bar virgin
females. From the progeny, wings from females that were not Tb and not Bar were of the correct
genotype (N55e11/X; dpp-Gal4/+) and were mounted. To test the sensitivity of the N55e11 allele to
genetic background, flies were generated that carried the N55e11 allele, as well as the Chmp1RNAi
transgene. For the third control cross, UAS-Chmp1RNAi-VDRC/Cy males were crossed to
N55e11/FM7Bar virgin females. From the progeny, wings from females that were not Cy and not
Bar were of the correct genotype (N55e11/X; UAS-Chmp1RNAi-VDRC/+) and were mounted.
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Figure 4.25 Cross design to test for an interaction between Chmp1 and Notch using the
dpp-Gal4 driver. A. Experimental cross to achieve Chmp1 knockdown with dpp-Gal4 in a
heterozygous N55e11 background. The F2 generation was raised at 28oC. B-D. Control crosses.
F1 generations were raised at 28oC. P is parental generation, F1 is first filial generation, F2 is
second filial generation. Only genotypes of interest are shown.
When Chmp1 was knocked down under the control of the dpp-Gal4 driver in a N55e11
heterozygous background, both the thickened vein phenotype and the frequency of notches
associated with N55e11 were slightly increased, which would seem to suggest that Chmp1
positively regulates Notch signaling (Table 4.2). Although this was unexpected because other
studies show that ESCRTs negatively regulate Notch signaling [61], it was a possible interaction
and it would fit with the Chmp1 knockdown wing phenotype. It is known that Notch negatively
regulates wing vein thickness. Thus, if Chmp1 positively regulated Notch signaling, then loss of
Chmp1 activity would reduce Notch signaling and cause the thick wing veins associated with
Chmp1 knockdown. However, notching frequency was highly variable depending upon the
genetic background (Table 4.2). For example, in flies that carried the N55e11 allele alone, notching
occurred in about 20% of wings. Flies carrying the N55e11 allele and just the dpp-Gal4 or the
UAS-Chmp1RNAi-VDRC transgene had an increased notching frequency to about 40%. When
the N55e11 allele was balanced with the FM7Bar balancer, the notching frequency increased to
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over 60%. Notching was more frequent at higher temperatures, consistent with the temperature
sensitivity of the N55e11 allele. The variability of the notching phenotype in different genetic
backgrounds makes the data gained from these crosses difficult to interpret.
Knockdown of Chmp1 caused a thickened wing vein when driven with either MS1096Gal4 or dpp-Gal4 (Figure 4.26C and F). A weaker but consistent wing vein phenotype, a slight
thickening in the distal L3 wing vein, was observed when dpp-Gal4 was used to drive Chmp1
knockdown as it drives Gal4 expression relatively weaker than MS1096-Gal4. Similarly, wings
heterozygous for the N55e11 allele had a thicker wing vein (Figure 4.26A and A’). When Chmp1
knockdown was driven with either MS1096-Gal4 or dpp-Gal4 in an N55e11 heterozygous wing,
the wing vein was thicker than observed with Chmp1 knockdown or in an N55e11 heterozygote
(Figure 4.26D and G). This is probably an additive effect, presumably due to a combination of
over-active DER signaling caused by loss of Chmp1 activity and the partial loss of Notch
activity associated with the N55e11 allele.
The results showing the sensitivity of the N55e11 associated wing phenotype to genetic
background are concerning, especially because testing suppression/enhancement of this
phenotype is an established method used for analyzing interactions with the Notch signaling
pathway. For example, the N55e11 allele was used in a similar experiment to provide evidence that
the Drosophila phosphocholine cytidylyltransferase (CCT, the rate-limiting enzyme in
phosphatidylcholine synthesis) positively regulates Notch signaling [127]. This single test was
not the only evidence provided to support the finding. However, the validity of results obtained
with this specific approach is questionable in light of the data presented here.
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Figure 4.26 Variable notching phenotypes associated with various genotypes. Light
micrographs of adult wings raised at 28oC. Distal is right, anterior is uppermost A. N55e11
heterozygous wing with a moderate wing phenotype (notching, deltas, and thick veins). A’.
N55e11 heterozygous wing with a milder wing phenotype (notching, delta, and thick veins). B.
Presence of MS1096-Gal4 in a N55e11 heterozygous wing completely suppressed notching. C
and F. Driving Chmp1 knockdown under the control of MS1096-Gal4 or dpp-Gal4 caused
thick wing veins. D. Driving Chmp1 knockdown under the control of MS1096-Gal4 in a
heterozygous N55e11 background suppressed notching and enhanced the wide veins and delta
phenotypes. E. The presence of dpp-Gal4 in a N55e11 heterozygous wing enhanced notching
frequency. G. Driving Chmp1 knockdown under the control of dpp-Gal4 in a N55e11
heterozygous wing slightly enhanced notching frequency, and enhanced the wide veins
phenotype. Percentage of wings of each genotype showing notching is indicated at the bottom
right of each panel.

Table 4.2 Notching frequencies of individual genotypes. Wings were counted from flies that
were raised at 28oC.
Notch signaling can be activated in a ligand-independent as well as a ligand-dependent
manner. Ligand-independent activation of Notch requires Deltex (Dx), an E3 ubiquitin ligase and
a positive regulator of Notch signaling. Dx promotes Notch monoubiquitination and induces
Notch endocytosis and incorporation onto the late endosomal membrane. At the late endosome,
γ–secretase mediates the cleavage of the intracellular domain (NICD), which propagates the
Notch signal [128, 129]. Dx also suppresses the incorporation of Notch into MVBs. This causes
retention of Notch in the endosomal membrane, increasing the number of Notch molecules
cleaved by γ–secretase and thereby increasing the Notch signal. The cleaved NICD can then
enter the nucleus and activate transcription factors that enhance or suppress expression of target
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genes. In Dx-induced ligand-independent activation of Notch, the location of the Notch receptor
is key; Notch must reach the late endosome to be activated, but must be kept out of the ILVs of
the late endosome/MVB, as this would remove the NICD from the cytoplasm and prevent it
being cleaved thus inhibiting the Notch signal [130]. Since Chmp1 is a component of the ESCRT
machinery, which is involved in MVB formation, it is possible that Chmp1 is involved in the
regulation of ligand-independent Notch signaling. If this is the case, faulty MVB formation
caused by Chmp1 knockdown could prevent the normal degradation/silencing of the Notch
receptor. This would allow more opportunity for Notch receptor cleavage, and could lead to
increased Notch signaling, which would be evident as ectopic wing margin and bristles (i.e.,
margin and bristles extend into the wing blade).
To test for involvement of Chmp1in the ligand-independent activation of Notch, the
hypomorphic carnation mutation car1, and the UAS-dx transgene were used. When dx is overexpressed, the Notch receptor is driven into the endocytic pathway and becomes over-activated.
In the wing, dx over-expression causes ectopic wing margin and bristles due to increased Notch
activation (Figure 4.29B). Carnation (Vps33p homologue) is a component of the homotypic
fusion and vacuole protein sorting (HOPS) protein complex that is involved in trafficking from
the early to the late endosome, and from the late endosome to the lysosome [129, 131, 132].
Mutation of Carnation, such as in the car1 mutant, can block progression of proteins, including
Notch, from the early endosome to the lysosome where Notch would become activated. This
causes loss of the Notch signal and therefore notching of the wing margin. Thus, the car1 allele
was used in combination with dx over-expression as a control to show the phenotypic
consequences of driving Notch into the endocytic pathway, and then blocking its activation (i.e.,
the opposite result of what was expected with Chmp1 knockdown and Dx over-expression). To
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generate the control, car1; dpp-Gal4/TM6Tb males were crossed to UAS-dx17 virgin females and
the progeny that were not Tb (car1/+; dpp-Gal4/UAS-dx17) were collected and wings mounted
(Figure 4.27).

Figure 4.27 Control cross design to show interaction between Car and Deltex. Females
that were not Tb were of the correct genotype. P is parental generation, F1 is first filial
generation. Only the desired genotype in the filial generation is shown.
When dx is over-expressed in a background heterozygous for car1, the ectopic wing
margin phenotype caused by dx over-expression is transformed into a notch phenotype (Figure
4.29C). Presumably, this is due to removal of Notch from the membrane by dx over-expression
in combination with interference of the early endosome/lysosome pathway due to the car1
mutation. This leads to a loss of Notch signaling indicated by wing notching. If loss of Chmp1
disrupts endocytic trafficking and blocks Notch progressing to the lysosome as the car1 mutation
does, then notching should occur when dx is over-expressed concomitantly with Chmp1
knockdown. Another possibility is that loss of Chmp1 stalls MVB formation and increases the
time Notch spends in the limiting membrane of the late endosome, so in this case, an increase in
Notch signaling could be expected, resulting in ectopic margin.
To test for a genetic interaction between Chmp1 and Dx, i.e., ligand-independent Notch
signaling, Chmp1 knockdown and dx over-expression were driven in the same wing under the
control of the dpp-Gal4 driver (Figure 4.28). UAS-Chmp1RNAi-VDRC/Cy virgin females were
crossed to Cy/If; D1/TM6Sb males and from the progeny, virgin females that were Cy and Sb, but
not If, were collected (UAS-Chmp1RNAi-VDRC/Cy; TM6Sb/+). In a separate cross, dpp101

Gal4/TM6Tb males were crossed to Cy/If; D1/TM3Ser virgin females, and from the progeny
males that were If and Ser, but not Cy (If/+; dpp-Gal4/TM3Ser) were collected. The UASChmp1RNAi-VDRC/Cy; TM6Sb/+ virgin females were then mated to the If/+; dpp-Gal4/TM3Ser
males, and males that were If and Sb, but not Cy or Ser (UAS-Chmp1RNAi-VDRC/If; dppGal4/TM6Sb) were collected from the progeny. These males were crossed to UAS-Dx17 virgin
females. Progeny from this cross that were not If and not Sb were of the correct genotype (UASChmp1RNAi-VDRC/+; dpp-Gal4/UAS-Dx17).

Figure 4.28 Cross design to test for an interaction between Chmp1 and Deltex. Females
that were not If and not Sb were of the correct genotype. P is parental generation, F1 is first
filial generation, F2 is second filial generation, F3 is third filial generation. Only the desired
genotype from each filial generation is shown.
As shown before, knockdown of Chmp1 with dpp-Gal4 causes thickening of the L3 wing
vein (Figure 4.29A). Interestingly, when Chmp1 was knocked down in a wing over-expressing
dx, the result was ectopic bristles within the wing blade, as well as a loss of marginal bristles,
which could be considered a weak notching phenotype (Figure 4.29D). Additionally, the distal
portion of the L3 wing vein was lost.
These phenotypes are puzzling, because loss of wing vein and ectopic bristles are
normally associated with gain of Notch function, while notching indicates a loss of Notch
function. The loss of the distal wing vein was never observed when dx was over-expressed under
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the control of dpp-Gal4, even though increased Dx activity is known to increase Notch signaling.
In fact, the opposite was observed; dx over-expression generated slightly thicker wing veins.
Likewise, wing vein loss was never observed under Chmp1 knockdown conditions alone. This
suggests that the vein loss is a specific result of loss of Chmp1 activity in combination with gain
of Dx activity. Over-expression of dx drives Notch into the endocytic pathway and prevents its
incorporation into the MVB. If Chmp1 knockdown inhibits normal MVB formation then the
combined effect of dx over-expression and Chmp1 knockdown might cause increased Notch
signaling, which could explain the loss of distal wing vein and the ectopic bristles. However, this
does not account for the minor notches observed, which may suggest that in some wing cells
Notch was blocked from progressing to the late endosome where it would be activated. This
seems unlikely as the literature reports that the role of Chmp1 and other ESCRT components is
not the trafficking of Notch to the late endosome, but rather moving Notch from the limiting
membrane of the late endosome into the ILVs of the MVB. Additionally, it does not seem likely
that the same combination of factors might increase Notch activation in some cells and decrease
it in other cells within the same tissue. The contradictory nature of these observed phenotypes
make the results of this experiment difficult to interpret. However, the phenotypes indicative of
activated Notch signaling, i.e., loss of the L3 wing vein and extra bristles within the wing blade,
were more obvious and consistent than the notching phenotype, which would indicate loss of the
Notch signal.
It is also interesting that over-expression of dx causes a slightly thickened wing vein,
especially considering that dx mutants also have thickened wing veins as well. This may suggest
that driving Notch into the endocytic pathway has different effects in different parts of the wing,
i.e., activating Notch at the wing margin, but inactivating it in the wing veins. An alternative is
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that the effect of a certain dose of Dx is different in different parts of the wing. Possibly, the
same amount of dx over-expression activates Notch at the wing margin, but has a dominantnegative effect in vein tissue that reduces Notch signaling.

Figure 4.29 Interaction between Chmp1 and Deltex. Light micrographs of adult female
wings grown at 25oC. Distal is right, anterior is uppermost. A. Chmp1 knockdown driven with
dpp-Gal4 causes a slightly larger wing vein. B. Driving over-expression of dx with dpp-Gal4
causes slightly wider wing vein, as well as ectopic wing margin. C. Driving dx over-expression
with dpp-Gal4 in a background heterozygous for car1 causes wing notching. D. dx overexpression and Chmp1 knockdown with dpp-Gal4 causes a wider wing vein, ectopic margin,
and a mild notching phenotype (loss of distal marginal bristles).
VII.

Testing for interactions between Chmp1 and regulators of the DER using Chmp1 overexpression lines
Heterozygosity for loss of function alleles of positive or negative regulators of the DER

suppressed and enhanced the Chmp1 knockdown phenotype, respectively. This result suggested
that Chmp1 negatively regulates DER signaling in the Drosophila wing. If Chmp1 overexpression leads to an increase in Chmp1 activity and thus decreased DER signaling, then, for
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example, heterozygosity for loss of function alleles of positive regulators of the DER
concomitant with Chmp1 over-expression might cause thinning or loss of wing veins.
To test for an interaction between Chmp1 and regulators of DER signaling, the en-Gal4
driver, the UAS-Chmp1 or UAS-HM-Chmp1 transgene, and a loss of function allele for either
positive or negative regulators of the DER had to be combined into the same fly (Figure 4.30).
en-Gal4; D1/TM3Sb virgin females were crossed to female virgins carrying loss of function
alleles for the DER regulators Sty (If/Cy;sty5/TM3Sb), Aos (If/Cy;argosw11/TM3Sb), or Rho and
Vn (If/Cy;ve,vn). From this cross, males that were If and D1 (not Sb) were collected (en-Gal4/If;
sty5, argosw11, or ve,vn/D1). These males were crossed to UAS-HM-Chmp1-3 or UAS-Chmp12/Cy virgin females. Wings from females from this cross that were not If, Cy, or D1 were of the
correct genotype (en-Gal4/UAS-HM-Chmp1-3 or UAS-Chmp1-2; rhove-1, vn1/+, en-Gal4/UASHM-Chmp1-3 or UAS-Chmp1-2; styΔ5/+, en-Gal4/UAS-HM-Chmp1-3 or UAS-Chmp1-2;
aosw11/+) and mounted onto a microscope slide in GMM.

Figure 4.30 Cross design using Chmp1 over-expression transgenes to test for an
interaction between Chmp1 and DER regulators. P is parental generation, F1 is first filial
generation, F2 is second filial generation, F3 is third filial generation. Only the desired
genotype from each filial generation is shown.
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Expression of UAS-Chmp1-2 under en-Gal4 control in a background heterozygous for
either aos or rho and vn resulted in similar phenotypes. In both cases, minor deltas were
observed and the posterior wing was smaller, indicated by a slight curving to the posterior of the
wing (Figure 4.31A and B). Additionally, sporadic and small portions of the L4 wing vein were
lost, suggesting that cells adopted an intervein instead of a vein fate (Figure 4.31A and B).
Expression of UAS-HM-Chmp1-3 in a background heterozygous for loss of function alleles for
either aos or rho and vn caused minor but specific phenotypes, including loss of the acv and delta
formation (Figure 4.31C and D). These phenotypes could indicate a loss of DER activity or a
gain of Notch signaling. However, as similar phenotypes were observed when Chmp1 was overexpressed in wings heterozygous for loss of function alleles for both positive and negative
regulators of DER signaling, this effect does not seem specific. This suggests that overexpression of Chmp1 has no significant effect on DER signaling and thus a precise dosage of
Chmp1 is not crucial for normal DER signaling in wing vein development.
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Figure 4.31 Chmp1 over-expression and DER regulators. Light micrographs of adult female
wings grown at 30oC. Distal is right, anterior is uppermost. A. en-Gal4/UAS-Chmp1-2;
aosw11/+. B. en-Gal4/UAS-Chmp1-2; rhove-1,vn1/+. C. en-Gal4/UAS-HM-Chmp1-3; aosw11/+.
D. en-Gal4/UAS-HM-Chmp1-3; rhove-1,vn1/+. Yellow arrows indicate loss of the anterior cross
vein (acv).
VIII.

Chmp1 knockdown in the eye disrupts ommatidia
Chmp1 knockdown experiments suggested that Chmp1 negatively regulates DER

signaling in the Drosophila wing. To investigate whether this was true for other Drosophila
tissues, and to gain more insight into the function of Chmp1 in the developing organism, Chmp1
was knocked down in the fly eye (Figure 4.32). During eye development, DER signaling is
involved in specifying photoreceptors of the ommatidia. Loss of DER signaling usually results in
loss of photoreceptors, while gain in DER signaling generally causes recruitment of additional

107

photoreceptors. So if Chmp1 negatively regulates DER signaling, then Chmp1 knockdown might
cause an increase in the number of photoreceptors within ommatidia.
To test this, two different drivers were used to drive Chmp1 knockdown in the eye:
sevenless-Gal4 (sev-Gal4), which drives Gal4 expression in R cell and cone cell precursors, and
eyeless-Gal4 (ey-Gal4), which drives Gal4 expression anterior to the morphogenetic furrow in
the eye disc during larval development (see Chapter 1 Section I.C for description of eye
development) [2]. sev-Gal4 or ey-Gal4 males were crossed to UAS-Chmp1RNAi-TRiP virgin
females and the progeny were grown at 25oC, 28oC, or 30oC. The heads from the progeny were
fixed, dehydrated, embedded in plastic, sectioned, stained and imaged on a light microscope (see
Chapter 3 Section VII for methods).

Figure 4.32 Cross design for Chmp1 knockdown in the Drosophila eye. The F1 generation
was grown at 25oC, 28oC, or 30oC. P is parental generation, F1 is first filial generation. All
progeny were of the desired genotype.
Driving Chmp1 knockdown with sev-Gal4 resulted in eyes that were largely wild-type,
with the exception that rare defects were observed at 30oC, such as symmetrical ommatidia and
loss of photoreceptor cells (Figure 4.33B). Symmetrical, or non-chiral ommatidia have either two
R3 or two R4 photoreceptors, instead of one R3 and one R4. Chirality is determined by the
position of the R3 and R4 photoreceptors within an ommatidium and is specified by the Notch
and Fz PCP signaling pathways [133, 134]. Therefore the presence of symmetrical ommatidia
could indicate faulty Notch or Fz PCP signaling.
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At 25oC a largely wild-type phenotype was observed when Chmp1 was knocked down
under the control of ey-Gal4. But at 28oC and 30oC, Chmp1 knockdown caused major defects in
ommatidial development (Figures 4.33C-E). These defects were usually severe enough to make
it difficult to determine the site of the equator of the eye, or to determine the chirality of
individual ommatidia. One common defect observed when Chmp1 knockdown was driven with
ey-Gal4 was misaligned ommatidia. In wild-type eyes, ommatidia are perfectly aligned with each
other within each half of the eye (Figure 4.33A). In eyes with Chmp1 knockdown, misaligned
ommatidia were observed, which suggests that ommatidial rotation during eye development was
impaired (Figures 4.33D and E). Misrotation of ommatidia is a classic problem associated with
both under- and over-active DER signaling [133]. In rare cases, symmetrical ommatidia were
observed, which again could indicate faulty Notch or Fz PCP signaling. However, as
symmetrical ommatidia were quite rare, and since chirality, when observable, was normal, it
appears Chmp1 knockdown has only a minor effect on these pathways.
By far the most common abnormality observed in eyes with Chmp1 knockdown was loss
of photoreceptor cells. Over-active DER signaling is known to cause recruitment of extra
photoreceptors, suggesting that loss of photoreceptors might indicate a loss of DER signal. This
would seem to contradict the results from the wing, which suggest that Chmp1 knockdown
increases DER signaling. However, DER ellipse alleles (e.g., EGFRElpB1 – an amino acid
substitution in kinase domain that activates tyrosine kinase activity and causes ligandindependent signaling) are gain of function alleles that cause loss of photoreceptors, similar to
the phenotype observed with reduced Chmp1 activity [127, 135, 136]. Since constitutively active
DER and Chmp1 knockdown result in similar phenotypes, it appears that Chmp1 knockdown is
equivalent to over-active DER. If Chmp1 knockdown disrupts the incorporation of the DER into
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MVBs, this could result in persistent DER signaling since the DER would still be able to signal
to the cytoplasm.
Chmp1 was also over-expressed in the eye using the sev-Gal4 and ey-Gal4 drivers at
25oC, 28oC, and 30oC. However, a wild-type phenotype was observed. This absence of a Chmp1
over-expression phenotype in the eye and the weak phenotype observed in the wing may suggest
that a precise dosage of Chmp1 in the cell is not critical for its normal activity.
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Figure 4.33 Chmp1 knockdown and over-expression in the Drosophila eye. Light
microscope images of one micron thick tangential sections of adult Drosophila eyes. Images
were taken at the equator of the eye, when possible. A. Oregon R. B. Chmp1 knockdown at
30oC, (sev-Gal4/+; UAS-Chmp1RNAi-TRiP/+). C. Chmp1 knockdown at 28oC, (ey-Gal4/+;
UAS-Chmp1RNAi-TRiP/+). D. and E. Chmp1 knockdown at 30oC, (ey-Gal4/+; UASChmp1RNAi-TRiP/+). F. Chmp1 over-expression at 30oC, (ey-Gal4/UAS-Chmp1-2).
Schematics below each panel show the arrangement of each ommatium, including chirality and
rotation. Ommatidia with dorsal chirality marked in purple, ommatidia with ventral chirality
marked in blue, and symmetrical ommatidia are marked in yellow. Open black circles indicate
ommatidia with fewer R cells than wild-type and thus chirality was undeterminable.
IX.

Drosophila Chmp1 localizes apically and to the cell membrane
Most studies on the subcellular localization of Chmp1 have been performed in cell

culture rather than in developing tissues, and different studies show different localizations for
Chmp1. Reports in cultured mammalian cells and Aspergillus nidulans show Chmp1 localization
to both the early and late endosome, localizations that are consistent with a role for Chmp1 as a
component of ESCRT-III [86, 97]. Other reports in cultured mammalian cells, zebrafish, and
Nicotiana benthamiana show localization to the nucleus [81, 85, 91, 95]. In mammalian cell
culture, the localization of Chmp1 seemed to vary by cell treatment and type, a finding that was
also observed in the zebrafish brain [91, 95]. Since the Chmp1 and HM-Chmp1 over-expression
lines appeared to have some normal Chmp1 activity (shown in Chapter 4 Section II), and overexpression of Chmp1 caused only weak localized phenotypes, the UAS-HM-Chmp1 fly line
provided a suitable way to study the subcellular localization of the Chmp1 protein in cells of a
developing tissue. Epithelial cells in embryos and wing imaginal discs were used to investigate
the localization of Chmp1. Embryos were tried first because it is normally easy to collect large
numbers (i.e., from a single embryo collection hundreds can be collected) and fairly
straightforward to prepare for immunostaining. en-Gal4, which expresses Gal4 in the anterior of
each parasegment, was used to drive expression of HM-Chmp1 and GFP. Therefore cells
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expressing HM-Chmp1 were marked by GFP expression. To achieve this, en-Gal4,UAS-GFP
homozygous virgin females were crossed to UAS-HM-Chmp1-1/ TM6TbSb males (Figure 4.34).
Embryos were fixed, an anti-c-Myc antibody was used to detect HM-Chmp1, and the embryos
were mounted in Vectashield mounting media with DAPI. Only embryos that showed both GFP
and c-Myc staining were imaged using a confocal microscope.

Figure 4.34 Cross design for HM-Chmp1 expression in both the anterior of embryonic
parasegments and the posterior wing disc in larvae. P is parental generation, F1 is first filial
generation. Only desired genotypes are shown in the F1 generation.
In embryos expressing HM-Chmp1 and GFP under en-Gal4 control, c-Myc staining was
observed specifically in GFP-expressing cells and no c-Myc staining was visible in the non-GFPexpressing cells. This suggested that the c-Myc antibody was specific for HM-tagged Chmp1.
HM-Chmp1 localized mostly to the apical plasma membrane of the embryonic epithelial cells
(Figure 4.35). Nuclear HM-Chmp1 was not detected, despite the the presence of an NLS
sequence in Drosophila Chmp1, and the fact that previous reports describe Chmp1 localizing to
the nucleus.
The subcellular localization of Chmp1 was also investigated in epithelial cells of the
imaginal wing disc. The en-Gal4 driver was used again to drive expression of HM-Chmp1 and
GFP in the posterior wing disc. To achieve this, en-Gal4,UAS-GFP homozygous virgin females
were crossed to males carrying a UAS-HM-Chmp1 insertion on either the second or third
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chromosome (Figure 4.34). Larvae were grown at 18oC. At a lower temperature, the UAS-Gal4
system is less active, so HM-Chmp1 is expected to be lower than at higher temperatures. This
reduces the possibility of excessive over-expression resulting in aberrant localization of the
protein. Third instar wing discs were dissected and an anti-c-Myc antibody was used to detect
HM-Chmp1 in the discs. The discs were mounted onto a microscope slide in Vectashield with
DAPI, and discs that showed both GFP and c-Myc staining were of the correct genotype and so
were imaged with a confocal microscope.
HM-Chmp1 consistently localized to the apical plasma membrane in the third instar
larval wing disc when expressed from multiple independent HM-Chmp1 transgene insertions
(Figure 4.35). These results suggest that the apical membrane localization observed is the
genuine localization of HM-Chmp1, as multiple independent HM-Chmp1 transgene insertions in
two separate tissues showed similar HM-Chmp1 localizations.
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Figure 4.35 Localization of HM-Chmp1 in wing imaginal discs. All images from enGal4,UAS-GFP/+; UAS-HM-Chmp1/+ or en-Gal4,UAS-GFP/UAS-HM-Chmp1 flies. Confocal
Z-series showing HM-Chmp1 localization (red) in wing discs. The Z-series began just above
apical region of the columnar epithelial cells of the disc proper. HM-Chmp1 expression was
driven under the control of the en-Gal4 driver using four independent HM-Chmp1 transgene
insertions. Cells expressing HM-Chmp1 were marked with GFP (green). Scale bar is 10µm. AD. Wing discs were immunostained with anti-c-Myc for HM-Chmp1 (red). One section from a
Z-series is shown. A’-D’. Images A-D merged with GFP (green) and nuclear (blue) images.
Orthogonal X and Y sections, indicated by yellow lines, are below and to the left of the image
respectively. White arrows indicate the apical localization of HM-Chmp1. The position of the
orthogonal sections is indicated by yellow lines. Z-series depth for A’ was 11.78µm, B’ was
6.38µm, C’ was 9.64µm, and D’ was 14.25µm.
X.

Chmp1 localizes to the late endosome
If Drosophila Chmp1 regulates DER signaling through its function in the ESCRT

complexes during MVB biogenesis, then Chmp1 should localize to the endosome. Localization
of HM-Chmp1 at the early endosome was investigated by looking for co-localization of HMChmp1 and the early endosome marker, Rab5. HM-Chmp1 and GFP were expressed in the
anterior of parasegments in embryos under the control of the en-Gal4 driver (Figure 4.34).
Embryos were collected and immunostained for HM-Chmp1 using anti-c-Myc and for Rab5
using anti-Rab5. No apparent co-localization was observed between HM-Chmp1 and Rab5,
suggesting that HM-Chmp1 does not localize to the early endosome (Figure 4.37A). Colocalization between Chmp1 and its known binding partner, Vps4, was investigated as well.
Using an antibody to detect Vps4, no obvious co-localization between Vps4 and HM-Chmp1
was observed (Figure 4.37C). Although Chmp1 has been shown to bind Vps4 in yeast, humans,
and Drosophila this binding is likely transient [72, 73], which could explain the lack of colocalization [82, 97, 110].
Localization of HM-Chmp1 at the late endosome was investigated by looking for colocalization of HM-Chmp1 and the late endosome marker, Rab9. HM-Chmp1 was expressed in
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embryos, along with YFP-tagged Rab9 under the control of the en-Gal4 driver (Figure 4.36).
If/Cy; D1/TM3Ser virgin females were mated to UAS-YFPRab9 males. From the progeny of that
cross, males that were Cy and Ser, but not If or Sb (UAS-YFP/Cy; TM3Ser/+), were collected and
crossed to If/Cy; UAS-HM-Chmp1-1/TM6TbSb virgin females. From the offspring of this cross,
males that were UAS-YFPRab9/Cy; UAS-HM-Chmp1/TM3Ser were collected and crossed to enGal4, UAS-GFP virgin females. Embryos were collected at 18oC, immunostained with an anti-cMyc antibody to detect HM-Chmp1, and imaged with a confocal microscope. YFP expression,
driven by the en-Gal4 driver, was only detected the anterior of each parasegment, along with
GFP and HM-Chmp1. Additionally, only a proportion of embryos (~ 25% expected) had all three
transgenes, so only a proportion of embryos expressed Chmp1, GFP, and YFP-Rab9.

Figure 4.36 Cross design for HM-Chmp1 and YFP-Rab9 expression in the anterior of
embryonic parasegments. P is parental generation, F1 is first filial generation, F2 is second
filial generation, F3 is third filial generation. Only the desired genotypes in filial generations
are shown.
Although the fluorescent signals from YFP-Rab9 and HM-Chmp1 did not completely
overlap, some co-localization was apparent (Figure 4.37B). This implies that Chmp1 localizes to
the late endosome and suggests that Chmp1 is functioning there. In light of the literature, this
localization is likely a function of the role of Chmp1 as a component of the ESCRT-III complex
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in MVB generation. This suggests that the negative regulation of DER signaling by Drosophila
Chmp1 may well be due to its function in MVB biogenesis. So, when Chmp1 is knocked down,
MVB formation is incomplete, resulting in persistent DER signaling due to a failure to separate
the DER from the cytoplasm.

Figure 4.37 Relative subcellular localizations of HM-Chmp1 with endosome markers and
Vps4. Confocal images of embryos driving UAS-HM-Chmp1-1 expression under the control of the enGal4 driver. Embryos were immunostained with anti-c-Myc for HM-Chmp1 (red). One section
from a confocal Z-series showing HM-Chmp1 localization is shown. Scale bar is 5µm. A.
Localization of HM-Chmp1 (red) and Rab5 (yellow) and merged image, (en-Gal4,UAS-GFP/+;
UAS-HM-Chmp-1-1/+). B. Localization of HM-Chmp1 and YFP-Rab9 (yellow) and merged image,
(en-Gal4,UAS-GFP/UAS-YFPRab9; UAS-HM-Chmp1-1/+). C. Localization of HM-Chmp1 and
Vps4 (yellow) and merged image, (en-Gal4,UAS-GFP/+; UAS-HM-Chmp1-1/+).
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CHAPTER 5
DISCUSSION
Many cell signaling pathways share a common cascade structure in which activation is
initiated by the binding of a ligand to a transmembrane receptor. The activated receptor then
transmits the signal to signaling components in the cellular cytoplasm. This usually leads to a
change in gene expression, which alters the activity of the cell. Down-regulation of cellular
signaling pathways is crucial for proper function of a cell and persistent signaling can result in
severe problems, such as deregulated growth. One method of down-regulating cell signaling
pathways is degradation of activated transmembrane receptors through the multivesicular body
(MVB) pathway. The ESCRT (Endosomal Sorting Complexes Required for Transport) -0, -I, -II,
and –III complexes mediate MVB generation, by which receptors are sequestered from the
cytoplasm into intralumenal vesicles (ILVs) of the MVB, thereby silencing the signal. ESCRT
function during MVB generation is required for the down-regulation of many signaling
pathways, including EGFR and Notch [58-61]. This study investigated the function of the
Chmp1 protein, a component of ESCRT-III. The ESCRT-III protein complex provides the core
function of ESCRT activity: the scission of the neck of the ILV, completing MVB formation.
Previous studies in a variety of organisms have implicated Chmp1 in MVB biogenesis,
protein sorting, mitosis, and both positive and negative regulation of growth [69, 81, 86-89, 91,
92, 100]. As most studies on Chmp1 have been performed in single cell culture, Drosophila
provided a useful model for investigating Chmp1 function in developing tissues. The research
presented in this dissertation suggests that Chmp1 negatively regulates DER signaling and wing
vein cell fate in the Drosophila wing. This is likely a result of the role of Chmp1 in the ESCRT-

118

III complex, which mediates the down-regulation of activated DERs via the MVB pathway and
lysosomal degradation.
I.

Chmp1 is essential
This is the first published investigation of Chmp1 function in invertebrates. Drosophila

provides a useful model for investigating Chmp1 function as it expresses a single Chmp1 protein
that shares all the functional domains identified in the vertebrate Chmp1 protein. Also, the wellestablished genetic tools available in Drosophila allow the fine control of Chmp1 expression
during tissue development. Fly lines expressing RNAi targeted at the Chmp1 transcript were
used to investigate the effect of loss of Chmp1 on survival. Ubiquitous knockdown of Chmp1
during fly development was lethal, suggesting that Chmp1 is an essential gene for Drosophila
development. This is consistent with the finding that Chmp1 is essential in Arabidopsis thaliana,
but contrasts with studies in Nicotiana benthamiana, and Aspergillus nidulans, in which Chmp1
was not essential for survival [85-87]. It appears, therefore, that loss of Chmp1 is not necessarily
cell or tissue lethal. However, the deregulation of cell signaling resultant from loss of Chmp1
activity can cause inviability in some organisms. This suggests that, although Chmp1 activity,
e.g., its molecular interactions and functional domains, appears to be conserved, the downstream
consequences of Chmp1 loss differs between species. When compared in a dendrogram showing
the evolutionary relationships between Chmp1 proteins, Drosophila Chmp1 is more closely
related to mammalian Chmp1 than to Chmp1 in plants or yeast [92]. So, like most Drosophila
proteins, it appears that Chmp1 function is better conserved between flies and humans, than
between flies and plants.
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II.

Chmp1 regulates the wing vein cell fate decision
The UAS-Gal4 system provided a way to limit Chmp1 knockdown to a specific tissue,

avoiding the lethality associated with ubiquitous Chmp1 knockdown. Thus, Chmp1 was knocked
down in the wing, one of the best characterized adult structures of the fly and a non-essential
tissue for survival. When Chmp1 knockdown was limited to the wing, thickened wing veins
resulted. Ideally, the strength of the knockdown, i.e., the difference in protein levels between
wild-type and Chmp1 knockdown flies, would have been measured. As no antibody has been
generated against Drosophila Chmp1, Chmp1 protein levels could not be detected via
immunoblot. Additionally, as RT-PCR would assay mRNA levels, it would not necessarily give
a valid indication of protein levels. However, expression of RNAi against Chmp1 caused a
reproducible and specific wing phenotype using multiple drivers and two independent RNAi
lines, strongly suggesting that the thickened wing veins were caused by reduced Chmp1
expression.
Thickened wing veins are classically associated with a cell fate change from intervein to
vein in the wing [14]. Therefore, the thickened wing veins observed with Chmp1 knockdown
were likely caused by a change in wing cell fate, rather than increased proliferation of wing vein
cells, suggesting that Chmp1 promotes intervein cell fate over vein cell fate. Supporting this
conclusion, the number of intervein cells between the thickened veins on a Chmp1 knockdown
wing appeared reduced, suggesting a change in cell fate, rather than over-growth of vein cells. A
cell fate change associated with loss of Chmp1 has not been reported previously in animal
studies, although in Zea mays loss of Chmp1 caused extra layers of aleurone cells to form [92].
This phenotype was likely caused by increased specification of aleurone cells from endosperm,
driven by failure to down-regulate transmembrane receptors through the MVB pathway [92, 93].
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The finding that Chmp1 regulates cell fate in plants is consistent with the finding that Chmp1
regulates wing vein cell fate in flies, and suggests a conserved role for Chmp1 in regulating cell
fate decisions.
III.

Chmp1 and DER signaling
DER signaling is required to promote wing vein development. Loss of DER signaling

causes loss of wing veins and gain of DER signaling causes wing vein thickening and formation
of extra wing veins [17, 36]. So it was possible that the thick veins observed with Chmp1
knockdown could be caused by a gain of DER signaling. This would mean that Chmp1
negatively regulates DER signaling. This is consistent with previous reports showing that other
ESCRT components are required for down-regulation of DER signaling [59, 137].
Genetic interactions between Chmp1 and regulators of the DER signaling suggest a role
for Chmp1 in the regulation of the DER. Reduced activity of negative regulators of DER
signaling in Chmp1 knockdown wings enhanced the Chmp1 knockdown phenotype.
Additionally, reducing the expression of Vn, a positive regulator of DER signaling, in Chmp1
knockdown wings partially suppressed the Chmp1 knockdown phenotype. This finding showed
that loss of Vn activity caused a loss of DER activation that partially counter-acted the gain in
DER activation caused by Chmp1 knockdown. Interestingly, the Chmp1 knockdown phenotype
was not suppressed by decreased activity of Rho, another positive regulator of DER signaling. A
genetic interaction between Chmp1 and Vn but not Rho is surprising, especially as Vn and Rho
appear to have synergistic roles in the wing [121, 122, 138]. This may be explained by
considering the functional roles of Vn and Rho in DER signaling. Vn is a ligand secreted by
intervein tissue that directly binds and activates the DER, while Rho is a membrane bound
protease that cleaves and activates the DER ligands, Spitz and Keren. Spitz and Keren act
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redundantly in the wing and only loss of activity of both alters wing vein patterning [15, 139].
Perhaps losing one copy of rho does not affect levels of DER activation even when Chmp1 is
reduced, as there is still enough Rho protein to cleave and activate the Spitz and Keren ligands.
Since Rho is an enzyme, it most likely can repeatedly cleave substrate. In contrast Vn is not reused. Additionally, it is thought that Vn provides a low, constant activation of the DER, while
Rho is a strong DER activator [17, 140]. Thus, reducing the activity of Rho would have less
effect on DER signaling than reducing the activity of Vn. Another possibility is that there is a
different timing requirement for Vn and Rho during wing development. An interaction between
Chmp1 knockdown and Vn, rather than Rho could indicate a later requirement for Vn than Rho
in the final determination of vein fate [15, 138]. However, since Rho is required late into wing
morphogenesis, this appears unlikely [17].
Loss of MAPK activity caused by altered activity of a single regulator of DER signaling
usually does not result in a vein-less wing. Instead, only portions of veins are lost, suggesting
that regulation of DER signaling in vein formation differs in different parts of the wing. Overexpression of the negative DER regulator aos causes loss of the distal portions of the L4 and L5
wing veins due to loss of DER signaling in these regions. Interestingly, when Chmp1 was
knocked down dorsally in wings over-expressing aos, the distal L4 and L5 were still lost, but the
remaining wing veins were thickened. Although Chmp1 knockdown caused thickening of the
wing veins, it appeared that Chmp1 knockdown could not reverse the loss of vein cell fate
specification caused by aos over-expression. This finding is consistent with a model in which
Chmp1 regulates DER signaling downstream of receptor activation and may suggest that Aos
can no longer inhibit DER signaling in vein cell specification beyond a certain time point during
development. After this time, loss of Chmp1 could still activate DER signaling, but Aos would
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no longer be able to down-regulate the DER. The idea of a switch in DER signaling during wing
development is supported by previous studies. For example, over-expression of aos at different
times during wing development has different phenotypic effects. Argos over-expression during
the pupal stage of development causes extra veins to form, while over-expression during larval
stages causes vein suppression [138]. Similarly, DER signaling promotes vein specification and
is active in the wing veins throughout most of wing development. However, from about 28 to 33
hours after pupal formation (hAPF), MAPK activity, an indicator of DER signaling, is lost in the
veins and increased in the intervein [138, 141, 142]. The importance of this event and its
implications for wing development are not well understood. It has been proposed that DER
activation is required to allow for maintenance of Dpp signaling in the vein, which is required for
wing vein differentiation, but that the late shift of DER signaling to the intervein is required for
the specification of intervein fates [138, 143].
To quantify the ability of the regulators of DER to modify the Chmp1 knockdown
phenotype, wing vein areas were measured. The area of wing veins was much more variable in
the wings with Chmp1 knockdown and altered DER activity compared to Chmp1 knockdown
alone. In Chmp1 knockdown wings that were also heterozygous for loss of function alleles of
DER regulators, small numbers of wings measured had wing vein areas that were comparable to
those of Chmp1 knockdown alone, while others were well above Chmp1 knockdown
measurements. This variability may have been caused by fluctuations in temperature during fly
development. As Chmp1 knockdown was driven with the UAS-Gal4 system, the Chmp1
knockdown phenotype was sensitive to temperature. In some cases, a developmental temperature
of two degrees (from 28oC to 30oC) was a difference between wings with slightly wider wing
veins and wings that were almost entirely wing vein. Minor fluctuations in temperature within
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the incubator in which the flies were grown could contribute to the differences observed. Also,
though the wings measured were all from flies of the same known genotype, there may be
variation in the genetic background between individual flies that results in differences in gene
expression. Therefore, individual flies may experience different levels of Chmp1 knockdown in
the wing that was not apparent from the Chmp1 knockdown phenotype, but is amplified in a
different genetic background. Nevertheless, for each genotype, the mean wing vein area was a
good representation of the wing vein thickness that was generally observed. Additionally,
reduction of all DER suppressors tested enhanced the Chmp1 knockdown phenotype, whereas
reduction of DER enhancers either suppressed or did not significantly alter the Chmp1
phenotype. The consistent directionality of the interactions between DER regulators and Chmp1
is good evidence that Chmp1 negatively regulates DER signaling.
Interestingly, no interaction was detected between Chmp1 and DER regulators when
Chmp1 was over-expressed in wings heterozygous for loss of function alleles of positive or
negative regulators of DER signaling. In light of the Chmp1 knockdown studies, this may
suggest that excessive Chmp1 protein in the cell has little or no effect on DER signaling during
wing vein development. Chmp1 knockdown, but not Chmp1 over-expression, results in
phenotypes in the fly, showing that while the cell does require Chmp1 for proper function and
signaling, an over-abundance of Chmp1 does not significantly alter cellular function. This could
offer support for Drosophila Chmp1 as a component of the ESCRT complex when regulating
DER signaling, rather than acting directly as a regulator of gene expression. It also suggests that
Chmp1 is not a limiting component of ESCRT function.
Studies in mammalian cell culture show that Chmp1 regulates cell growth [88, 89, 91]. In
contrast, the studies presented here did not indicate a role for Drosophila Chmp1 regulation of
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growth, but rather in regulation of DER signaling in cell fate specification. However, human
pancreatic [89] and renal [88] tumor cells show a loss of Chmp1A activity, and a gain of EGFR
signaling is often observed in cancerous cells [144-146]. So it is possible that an increase in
EGFR signaling caused by loss of Chmp1A activity could contribute to tumorigenesis.
Therefore, the Drosophila wing may provide a good model for assaying the activity of ESCRT
components to better understand their role in tumor formation.
IV.

Clones of Chmp1 knockdown in the wing
Chmp1 interacted genetically with DER signaling components, suggesting that Chmp1

negatively regulates DER signaling. If Chmp1 negatively regulates DER signaling, downstream
targets of the DER should be affected by loss of Chmp1 activity. Clones of Chmp1 knockdown
were generated in the developing wing to assess the effect of Chmp1 knockdown on expression
of Bs, which is negatively regulated by DER signaling. Unexpectedly, small clones of Chmp1
knockdown in the third instar wing disc had no effect on Bs expression. However, Bs expression
was decreased in large clones (>120 cells) that spanned wing vein and intervein regions. Large
clones of Chmp1 knockdown were rare, which may mean that Chmp1 knockdown clones were
unhealthy and died or grew slowly when generated early in wing development. If this is the case,
it would suggest that Chmp1 is required for proper cellular function in Drosophila wings in
addition to its role in DER signaling. Another possible explanation for seeing few large clones is
cell competition. In the wing, cells of a specific genotype may not survive as wing clones, even
though they can make a perfectly formed wing by themselves, as they are “out-competed” by
surrounding wild-type cells [147]. Chmp1 knockdown clones in the wing may be out-competed
and thus rare in the developing wing.
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Clones of Chmp1 knockdown were also generated for analysis in the adult wing. In the
majority of Chmp1 knockdown clones located within intervein regions, clusters of cells within
the clone adopted vein cell fate. On the other hand, some clones within intervein tissue had no
effect on wing cell fate. When Chmp1 knockdown clones overlapped wing veins, thickening of
the wing vein occurred, though the wing vein thickness was only increased by a few cells’ width,
similar to knockdown in the entire wing, and not throughout the entire clone. Thus, not every
Chmp1 knockdown cell adopts a vein fate. This suggests that other factors, such as the location
of the clone within the wing, are involved in determining vein or intervein cell fate in Chmp1
knockdown clones. However, there is still the question of why intervein cells can adopt a vein
fate in Chmp1 knockdown clones but not when Chmp1 knockdown is driven with MS1096-Gal4
and other drivers. It could just be a case of stronger knockdown of Chmp1 in the clones than with
drivers. For example, the FLP/FRT-Gal4 system uses an actin promoter to drive expression of
Gal4 constantly and at a fairly high rate. In contrast, promoters of developmental genes, such as
engrailed (en-Gal4) and patched (ptc-Gal4), may have variable expression over time or stop
expressing early.
If Chmp1 acted upstream of the DER signaling pathway, by either directly repressing or
activating the DER or one of its regulators, Chmp1 knockdown clones might have induced vein
cell fate regardless of their location on the wing. However, this was not the case. Instead,
receptor deregulation caused by loss of Chmp1 may just alter the balance of signaling between
pathways involved in vein specification, i.e., the DER signaling pathway, making a cell more
likely to adopt a vein fate. This is consistent with a role for Chmp1 downstream of the DER,
suggesting that Chmp1 knockdown does not in itself activate DER signaling. Rather, Chmp1
regulates the active DER signaling pathway. If the DER is not activated, then presumably loss of
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Chmp1 can have no effect on the DER signal. However, when the DER is active loss of Chmp1
might boost the signal to a level that induces vein formation in the wing.
V.

Chmp1 and Notch signaling
In these studies, experiments using Chmp1 knockdown to investigate Chmp1 regulation

of Notch signaling were inconclusive. No strong evidence for Chmp1 as a regulator of Notch
signaling was obtained. However, a possible minor genetic interaction was observed between
Chmp1 and the Notch regulator, Deltex. When Chmp1 was knocked down in a wing overexpressing Deltex, a minor but consistent loss of wing bristle was observed in the wing.
Transgenic fly lines were created that allowed for expression of either a wild-type or
HM-tagged Chmp1 protein, enabling investigation into the effects of Chmp1 over-expression, as
well as Chmp1 protein localization. All of these lines expressed an active Chmp1 protein, as they
were able to partially or fully rescue the Chmp1 knockdown phenotype. Chmp1 over-expression
in the wing resulted in widening of the distal tip of the wing vein, or deltas, suggesting that
Chmp1 may regulate Notch signaling. Wing vein deltas are also observed when activity of the
Notch ligand, Delta, is lost. Although this effect was weak, it is consistent with previous
literature showing that ESCRT machinery regulates Notch signaling. For example, in a genomewide study to identify modifiers of Notch signaling in Drosophila, Chmp1 was identified as a
possible negative regulator of Notch[115]. Chmp1 knockdown with an RNAi line from the
VDRC in the thorax caused notum migration malformation, which was likely due to upregulation
of Notch signaling [115]. Additionally, loss of Drosophila ESCRT-II component Vps25 caused
endosomal accumulation of the Notch receptor and enhanced Notch signaling [61].
If Chmp1 negatively regulated Notch signaling in Drosophila, then Chmp1 overexpression in the wing might cause reduced Notch signaling, which could result in the deltas
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observed. One possible explanation for this finding is that Chmp1 over-expression caused
increased processing of Notch into the ILV. This would imply that Notch normally signals after
it has been endocytosed, which is consistent with previous studies showing that the Notch
Intracellular Domain is cleaved at the endosome. The deltas observed under Chmp1 overexpression could also be caused defects in the processing of Delta, rather than Notch. Delta, as
well as other Notch ligands, requires monoubiquitination and endocytosis, followed by either
degradation or recycling back to the membrane for proper activity [148].
If Chmp1 negatively regulates Notch signaling, then loss of Chmp1 activity should
increase Notch signaling. In the wing, phenotypes associated with increased Notch activity could
include loss of wing veins, or ectopic wing margin and bristles. These phenotypes were not
apparent when Chmp1 was knocked down in the wing, suggesting that Notch activity is not
increased. However, the findings presented here do not rule out a role for Chmp1 in regulation of
Notch signaling. It is possible that Chmp1 regulates Notch signaling during wing development,
but Chmp1 knockdown conditions were not sufficient to generate a Notch-related phenotype.
VI.

HM-Chmp1 localization
In the light of previous literature, it seems likely that the regulation of DER signaling by

Chmp1 is a result of its activity in MVB generation as a part of the ESCRT-III complex. This
would place Chmp1 at the endosome, which has been verified in mammalian cultured cells,
Arabidopsis, and yeast [86, 93, 97]. The HM-tagged version of Drosophila Chmp1 is active and
localized to the apical plasma membrane. Similar localization was observed in both embryonic
and imaginal disc epithelial cells, and with several independent UAS-HM-Chmp1 fly lines,
suggesting that it is the genuine subcellular localization for HM-Chmp1. When comparing the
subcellular localization of Chmp1 across published studies, it becomes apparent that Chmp1
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localization varies between cell types [91, 95, 97]. However, the membrane localization observed
for HM-Chmp1 is similar to the localization observed for Chmp1A observed in mouse acinar
pancreatic tumor cells (CRL-2151) in a paper published on the effects of all-trans retinoic acid
(ATRA) and Chmp1A in pancreatic tumor cells [95].
Co-localization was not observed between HM-Chmp1 and the early endosome marker,
Rab5. However, HM-Chmp1 did show some co-localization with a late endosomal marker,
Rab9. This suggests that a proportion of Chmp1 localizes to the late endosome, but not to the
early endosome in Drosophila. This contrasts with reports that Chmp1 was detected at both early
and late endosomes in Aspergillus nidulans and mammalian cell culture [86, 97]. However, the
late endosomal localization of Chmp1 is supported by studies in yeast, showing that ESCRT-III
components are only present on the endosomal membrane late in MVB biogenesis [72, 73]. The
localization of Drosophila Chmp1 to the late endosome is compatible with a role for Chmp1 in
MVB biogenesis, and supports the idea that this is the mechanism for down-regulating the DER.
There is published evidence supporting a role for ESCRT function in the nucleus. For
example, in cultured human cells the ESCRT-I component Tsg101 has been reported to repress
the cyclin-dependent kinase p21 by directly binding its promoter [149]. Tsg101 may also act as a
cofactor in regulating gene expression in cultured mammalian cells [150, 151]. Several studies
report a role for Chmp1 in the nucleus, and the few mechanistic studies on Chmp1 pin the effects
observed under Chmp1 mis-expression to its nuclear function. [90, 91, 95]. Though Chmp1 was
not detected via immunostaining in the nucleus of the Drosophila tissues investigated here, the
conservation of the NLS suggests that Drosophila Chmp1 may play a role in the nucleus. Other
studies in mammalian cultured cells have reported that Chmp1 may not always be present in the
nucleus, as it is only detectable at specific phases of the cell cycle, or upon certain cell treatments
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[81, 90, 95]. Thus it is possible that the nuclear localization of Drosophila Chmp1 was not
detected because it is transient. Chmp1 appears to recruit BMI1 to condensed chromatin in the
nucleus of cultured human cells [81, 91]. This is interesting because BMI1 can work as a part of
PRC1, a protein complex which maintains a transcriptional repressive state in many genes by
mediating monoubiquitination of histone H2A-K119 [152]. As ESCRTs 0-II can recognize
monoubiquitinated proteins, this may explain the presence of ESCRTs in the nucleus. Despite
these findings, there is no well established role for ESCRTs in the nucleus. All characterized
roles for the ESCRT machinery involve the scission of membranes, but this activity does not
explain the localization of Chmp1 to condensed chromatin or its interaction with BMI1. It is
possible that the role of Chmp1 in the nucleus is independent of the ESCRT-III complex, or that
the ESCRT complexes play a role in the nucleus that has not yet been described. As the role of
Tsg101 in the nucleus has not been linked with other ESCRT components or known functions of
ESCRTS, it may well be independent from the well-established ESCRT activities.
Co-immunoprecipitation and mass spectroscopy experiments have identified many
binding partners for Drosophila Chmp1, several of which are regulators of gene expression at the
level of translation [2]. In addition, ESCRT-II components interact with ELL proteins, which are
elongation factors for RNA polymerase II [153]. Chmp1 may also be involved in the
maintenance of chromosome integrity during mitosis [100]. Together, these results suggest
diverse functions for ESCRT proteins, many of which are not well characterized. So it remains
possible that Chmp1 regulates DER signaling in other ways, in addition to receptor downregulation through the MVB pathway.
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VII.

Concluding remarks
When Chmp1 was knocked down in the Drosophila wing, the DER was deregulated,

causing wing cells to adopt a vein over an intervein fate. A role for Chmp1 determining in cell
fate specification through receptor down-regulation is consistent with the function of Chmp1 in
the ESCRT-III complex. Chmp1 binds Vps4, which completes ILV formation at the MVB. If
loss of Chmp1 function caused incomplete ILV formation, this might result in retention of
transmembrane receptors in the limiting membrane of the endosome, rather than incorporation
into the ILV (Figure 5.1). Indeed, in Arabidopsis thaliana, Chmp1 mutation resulted in the
presence of membrane proteins in the limiting membrane of the MVB and vacuole [87].
Additionally, in mammalian cultured cells knockdown of UBPY, a binding partner of Chmp1,
caused accumulation of the EGFR on endosomes [108]. Loss of ESCRT-III component activity
in Drosophila also impaired ILV formation [137]. Therefore, the increased DER signaling
observed in Chmp1 knockdown wings may be a consequence of incomplete ILV formation,
resulting in a failure to isolate the DER from the cytoplasm and retention of the DER in the
limiting membrane of the endosome, where it continues to signal.
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Figure 5.1 Model for Chmp1 regulation of the DER through the MVB pathway. 1.
Activating ligand binds to the extracellular domain of the DER. This activates the DER, which
transmits the signal to the cell through the MAPK pathway. The activated DER is
ubiquitinated. 2. Ubiquitination of the DER signals endocytosis of the activated receptor. 3. The
ESCRT protein complexes normally mediate incorporation of the DER into ILVs of the MVB.
4. The ILVs containing the DER are delivered to the lysosome, where the DER is degraded.
Loss of Chmp1 from the ESCRT-III complex causes incomplete scission of the neck of the ILV
and causes the DER to accumulate in the limiting membrane of the MVB, so the receptor is still
able to signal to the cytoplasm.
VIII.

Possible future studies
ESCRT components have been shown to regulate several pathways in Drosophila.

Investigations into Chmp1 regulation of other pathways in other tissues could be informative.
This could be tested similarly to DER signaling components. For example, Chmp1 could be
knocked down in wings heterozygous for regulators of other pathways, such as Dpp or Hh.
Additionally, the work on Chmp1 in the eye could be expanded. Chmp1 knockdown in the eye
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caused loss of photoreceptors. This phenotype could be investigated at earlier stages. For
example, in the third instar eye imaginal disc immunostaining can be used to identify at what
stage the specific photoreceptors are lost during eye development. Additionally, genetic
interactions with DER, Notch, and other pathways in the eye could be investigated.
Further testing for interactions between Chmp1 and proteins involved in endocytosis,
such as clathrin, could link Chmp1 to its role in the MVB pathway more firmly. For example,
Chmp1 could be knocked down in flies carrying loss of function alleles for proteins involved in
endocytosis that have no wing phenotype in the heterozygous state. If the Chmp1 knockdown
phenotype is enhanced in these different genetic backgrounds, then a role for Chmp1 in
endosomal trafficking in the wing would be supported.
Chmp1 co-localized with Rab9, a marker for the late endosome. This suggests that
Chmp1 functions at the late endosome, probably as a component of the ESCRT-III complex in
MVB generation. A next step in Chmp1 research would be tracking the endocytosis of signaling
receptors, including the DER or Notch receptor, under Chmp1 knockdown or over-expression
conditions. If Chmp1 knockdown caused accumulation of the DER or Notch in the endosomal
membrane, as identified by co-localization with an endosomal marker, then a role for Chmp1 in
regulating these pathways through the MVB pathway would be better supported.
Though no nuclear Chmp1 localization was detected in epithelial cells of the Drosophila
embryo or imaginal disc, there have been multiple studies showing a nuclear localization and
suggesting a nuclear function for Chmp1 [81, 89-91]. In cultured mammalian cells, nuclear
Chmp1 was detected at specific stages of the cell cycle or upon certain cell treatments [81, 90,
95]. So it is possible that Chmp1 does localize to the nucleus in Drosophila cells, but that it just
was not detected. If Chmp1 localizes to the nucleus at specific times during the cell cycle, then it

133

might be detected in the nucleus upon imaging of live cells, or fixed synchronized cells in
culture. Investigation of Chmp1 localization in live cells, e.g., in a cultured imaginal disc, would
require the generation of a transgenic fly line that could express fluorescently tagged Chmp1
protein. This would allow live imaging of Chmp1 localization in Drosophila tissues.
Unfortunately, fluorescent tags are often large, and there is always the possibility of interference
of the tag with the function of the protein. Alternatively, Chmp1 localization could be
investigated cultured S2 cells (Drosophila cell line), which would allow for synchronization of
the cell cycle and observation of Chmp1 localization in fixed cells using a smaller epitope tag on
the Chmp1 protein. However, much of the power of using Drosophila in the lab is the ease of
genetics and the ability to study the tissues of an entire organism. So moving to insect cell
culture might be considered a step backwards.
Creation of a Drosophila-specific Chmp1 antibody, along with Chmp1 mutants, would be
useful in further studies with Chmp1. Different mutations could be generated to investigate
which functional domains or regions of the Chmp1 protein are required for proper
function/regulation of DER signaling, and signaling of other pathways in Drosophila. Generation
of a Chmp1 mutant with the NLS deleted could be informative about any nuclear function for
Chmp1 in Drosophila. Additionally, it could be interesting to create a transgenic fly line that
allows for expression of Chmp1 from a different species, such as humans. If human Chmp1A
could rescue a Chmp1 mutant phenotype, that would imply that the functions are highly
conserved and the findings in Drosophila are transferrable.
Clones of Chmp1 knockdown occasionally caused a cell fate change from intervein to
vein cell in the adult wing. Additionally, clones of Chmp1 knockdown caused an increase in
DER signaling and a decrease in Bs expression. However, Chmp1 knockdown did not always
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have an effect on Bs expression. Large clones of Chmp1 knockdown were required to see a
change in Bs expression in the wing disc, despite the fact that small clones of Chmp1 knockdown
could generate vein in the adult wing. A more direct readout of DER pathway activation is
phosphorylation of ERK. Additionally, Rho expression is indicator of DER activation. In the
developing wing, one of the first markers of wing vein cells is Rho expression. So it would be
informative to generate clones of Chmp1 knockdown in the wing disc to see if ERK is
phosphorylated in any of the clone cells, or if Rho expression was activated. This would offer
more definitive evidence for a role for Chmp1 in regulation of DER signaling.
The studies presented in this dissertation suggest that the choice of vein or intervein cell
fate in the Drosophila wing is a good model for investigating the activity of ESCRT components.
Thus, the activity of other ESCRT components in regulation of cell signaling pathways involved
in vein patterning could be investigated in the wing. Many of the interactions of ESCRT
components have only been suggested through biochemical assays. Therefore, genetic interaction
studies similar to those used in these studies could be used to establish functional interactions
between these pathways/proteins. Genetic screens involving ESCRT components could identify
which components are required for ESCRT function in pathways involved in vein development.
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CHAPTER 6
PROJECTS INVESTIGATING FRIZZLED (FZ) PLANAR CELL POLARITY (PCP)
SIGNALING IN DROSOPHILA
In addition to DER and Notch signaling, Chmp1 may regulate the Frizzled (Fz) Planar
Cell Polarity (PCP) pathway. Investigations of Chmp1 in Fz PCP signaling, as well as
contributions made to other Fz PCP signaling projects, are discussed in this chapter.
I.

Background on PCP
Cell polarity is established by an asymmetrical distribution of contents within a cell and

is critical for cellular specification and diversity. One example of cell polarity is the polarization
of epithelial tissues on the apical-basal axis, which gives cells a top and a bottom. However, cells
that make up epithelial tissues are not only polarized on the apical-basal axis, but also within the
plane of the epithelium. This type of polarity is called PCP. The Fz PCP pathway controls PCP
and was first identified for its role in patterning the fruit fly cuticle. It is conserved in vertebrates
where it is referred to as a non-canonical Wnt signaling pathway [154, 155]. The Fz PCP
pathway is also involved in cell fate specification, as well as cell migration events, including
convergent extension movements during gastrulation and neurulation in vertebrates [3, 156].
Mutations in human Fz PCP pathway genes have been linked to neural tube defects such as
anencephaly and spina bifida, and also with epileptic seizures [157-161]. Additionally, in
humans and mice, defects in Fz PCP have been linked to some cystic kidney diseases, likely
related to defects in ciliogenesis [155, 162-166].
Despite the importance of the Fz PCP pathway in human development and disease, it is
still incompletely understood. From studies in Drosophila, it is known that within each epithelial
cell, six Core Fz PCP pathway proteins, Fz, Dishevelled (Dsh), Diego (Dgo), Flamingo (Fmi,
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also known as Starry-night, Stan), Strabismus (Stbm, also known as Van-gogh, Vang), and
Prickle (Pk), must undergo a series of specific interactions and become asymetrically localized in
order to establish proper PCP. Although much is known about the interactions and subcellular
localizations of these proteins, there is no consensus on a global signal that initiates Core PCP
protein localization within the cell, how the Core PCP proteins interpret that signal, or how the
signal is transduced. The Fz PCP pathway has been best studied in the fruit fly, which provides
an easily manipulatable system in which to study this pathway. In these studies, the eye and wing
were used to investigate Fz PCP signaling.
II.

The Fz PCP pathway in the Drosophila wing
With respect to Fz PCP signaling, the wing is the most widely used and best

characterized epithilial tissue of the fly (see Chapter 1 section I.B for details on wing
development and anatomy). The developing fly wing is composed of an epithelial cell layer of
hexagonally packed cells. Each wing cell produces a single distally-pointing wing hair, resulting
in an adult wing decorated with a regular array of hairs. Traditionally, the study of PCP in the
wing focuses on the formation and polarity of these hairs. Determining the initiation site of hair
formation, as well as the number of hairs produced within a cell, are processes that require the
proteins of the Fz PCP pathway [167-169]. During the pupal stage of wing development, within
each epithelial cell the Fz PCP Core proteins localize apically in the adherens junction (AJ) plane
and asymmetrically to the proximal and distal ends of each epithelial cell [170] (Figure 6.1A).
Fz, Dsh and Dgo localize to the distal edges of the cell, Stbm and Pk localize to the proximal
edges, and Fmi localizes to both proximal and distal edges. The apical and lateral localizations
are both crucial for proper PCP, as failure to appropriately localize all six Core PCP proteins
results in PCP defects, such as altered hair initiation site, altered hair polarity, and cells carrying
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multiple hairs [171-176]. There is no consensus on what global signal initiates the asymmetric
localization of Fz PCP pathway components within wing cells and establishes direction in the
tissue. One candidate is a group of proteins, including the atypical protocadherins Fat (Ft) and
Dachsous (Ds), gradients of which have been proposed to provide a global signal for Fz PCP
protein localization and so direct wing cell polarity. This idea is supported by evidence that Ft
and Ds play a role in microtubule orientation, and that the subcellular localization of the Core
proteins depends upon microtubule-based transport of Fz to the distal end of the cell [173, 177].
Wnts, extracellular proteins that transmit signals into the cell through Frizzled family
receptors, have also been proposed as a global cue for establishing polarity. In vertebrates, loss
of Wnts can cause PCP defects suggesting that Wnts are involved in Fz PCP [178-180]. In flies
evidence for Wnts as a directional cue for Fz PCP signaling is lacking, though recent work
suggests Wingless (Wg) and Wnt4 may act redundantly in the wing to establish proper PCP
[181-183]. In the wing, the localization of Fz PCP pathway components is correlated with
cytoskeletal reorganization and the distal formation of an actin rich hair. It is thought that the
position of Fz within the cell is the main determinant of where a wing hair forms, i.e., Fz
localizes distally and the wing hair forms at the distal end of the cell [174]. However, the
mechanisms by which this occurs are unknown.
III.

The Fz PCP pathway in the Drosophila eye
In addition to DER signaling, development of the Drosophila eye also requires Fz PCP

signaling, but in this case it controls a cell fate specification event that is critical for patterning of
the eye [3]. The fly eye is a complex structure composed of about 800 ommatidia. The
organization of photoreceptors within each ommatidia has a chirality, or handedness, which
differs between ommatidia in the dorsal and ventral halves of the eye. This means that ventral
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ommatidia are a mirror image of dorsal ommatidia (see Chapter 1 section I.C for eye
development and anatomy). Fz PCP signaling is involved in the establishment of the chirality, or
handedness of each ommatidium, by specifying which photoreceptors become the R3 and R4
cells (Figure 6.1B). Fz PCP signaling also directs the direction of ommatidial rotation, as the
specification of R3 and R4 photoreceptors largely determines the direction of rotation. The
R3/R4 precursor cells can differentiate into either R3 or R4. The Fz PCP pathway signals from
the future R3 photoreceptor through Fz to Stbm in the future R4 photoreceptor. Fz becomes
active and signals from the R3/R4 precursor closest to the equator, which becomes committed to
an R3 fate, while the other precursor closer to the pole of the eye adopts the R4 fate.
Downstream targets of the Fz PCP pathway drive and reinforce the cell fate decision. For
example, Fz signaling promotes Delta activity in future R3 photoreceptors and results in
activation of Notch in the future R4 photoreceptors [24, 25]. Thereby the Fz PCP pathway
establishes the proper chirality of each ommatidium, as well as the correct direction of rotation.
When Fz PCP signaling is disrupted in the eye, resulting phenotypes may include achiral, or
symmetric ommatidia, in which the R3 and R4 photoreceptors become either both R3 or both
R4, misrotation, in which the ommadia do not rotate the full 90o, and opposite chirality, in which
a ventral ommatidium adopts a dorsal chirality or vice versa.
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Figure 6.1 The Fz PCP pathway polarizes cells of the Drosophila wing and eye. In the wing
(left panel), Fz PCP core proteins localize to opposite ends of each cell, polarizing the cell. The
wing hair is produced at the distal end of the cell. In the eye (right panel), Fz PCP core proteins
localize to the apical membrane bordering the R3 and R4 cell precursors. This leads to the
specification of R3 and R4 cells and proper ommatidial rotation within each hemisphere of the
eye.
Project 1: Chmp1 may regulate Fz PCP signaling
Introduction: As a component of the ESCRT-III complex, Chmp1 is involved in the
regulation of many cellular signaling pathways and processes. Some Fz PCP core proteins
undergo endocytosis during signaling, so they may require the ESCRT machinery for proper
regulation of signaling [184]. When Fz PCP signaling is disrupted in the wing, classic PCP
phenotypes result (i.e., cells carrying multiple hairs, altered hair polarity). Therefore, to
determine whether Chmp1 regulates Fz PCP signaling, Chmp1 was knocked down and overexpressed in the wing. Indeed, Chmp1 knockdown and over-expression lead to defects in PCP,
suggesting that Chmp1 regulates Fz PCP signaling.
Methods: Fly crosses for Chmp1 knockdown and over-expression are described in
Chapter 4, Figures 4.3 and 4.18 respectively. To test for interactions between Chmp1 and Fz
PCP signaling components, Chmp1 was also knocked down in wings heterozygous for loss of
function alleles of Fz PCP Core genes, fz (fzP21), stbm (Vang1), and pk (pkpk-sple14). Wings from
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females with Chmp1 knockdown, and Chmp1 knockdown in a background heterozygous for loss
of function alleles of Fz PCP genes were mounted in GMM onto a glass slide and imaged with a
light microscope.
Results and Discussion: Ubiquitous knockdown of Chmp1 in the dorsal wing under the
control of the MS1096-Gal4 driver caused thickening of dorsal wing veins (Figures 4.3 and 4.7),
but gave no classical Fz PCP phenotypes, e.g., altered hair polarity or cells carrying multiple
hairs. However, localized Chmp1 knockdown caused Fz PCP phenotypes at the boundary of
Chmp1 knockdown and wild-type cells. Chmp1 knockdown in the posterior wing under the
control of the en-Gal4 driver caused the expected thickening of posterior wing veins (L4 and L5)
(Figures 4.4 and 6.2B). Additionally, wings cells carrying multiple hairs were observed adjacent
to the anteroposterior (AP) boundary of these wings, which was also the boundary of Chmp1
knockdown (Figure 6.2B). The wing hairs in this region adopted an anterior rather than a distal
hair polarity, while the wing hairs in the rest of the wing remained wild-type (Figure 6.2B).
When Chmp1 was knocked down with ptc-Gal4, which has both anterior and posterior
boundaries of expression (Figure 4.4), altered hair polarity and additional hairs were again
observed at the boundaries of Chmp1 knockdown and wild-type cells (Figure 6.2C). At the
anterior boundary of ptc-Gal4 expression wing hairs took on an anterior polarity, and at the
posterior boundary of ptc-Gal4 expression wing hairs adopted a posterior polarity. These results
indicate that the Fz PCP pathway may have been disrupted, and suggests a possible role for
Chmp1 in regulation of Fz PCP signaling. It seems that a gradient of Chmp1 activity was
required to disrupt wing hair patterning, as the phenotypes were only observed at the boundaries
of Chmp1 knockdown.
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The Fz PCP signaling pathway involves cell-to-cell signaling of asymmetrically localized
transmembrane proteins. A gradient of Chmp1 activity may have created a gradient of Fz PCP
Core protein activity, possibly due to reduced down-regulation of Fz through the MVB pathway,
which would alter cell-cell signaling of Fz PCP components. This could explain why the wing
hair defects were only observed at the boundary of knockdown in the wing. A boundary/gradient
of Chmp1 knockdown would not exist in the remaining wing, which kept a wild-type hair
polarity. If loss of Chmp1 activity cause retention of Fz PCP Core proteins in the limiting
membrane of the late endosome/MVB, it is possible that the localizations of Fz PCP Core
proteins could be changed.
When Chmp1 was knocked down in a localized pattern, wing hair polarity was reoriented
away from the Chmp1 knockdown region, suggesting that wing hairs point away from low
Chmp1 activity (Figure 6.2B and C). Interestingly, wing hairs point away from low Stbm and
towards low Fz activity, suggesting a possible role for Chmp1 in regulation of these proteins
[185, 186]. Specifically, Chmp1 knockdown might cause either low Stbm or enhanced Fz
activity.
To investigate a role for Chmp1 in Fz PCP further, Chmp1 was knocked down in wings
heterozygous for loss of function alleles of fz (fzP21), stbm (vangTBS42), and pk (pkpk-sple14). Wings
heterozygous for these Fz PCP loss of function alleles appear wild-type, apart from weak hair
polarity changes in the proximal part of the wing in vangTBS42 wings. As previously shown,
uniform knockdown of Chmp1 with MS1096-Gal4 caused thickened wing veins but no classic Fz
PCP phenotypes (Figure 4.7B). However, uniform knockdown of Chmp1 with MS1096-Gal4 in
vangTBS42 heterozygous wings caused hair polarity defects as well as multiple hairs (Figure
6.2D). In these wings the PCP defects were mostly observed around thickened wing veins, and
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reoriented hairs pointed away from the thickened wing veins. As wing hairs usually point away
from low levels of Stbm, this suggests that there is loss of Stbm activity in the thickened wing
veins compared to the intervein tissue. This effect was specific for Stbm, as uniform Chmp1
knockdown in fzP21 (MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; fzP21/+) or pkpk-sple14
(MS1096-Gal4; UAS-Chmp1RNAi-VDRC/pkpk-sple14) heterozygous wings did not cause any
significant PCP phenotypes.
An interaction with Stbm and not Fz was surprising, considering that Fz is endocytosed
and degraded during signaling, a process that should be affected by loss of ESCRT activity
[184]. The specificity of the phenotype to thickened wing veins could suggest that in a Chmp1
knockdown wing, vein cells are more sensitive to loss of Stbm activity than the remaining wing.
However, if loss of Chmp1 in the wing disrupts the role of the ESCRT-III complex in protein
degradation, then heightened Stbm activity due to decreased down-regulation might be expected.
Loss of Stbm activity is also possible though, as investigations with ESCRT components have
shown that the ESCRT complexes may both positively and negatively regulate signaling
pathways, depending upon the context of signaling [187]. More likely, these results suggest an
interaction between Stbm and DER signaling in wing development. Results from Chapter 4
indicated that Chmp1 may negatively regulate DER signaling, which is active in the wing vein.
Perhaps there is crosstalk between the DER and Fz PCP signaling pathways during wing
development. In fact, both DER and Notch signaling pathways interact with the Fz PCP
signaling pathway during eye development [24, 25, 133, 188].
Over-expression of Chmp1 also caused occasional wing hair phenotypes, including minor
hair polarity changes and additional wing hairs, which provides further support of a role for
Chmp1 in regulating Fz PCP signaling. Though a gradient of Chmp1 knockdown was required to
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cause wing hair defects, uniform Chmp1 over-expression on the dorsal wing with MS1096-Gal4
was sufficient to cause wing hair phenotypes (Figures 4.18 and 6.2A). The difference in vein
phenotypes observed from Chmp1 knockdown and over-expression suggest that loss of Chmp1
activity has different effects on cellular signaling pathways than Chmp1 over-expression. This
would mean that if Chmp1 knockdown phenotypes are due to faulty ESCRT function and
incomplete MVB generation, then the Chmp1 over-expression phenotypes may have a different
cause. Studies in cultured mammalian cells show that Chmp1 over-expression causes an increase
in phosphorylation, thus activity, of nuclear factors, such as ATM and p53, possibly through
Chmp1’s nuclear function [89, 90]. If Chmp1 has multiple distinct roles, then it is possible that
knockdown and over-expression disrupt different cellular processes. So it is possible that the
function of Drosophila Chmp1 is not limited to the ESCRT’s role in MVB formation, but there
might also be a nuclear function despite the fact that this study detected no nuclear localization.
It is also possible that Chmp1 over-expression has the opposite effect to loss of Chmp1,
in that the ESCRT complex becomes hyper-active when Chmp1 is over-expressed. This could
lead to different Chmp1 knockdown and over-expression phenotypes associated with its role in
regulating DER signaling, for example. However, both over-activity and loss of most Core PCP
proteins results in PCP phenotypes, e.g., extra hairs and altered hair polarity. Therefore the
opposite effects of Chmp1 knockdown and over-expression on ESCRT activity might result in
similar PCP phenotypes.
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Figure 6.2 Chmp1 may regulate Fz PCP signaling. Light micrographs of wings from adult
Drosophila females. Distal is right, anterior is uppermost. A. MS1096-Gal4/X; UAS-Chmp12/+, raised at 30oC. B. UAS-Chmp1RNAi-VDRC/ptc-Gal4, raised at 28oC. C. en-Gal4/UASChmp1RNAi-VDRC, raised at 30oC. D. MS1096-Gal4/X; vangTBS42/UAS-Chmp1RNAi-VDRC,
raised at 28oC. Panels to the right are higher magnification images of the boxed in regions of
the panels on the left. Red circles around cells carrying additional hairs. Red arrows indicate
altered hair polarity; blue arrows indicate wild-type hair polarity.
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Project 2: Expression of pk and sple in pupal wings
Introduction: One of the Core Fz PCP genes, prickle, encodes two protein isoforms that
are involved in PCP in the fly, Pk and Sple (Figure 6.3). The two isoforms are active in all
tissues studied [189]. However, loss of single isoforms affects different epithelial tissues in the
fly. Loss of Sple activity results in phenotypes in the eye, abdomen, and legs while loss of Pk
activity causes phenotypes in the thorax and wings [189]. Work from the Collier lab indicates
that in the wing both Pk and Sple are active but may be required for Fz PCP signaling at different
times during pupal wing development [190-192]. Specifically, Sple may be required for an early
signaling event at around 18 hours after pupal formation (hAPF), while Pk may be required for a
late signaling event at around 32hAPF [191, 193-195].

Figure 6.3 Genetic structure of the prickle gene. The pk gene expresses two transcripts
involved in Fz PCP, pkpk and pksple, which encode for the Pk and Sple protein isoforms,
respectively. Green boxes represent encoded exons, brown lines indicate splicing of exons. The
pk and sple transcripts share a large 3’ region, but contain different 5’ exons and have
independent promoters. Yellow arrows indicate the position of primers used to amplify
fragments of pk and sple cDNA.
If Pk and Sple are required at different time points during development, then this might
be reflected in the regulation of their expression, i.e., Sple would be expressed at the 18hAPF
time point, and Pk would be expressed at the 32hAPF time point. To test this hypothesis, the
presence of pk and sple mRNA was analyzed at these two time points in the developing fly wing.
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Methods: Wild-type flies were grown in large bottles. Developing flies were collected at
the pre-pupal stage and separated into two groups - one was aged for 18 hours and the other for
32 hours. At 18 or 32hAPF, the pupae were dissected from their pupal cases and the left and
right wings were removed. Immediately after dissection, the total mRNA was collected from the
pupal wings with a Qiagen QIAShredder kit. cDNA from the pupal wing mRNA was generated
by reverse transcription (RT) using the ImProm-II Reverse Transcription System (Promega) and
polyT primers (Invitrogen). The RT reaction was run at 37oC for one hour. Pk, Sple, and Actin
control cDNA generated from RT was PCR amplified using custom primers (Invitrogen) (Table
6.1 and Figure 6.3). The control RTPCR reaction omitted addition of reverse transcriptase.
Optimal annealing temperatures for pk, sple, and actin primers were determined by temperature
gradient PCR reactions using cDNA generated from embryo RNA extractions. The parameters
for the PCR reactions were as follows: an initial denaturing step at 94oC for 4 minutes, followed
by 35 cycles of denaturing at 94oC for 30 seconds, annealing at 55oC (pk) or 60oC (sple and
actin) for 30 seconds, and elongation at 72oC for 1 minute and 30 seconds. Control PCR
reactions omitted the addition of template. The PCR product was run on a 1.2% agarose gel for 1
hour at 120V and analyzed on a GelDoc system. PCR reactions were usually successful with as
little as two pupal wings from a single fly.

Table 6.1 Primers used to amplify pk, sple, and actin cDNA. Primers listed are 5’ to 3’.
Results and Discussion: Though amplification of a pk cDNA fragment was never
optimized it was detectable at both 18 and 32hAPF, as was sple (Figure 6.4). This suggested that
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the activity of Pk and Sple in Fz PCP signaling in the wing was not controlled by the expression
of each isoform at the level of mRNA and suggested that further studies (i.e. optimization of Pk
PCR or qPCR) were unnecessary. So it is likely that the activity of Pk and Sple are controlled in
ways other than at the level of transcription. For example, it is possible that the Pk and Sple
proteins are differentially degraded or stabilized at these time points during development. It is
also possible that there is translational control that differs at different time points. Additionally, it
is possible that expression of Pk and/or Sple is regulated by microRNAs with incomplete
complementarity to the mRNA transcripts, which would mean that translation of Pk and Sple
mRNA transcripts would be stalled and differences in expression may not be reflected in mRNA
levels [196]. It is also possible that Sple and Pk are both expressed throughout Fz PCP signaling,
but that the protein structure of Sple and Pk is altered by binding other proteins, or that they are
modified in a way that activates or deactivates them depending on the requirement for Fz PCP
signaling. In fact, there is evidence of Drosophila Pk phosphorylation, which is important for
localization and endosomal trafficking of Pk, as well as its prenylation in vivo, which is
important for its recruitment to the membrane and proteosomal degradation [197-199].
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Figure 6.4 Amplification of pk, sple, and actin cDNA fragments. PCR products were run on
a 1.2% gen containing ethidium bromide at 120V for 1 hour alongside a 1kb DNA ladder. A
and B are from pupal wings at18hAPF. C is from pupal wings at 32hAPF.
Project 3: Pk and Sple protein isoforms in patterning of the Drosophila eye
Introduction: Patterning of the fly cuticle requires the Fz PCP pathway. The polarity of
hairs may be considered as a ‘readout’ of Fz PCP signaling events that occurred during
development. As mentioned above, the two isoforms of the Prickle protein, Pk and Sple, are
active in the epithelial tissues of the fly, but loss of Pk causes PCP defects in some epithelial
tissues, while loss of Sple affects others [189]. This suggests that the Fz PCP pathway has a
differential requirement for Prickle isoforms depending upon the tissue. Unpublished studies
from the Collier lab suggest that in the fly cuticle, Pk and Sple actually have opposite effects on
the direction of (or the hair polarity established by) Fz PCP signaling. In fact, ubiquitous overexpression of pk or sple in flies mutant for pk and sple (pksple14) results in opposite hair
polarities over most of the cuticle. Though the eye develops in a different manner from the rest
of the cuticle, we wondered whether Pk and Sple had opposite effects on eye development as
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well. Specifically, that ommatidia in an eye expressing only Pk would have an opposite chirality
to ommatidia in an eye expressing only Sple.
Methods: pk or sple transcripts were over-expressed in a pksple14 background.
pksple14/pksple14; tub-Gal4/UAS-Sple flies over-express Sple ubiquitously under the control of
the tub-Gal4 driver in flies lacking active Pk and Sple. pksple14/pksple14, act5c-myc-pk flies
express myc-tagged Pk ubiquitously under the control of an actin promoter in flies lacking active
Pk and Sple. myc-Pk can rescue the pk- phenotype, suggesting that the myc tag does not inhibit
normal Pk activity. Eyes were prepared as described in Chapter 3, Section VIII.
Results and Discussion: Expression of Sple in pksple14 flies resulted in nearly wild-type
eyes (Figure 6.5C). The equator was easily identified and most ommatidia were of the correct
chirality and rotated properly. Occasionally symmetrical, or achiral, ommatidia were present.
Also, occasional ommatidia had the opposite chirality or misrotation; however these ommatidia
were uncommon (Figure 6.5C). This shows that the eye can develop almost normally in the
absence of the Pk isoform and ubiquitous expression of Sple, suggesting that the Sple isoform is
sufficient for eye development, which is consistent with other published work [189]. It also
suggests that the spatial or temporal control of Sple expression is not important.
Expression of Pk in pksple14 flies caused severe defects in eye patterning (Figure 6.5B).
The site of the equator was uncertain in these eyes. This means that large numbers of ommatidia
in each hemisphere of the eye had chirality opposite to wild-type, and appear to have rotated in
the opposite direction as wild-type. Additionally, ommatidia were present with incomplete
rotation. However, because the position of the equator was unknown in these eyes, making any
judgment about the numbers of ommatidia with opposite chirality from normal was difficult. In
order to obtain a more useful result, this experiment needs to be repeated with a marker of the
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equator. The best way forward may be to study the eye imaginal disc. The position of the equator
is known in the eye disc. If the developing photoreceptors are labeled, for example with an
antibody against the neuronal marker Elav, in combination with a marker for the R3 or R4, such
as the transgene E(spl)mdelta0.5lacZ, which marks the R4 with β–galactosidase expression, the
chirality and rotation of ommatidia in each half of the eye can be compared more reliably.

Figure 6.5 Pk and Sple in Fz PCP signaling in the Drosophila eye. Light micrographs of one
micron thick tangential sections of the Drosophila eye with cartoon interpretation below.
Dorsal-type ommatidia are indicated in purple, ventral-type ommatidia are indicated in blue,
achiral ommatidia in red. A. Oregon R. B. act5c-myc-pk, pksple14/pksple14. C.
pksple14/pksple14; tub-Gal4/UAS-sple.
Project 4: Localization of the Sple isoform in pupal wing cells
Introduction: In the Drosophila wing, Fz, Dsh, Dgo, and Fmi localize to the distal edge of
developing wing cells, while Pk, Stan, and Fmi localize to the proximal edge. As previously
mentioned, the Core Fz PCP protein, Prickle is expressed as two isoforms relevant for PCP, Pk
and Sple. It is well documented that the localization of Fz PCP Core proteins is crucial for proper
Fz PCP signaling. However, while the localization of the Pk isoform has been characterized,
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Sple localization remained uninvestigated. Though Sple is known to have some activity in Fz
PCP signaling in the wing, its function is poorly understood [189]. Work from the Collier lab
suggests an early requirement for Sple in Fz PCP signaling [190]. Determining the subcellular
localization of Sple, will provide more information on its function.
Methods: One problem in visualizing the subcellular localization of membrane proteins is
that when the protein localizes to a cell-cell boundary, it is not normally possible to know
whether it is present in just one cell or both. Expression clones can overcome this problem
because they allow for visualization of all edges (anterior, posterior, proximal, and distal) of
clone cells that are adjacent to cells that do not express the protein. To investigate the
localization of Sple, clones expressing Sple tagged with an N-terminal myc epitope (myc-Sple)
were generated. The myc-Sple protein could rescue loss of Sple activity (sple1), suggesting that it
was active and the myc tag did not inhibit its function. The localization of myc-Sple was
investigated in wings lacking Pk activity (a pk30 mutant).
Clones of myc-Sple were induced in a pk30 background (see Chapter 1 section 2D and 2E
for information on generating clones). To achieve this, an act>STOP>myc-sple fly line was
used. This fly line carries a myc-sple transgene that is downstream of an Actin promoter, but
separated from the promoter by a polyA stop sequence flanked by two FRT sites (>). hs-flp; pk30
virgin females were crossed to pk30, act>STOP>myc-sple males. The F1 generation was heat
shocked at 37oC for one hour at 4-5 days (120-144 hours) into development to induce Flippase
(Flp) expression and removal of the PolyA stop sequence in a subset of cells. First, female
larvae, identified by their genitalia (hs-flp/X; pk30, act>STOP>myc-sple/pk30), were collected and
wing imaginal discs were dissected and fixed (for method, see Chapter 3 section VI) to ensure
that clones were being generated. Clones were identified as small groups of cells within the
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imaginal disc that exhibited localization of myc-Sple to the membrane as detected with an antimyc antibody. Next, female pre-pupa from the same cross were collected and aged for 32 hours.
After aging, each pupa was removed from its pupal case. The posterior and anterior ends of the
pupae were cut with forceps to allow for fixative penetration, and the insides of the pupae were
washed out with 1X PBS. The pupae were then immediately transferred to a fixative solution
(8% paraformaldehyde, 200mM sodium cacodylate, 100mM sucrose, 40mM potassium acetate,
10mM EGTA), where the wings were dissected off and the pupal sacs removed. The wings were
rinsed in 0.01% PBS-TritonX (PBST) and blocked in 5% BSA in 0.01% PBS-TritonX (BSAPBST) for 20 minutes. They were then incubated with an anti-c-myc antibody (1:500, diluted in
BSA-PBST) at 4oC overnight. The primary antibody was removed and the pupal wings were
rinsed 3 times and washed 3 times for 10 minutes each in PBST. Wings were blocked again for
20 minutes in BSA-PBST, followed by incubation with an anti-mouse Alexa-488 antibody
(1:500, diluted in BSA-PBST) for 3 hours protected from light. The pupal wings were rinsed 3
times and washed 3 times for 10 minutes each in PBST. The wings were incubated in rhodamine
phalloidin (1:100, diluted in PBST) for 30 minutes. They were then rinsed 3 times and washed 3
times for 10 minutes each in PBST at room temperature and finally mounted on a glass
microscope slide in Vectashield mounting media with DAPI. Wings were imaged on a confocal
microscope.
Results and Discussion: myc-Sple localized to the opposite edge of the cell as the wing
hair. This is likely the same localization as Pk, and opposite of the expected localization of Fz,
although this has never been tested in these wings [197]. This is consistent with a recent study
showing that Sple localized to the opposite edge of the cell as the wing hair [197]. The similar
localizations of Pk and Sple with respect to hair formation show that the difference in Pk and
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Sple function may not be due to different localizations. sple over-expression reverses hair
polarity in the wing, i.e., hairs point proximally, rather than distally. It could be that Sple
localizes proximally like Pk, and so directs hair formation to the proximal edge of the cell.
Alternatively, a distal Sple localization could drive a proximal site of hair formation. These
results support the latter, as Sple localized opposite to the site of hair formation. These results
suggest that the relationship between the site of hair formation and localization is the same for Pk
and Sple. However, Pk and Sple may very well have different localizations with respect to Fz
localization.
The results above (Project 2) showed that pk and sple transcripts are both detected during
the two Fz signaling events, suggesting that their activity in Fz PCP signaling is not regulated by
their transcription. Instead, the functional differences may lie in binding partners or
modifications. The Pk and Sple proteins are identical in amino acid sequence, except in the Nterminal regions. Pk has 13 N-terminal amino acids that are not critical to its function. On the
other hand, the Sple protein has a large N-terminal region that appears to be almost entirely
unique, with the exception of a small (30 amino acid) region that is shared with other arthropods,
but not with vertebrates. This region may facilitate interaction with proteins with which Pk does
not interact. Alternatively, it could inhibit interaction with proteins with which Pk binds. Another
possibility is that Sple is needed to form and localize protein complexes important in controlling
the direction of Fz PCP signaling. If Sple does bind proteins that Pk does not, these binding
partners may modify the Sple structure to change its function. A useful future study for
investigating Sple function would be to identify proteins that the N-terminal region binds in
Drosophila cells. This would help characterize the function of Sple in Fz PCP signaling.
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Figure 6.6 Sple localization in the Drosophila pupal wing. A clone expressing myc-Sple in
the posterior wing of a female of the genotype hs-flp/X; pk30, act>STOP>myc-sple/pk30. Max
projections of confocal Z-series. A. Detection of myc-Sple (green) with anti-myc. White arrows
show localization to the edge of the cell. B. The prehairs are composed of Actin, which was
detected with rhodamine phalloidin. C. Merge of A and B, showing localization of myc-Sple to
the opposite edge of the cell as the prehair.
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